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Abstract 
The Switch Drug Phenomenon
A  Phenomenological Inquiry into the Role of Nicotine 
Replacement Therapy in Smoking Cessation Behaviour
Roger Sherlock BSc Mgmt.
This thesis sets out to explore consumers’ health behaviour in an era o f increased 
consumer autonomy w ith the emergence o f a new category o f drugs; those that have 
‘switched’ from  prescription (Rx) control to over-the-counter (OTC) availability. 
The switching o f drugs presents an opportunity fo r consumer researchers to explore 
preventive health behaviour and the move to more self-medication practices by 
consumers.
N icotine replacement therapy (NRT), to help those who wish to stop smoking, has 
been one o f the most high profile switches in  recent years. Smoking is a major 
health issue worldwide but research remains dominated by the medical community. 
NRT as an OTC requires researchers to adopt a consumer orientation yet research 
has been lacking on OTCs generally and consumer behaviour in  particular.
This study examines the role that NRT plays in  the preventive health behaviour o f 
consumers quitting smoking through in-depth phenomenological interviews. As a 
paradigm and methodology Existential-phenomenology places the consumer at the 
centre-stage o f the inquiry, recognising the importance o f experience as a method to 
gain understanding o f a chosen phenomenon. This paradigm, in line w ith  many 
others in the fie ld  o f interpretative research, recognises that the consumer o f the 
nineteen nineties is qualitatively different from  our earlier understanding.
The results are presented as themes that emerged from  the interpretation o f the 
phenomenological interviews and aim to capture the meanings that consumers hold 
in  relation to NRT, as an OTC. The themes are framed from  two case studies; 
detailed presentations o f the consumption stories o f two respondents. The themes 
are reflective o f the consumer’s meaning categories and uncover many salient 
aspects, not previously indicated in  the literature.
F inally, the conclusions and implications fo r switch drugs and health care are 
presented w ith some recommendations fo r further research on this emerging area.
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Chapter One.
New Approaches to the Health Care Consumer.
1.1 Introduction.
The objective of this study is to examine consumers’ experiences of using 
Nicotine Replacement Therapies (NRTs) when attempting to quit smoking, with 
the aim of uncovering the meanings associated with this phenomenon. While the 
area of smoking has received much attention from many disciplines, smoking 
cessation research has remained the preserve of the medical specialist. Few 
consumer researchers have focused on health behaviour generally and smoking 
cessation in particular.
However, particular imperatives to address such cessation behaviour exist with 
the advent of a range of products, available without the normal restrictions 
associated with prescription drugs. Termed switch drugs, because of their status 
moving from prescription status (Rx) to over-the-counter status (OTC); this 
category of drugs enhances the autonomy of the consumer in their purchase and 
use.
As a result there is a need to adopt a new approach to researching the role that 
such products play in the consumers health behaviour repertoire. In this regard, 
this study aims to uncover the meanings that consumers associate with the use of 
NRT in their smoking cessation attempts. Qualitative methods have typically 
been used to investigate such consumer meanings; the specific qualitative 
approach to be adopted here will follow the parameters of interpretative inquiry
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methods, reflecting the desire to establish meanings, rather than enhance 
explanation or aid prediction. In addition, it is felt that utilising consumers’ 
experience, often a neglected source for research, will provide the best route to 
uncover the meanings associated with the use of NRT. A further feature to this 
thesis will be an emphasis on the meanings that consumers ascribe to health 
behaviours and related products rather than those suggested or imposed by either 
professional or commercial agencies.
1.2 Overview.
Chapter two attempts to locate a theoretical home for this thesis. Two possible 
areas are located in the literature. The first establishes NRT as an instance of a 
broader trend of self-care and self-medication. The second positions NRT usage 
in the broader domain of preventive health behaviours. In this light it shares 
common features with dieting, exercise, and check ups. The range of 
characteristics associated with such health behaviours will be examined with 
particular reference to NRT. Chapter three is in a more descriptive vein and 
looks at the wider context of the pharmaceutical market and the emergence of 
switch drugs. In particular, the evolution of NRT as an OTC and the dynamics of 
the Irish smoking cessation market are examined.
Following this, chapter four details the methodology used to uncover the 
meanings associated with the use of NRT by consumers attempting to stop 
smoking. The focus on consumers’ experience as a source of the meanings 
entails the use of existential-phenomenology as a paradigm and methodology.
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The philosophical tenets of this approach are explored in the context of the 
broader interpretive paradigm and are followed by an examination of 
hermeneutics; both the philosophy and the method used to analyse the 
experiences of the respondents surveyed.
Chapter five presents the findings in terms of themes that emerged through the 
analysis of the texts of the interviews conducted. Two case studies are presented 
to illustrate the characteristics of the respondents’ experiences and to provide the 
categories of the themes that emerged. The themes are then examined in respect 
of the current theoretical knowledge, leading to conclusions on the areas of self- 
care and preventive health behaviour.
The final chapter assesses the implications for health care, health professionals, 
and the OTC industry. Also the contribution of this type of research to health 
care is assessed, with suggestions for further research.
1.3 New approaches to the Health Care Consumer in Consumer 
Research.
Approaching the end of the century, consumer research, in line with many other 
disciplines, is grappling with many fundamental issues on the nature, scope and 
orientation of its endeavours. Much of this soul-searching has been at ontological 
and epistemological levels, reflecting a deep-felt need to return to basics and 
perhaps supersede its earlier role as provider of functional market information. 
The primary force behind the evolution of the marketing discipline was the focus 
on the profitability of the commercial enterprise engaged in marketing; in
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essence an orientation to explore issues from the viewpoint of the producer. 
Later, throughout the sixties and seventies, the focus moved to a more 
psychological or behavioural one; the era of motivational research. While the 
consumer as an individual received much greater attention as a result of 
increasing power and vocality, the emphasis remained on sales, profit, and more 
generally, ‘buying’ behaviour. A persistent trend throughout this era was the 
emphasis on attaining scientific credibility and the academic legitimacy it 
confers, with avoidance of the less commercial aspects, loosely termed ‘art’. The 
heels of the marketing discipline have been firmly dug into a rigid positivistic 
framework, albeit that the notion of marketing as a science has been shown to be 
unattainable (Brown, 1996).
For consumer research in particular, the debate over the past two decades has 
mirrored the broader debate in the marketing discipline. The debate, albeit with 
varying terminology, has revolved around ways of seeking knowledge and has 
been polarised as positivistic/neopositivistic versus interpretive, details of which 
will be explored in chapter four.
Behind this philosophical debate, there has been, at a wider ideological level, a 
challenging of the concept of what constitutes the consumer. Previously viewed 
as the passive recipient of marketing effort at the end of the production- 
consumption span (the ‘end consumer’), current thinking sees the consumer as 
an active, central player in the consumption game (see Holbrook and Hirschman, 
1982; Hirschman and Holbrook, 1982). The use of goods, and for that matter art 
and entertainment, has become an integral part of the human condition and the
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traditional hierarchy between marketing forces and the public has become 
blurred.
Described as the postmodern condition, this much misunderstood and maligned 
perspective attempts to capture the meaning of consumers and consumption at 
the end of the twentieth century. Originating in art and architecture, 
postmodernism has received attention in a variety of disciplines (psychology, 
anthropology, sociology, and media studies) but little from mainstream 
consumer research. An often frustrating aspect of the literature on postmodernity 
is the lack of clear definitions and boundaries, the use of ambiguity, and the 
sometimes irreverent treatment of any conventional inquiry making it hard to 
grasp and difficult to apply. However those at the forefront of consumer research 
have begun to use the postmodern condition as the canvas to explore consumer 
behaviour, through a range of paradigms and methodologies, although frequently 
not overtly alluding to a postmodern dimension.
While postmodernity has received extensive philosophical treatment (see Firat 
and Venkatesh, 1995), it is best illustrated by the emergence of many 
postmodern aspects in the marketplace, principally through marketing practice. 
Marketing and consumption have entered every aspect of western life and 
culture; advertising campaigns have entered the popular consciousness 
(Guinness’ ‘anticipation’ campaign), and have taken on the role of mini-soap 
operas (Gold Blend coffee). Others have incorporated the use of parody 
(Boddington’s ale, Nike-style), and self-referential market research ‘speak’ 
(Guinness’ ‘didn’t you see a oak tree tossing in a maelstrom in your Guinness?’).
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The above examples also demonstrate the pastiche, chronology and fragmented 
nature associated with postmodemity. Perhaps the clearest manifestation is the 
existence of hyperreality, where what is now seen as authentic is, in fact, a 
simulation (real ale and beer, Disney, real Irish bars). Postmodernists revel in the 
playful, inverted way that the traditional hierarchies and orthodxies are tackled 
(low culture, pop art) and a belief that ‘anything goes’. This has led to pluralism 
in thinking and approach.
These new meanings of the consumer and role that consumption plays in 
ordinary life require different approaches to the examination of consumption. 
Firat states that the new postmodern consumer is qualitatively different to the 
consumer of the past (Firat, 1991), with each ‘act’ of consumption presenting the 
possibility of representing a different image for the consumer. For example, the 
consumption of a car can represent an image of charming, efficient, risk-taker, 
family-orientated, each possible in a different context. As a result, this 
alternative view of consumption can be viewed as having emancipatory potential 
(Firat and Venkatesh, 1995).
Consumer researchers have been described as either deliberately or inadvertently 
addressing the presence of postmodernism (Brown, 1995) and it is undeniable 
that a type of pluralism exists in the approaches adopted since the mid-eighties. 
An example of this pluralism, without implicit mention of postmodernism is 
Murray and Ozanne’s (1991) perceptual map of the different approaches 
available to seeking knowledge in consumer research. Their map focuses on the 
two axes of subjective/objective and conflict/order, but does not incorporate or
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allude to any postmodern dimension. Another more explicitly postmodern 
example is the manner in which many researchers are approaching consumption 
as text or narrative where the meanings of an act of consumption are not fixed by 
the producer or marketer, but negotiated by the consumer and may be more 
idiosyncratic.
The implications for consumer health-care research are particularly significant. 
The move towards the patient becoming a consumer and using products in their 
health-care reflects the move away from the traditional hierarchy of the 
doctor/provider-patient relationship, the decrease in the focus on science or drug 
technology to solve problems, and the fragmentation of markets to more 
individually tailored treatments. In all, the trend towards self-medication can be 
viewed as a microcosm of the postmodern condition.
With the exception of Robin Gregg’s (1995) interpretation of women’s 
paradoxical experiences of pregnancy in a high-tech age, Gould’s exploration of 
allergy sufferers (Gould, Considine, and Oakes, 1993) and Reimen’s 
phenomenology of the caring interaction for patients with nursing (Reimen, 
1998), health-care research has remained dominated not only by the 
scientific/medical community, but by positivistic paradigms. Consumer research 
has been slow to explore health-care generally, but it appears to be increasing in 
importance, with self-care identified as a ‘mega-trend’ for the coming century. 
Efforts, such as Moorman and Matulich’s (1993), to examine consumers’ 
preventive health behaviour, do not fully address the use or consumption of 
products as a part of self-care nor do they allow for the individual, often
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paradoxical, nature of consumers’ health-care. Also, the emphasis remains on the 
health care system and structures rather than on the personal aspects of the 
individuals’ health regime.
Given that the nature of much of the research reflecting the postmodern 
condition revolves around the more contemporary, mainstream, even fashionable 
aspects of consumption (advertising, jeans, the Disney experience), it is not easy 
to see its usefulness for health-care research. At first sight health care products 
may seem an unpromising area for postmodern analysis. However OTCs may 
prove an exception. Marketing for this product class utilises all the features of 
mainstream marketing activity, for example advertising and branding. So 
arguably OTCs’ ‘emancipatory potential’ may thus promote consumer 
autonomy.
Approaching this study of the use of nicotine replacement therapy (NRT) to quit 
smoking, it is necessary to focus on the consumer’s individual experience of 
using NRT. Giving voice to the consumer, through a phenomenological 
exploration, recognises a need to focus research away from the hierarchical 
medical domain to the real producer of meaning, the consumer. It is through the 
examination of consumers’ experience that we can better understand their self- 
care, preventive health care behaviour, and the associated meanings of NRT.
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Self Care and Consumers’ Preventive Health Behaviour.
2.1 Introduction.
As outlined in chapter one, this chapter will follow two broad theoretical 
sections. The first section situates NRT in the wider stream of literature focusing 
on the move from professional to self-care and increasing self-medication. The 
second positions NRT consumption in the related literature dealing with 
preventive health behaviours in general. There is a considerable corpus of 
research dealing with such behaviours, from dietary care to health check-ups, 
and their correlates. The components or characteristics of consumer preventive 
health behaviour are examined with special focus on smoking cessation. It will 
be argued that there is a need to explore this particular preventive health 
behaviour with emphasis on the products involved. It is only through the use of 
such products that a better understanding of the meanings of the behaviour itself 
can be achieved. Also it is argued that, to achieve such an understanding, it is 
necessary to adopt a consumer-centred approach.
2.2 The Emergence of Self-Care as a ‘Megatrend’.
Consumers are increasingly calling for control over their own health and have 
more confidence in asking for advice and in deciding on action to be taken 
outside the traditional health care structures, such as visits to the doctor. What is 
deemed to be ‘alternative medicine’, by the medical community at least, is 
becoming the norm in the minds of many consumers who wish to enhance their
Chapter Two.
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health; acupuncture, reflexology, and hypnosis are used to alleviate or treat a 
range of ‘medical’ symptoms, including smoking cessation, or to enhance health 
generally.
The use of medicines, available without prescription, over-the-counter (OTC) in 
pharmacies or in the supermarket is increasing rapidly. Apart from the more 
familiar headache or stomach upset remedies, the OTC market now includes a 
range of more medically sophisticated products such as home cholesterol testing 
kits, diet aids, vitamins, and heartburn drugs. The move towards self-medication 
has been identified as a ‘megatrend’ for the coming century (Nasbitt, 1990). This 
trend reflects a desire by governments to contain the health care costs associated 
with prescribing medicines through the deregulation of prescription drugs, and 
also an acceptance by health care professionals of the rise of a consumer with the 
ability and desire to look after their health.
2.3 Consumer Research Issues for Switch Drugs.
Given the enormous effort being directed at switching prescription drugs to OTC 
by the pharmaceutical industry, there is and has been little academic research on 
the area. Research in the pharmaceutical sector has focused primarily on the 
prescription drug market with emphasis on topics such as labelling and risk 
disclosure (Morris and Kanouse, 1981; Morris, Ruffner and Klimberg, 1985), 
generic drugs (Kendall, Ug, and Schoner, 1991), and direct-to-consumer 
advertising of prescription drugs (Morris, Mazis and Brinberg, 1989). Some 
research has addressed switch drugs directly or indirectly (Kotzan, Carroll, Perri,
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and Fincham, 1987; Branstad, Kamil, Lilja, and Sjoblom, 1994; Gould et al.,
1993) but the majority of research has been on OTCs (Lumpkin, Strutton, Lim, 
and Lowrey, 1989; Synder, 1995; Kline & Co., 1996). The lack of focus on 
switch drugs and the rationale for this study is best articulated by Hoy (1994, pp. 
94.);
Although a variety of arguments substantiate the opportunity for switch 
drugs, actual attempts to survey consumer sentiment regarding this issue 
is lacking ... Further research is needed to examine self-care as a form of 
consumer behaviour.
Hoy goes on to comprehensively list the research issues for switch drugs 
generally and this serves as a template for evaluating the research to date and 
possible future research efforts. The implications of the switch to OTC status 
depend on the particular type of drug but typically involve four key areas; health 
and safety, economic, marketing, and consumer behaviour (Hoy, 1994).
Health and safety considerations are twofold. First, increasing OTC availability 
may encourage greater self-diagnosis, which in turn may be incorrect. Second, 
the OTC selected may be either inappropriate or improperly administered. The 
parties most at risk in this regard are children and the elderly.
A key economic consideration is that, while switch drugs and OTCs are typically 
less expensive, they are not usually covered by either State or private medical 
schemes. This contrasts with many heavily used prescription drugs where all the 
associated costs are paid for by state medical schemes. Again the younger and
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older members of society are most vulnerable, as they are more likely to be 
dependent on such state schemes than other groups.
From a marketing viewpoint the control of all promotional activity differentiates 
prescription drugs from OTC drugs. Direct to consumer advertising for 
prescription drugs has become a feature in the USA but this has not impacted on 
Europe. However, OTC drugs benefit from somewhat more relaxed promotional 
regulations, with the benefit of greater awareness at a consumer level through 
media advertising. In essence a switch drug will utilise the media and 
promotional tools associated with OTC drugs, most important of these are the 
use of labelling, leaflets, in-store point-of-sale and media advertising.
A summary of the consumer behaviour issues across switch, (Rx) and OTC 
drugs are in Table 2.1, below. Product image is critical when a drug alters status. 
In the same way as a generic drug can be perceived as inferior and less 
efficacious than a branded prescription drug, the switch to OTC status may 
create perceptions that the OTC ‘version’ is somehow diluted. The positioning of 
a drug as being ‘prescription strength’ can either enhance its view as being more 
efficacious or conversely be perceived as too high risk to be used without 
medical supervision. Also it may be perceived as the weaker version of the 
prescription drug in OTC format or, without exploiting its prescription heritage, 
it may be viewed as ‘just’ another OTC.
Most importantly from a consumer behaviour viewpoint, the influence on choice 
of switch drugs is strongly associated with recommendation and word-of-mouth
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of family, friends, doctors, and pharmacists. In the case of prescription drugs no 
such word-of-mouth dynamic operates to any significant degree.
Table 2.1 Consumer Behaviour Considerations For switch Drugs.
Similarities of A Switch Drug & Rx Similarities of  A Switch Drug & PTC.
Awareness of physical symptoms 
requiring medical attention.
Requires a propensity to engage in self- 
care behaviour.
Requires awareness of product 
availability.
Consumers have control over which 
brand they chose.
Younger consumers more likely to use.
Cthers may recommend product/brand 
usage.
Differences of A Switch Drug & Rx. Differences of A Switch Drug & PTC.
May not be used as heavily by older
consumers as Rx.
May be perceived as riskier than existing 
PTC if positioned as ‘prescription 
strength’.
May not be perceived as efficacious as 
Rx.
May be perceived as more efficacious if 
positioned as ‘prescription strength’.
May not be perceived as risky as Rx if 
positioned as now being available PTC.
Source: Hoy, 1994.
In addition to the consumer behaviour dimensions above, Hoy sets out a number 
of research questions associated with switch drugs which clearly place research 
on this topic within the broader area of preventive health behaviour;
• What would motivate consumers to use switch drugs?
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• How might consumer’s health care change with the availability of switch 
drugs?
• What is the domain of self-care as a form of consumer behaviour? What are 
the implications for public policy?
• How extensive is the consumer demand for switch drugs?
• How does word-of-mouth communication effect the motivation to use OTC 
products?
• What is the influence of word-of-mouth communication on OTC product or 
brand choice? What are the ramifications for switch drugs?
While such observations are tantalising to the potential researcher, they give 
little empirical direction; however they do provide a framework in which to 
explore the use of switch drugs, particularly in the context of preventive health 
behaviour research.
2.4 Consumer Research on Switch and OTC Drugs.
This section broadens the discussion by examining switch drugs under the 
general heading of OTCs of which they are a subset. The justification for so 
doing is that many of the issues pertaining to OTCs seem applicable to the more 
specific case of NRTs.
In summary OTC consumers tend to be women, younger, married with children 
and have high levels of education, income, and ‘consumer sophistication’ (Hoy,
1994). These demographic indicators are quite in line with the findings on 
preventive health behaviour. US research on buying decisions reflects a similar
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profile of the OTC consumer but includes additional data on the most important 
factors used in OTC purchasing decisions, detailed in Table 2.2, below. This 
mail survey of 500 adult consumers asked the respondents to list the factors they 
considered important when purchasing an OTC. While the pharmacist is clearly 
the most important factor in the purchase of OTCs, age, income, and education 
were significant moderating variables mediating the relative importance of the 
pharmacist and indeed of most of the remaining five influences (Kline & Co., 
1996).
Younger consumers (30 or less) were less likely to consult the pharmacist, 
relying on recommendation by family or friends, and were more likely to read 
about a product in advance, and purchase it for themselves. Middle aged 
consumers did not seek recommendation from friends or family but relied on the 
pharmacist, and were normally purchasing for their family. Both the above 
groups will seek the doctor’s recommendation, but only half as much as the older 
(60+) age group. This age group mainly relies on the pharmacist’s 
recommendation and they do not seek the advice of others to the same degree.
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Table 2.2 Factors in OTC Purchasing decisions by Age (%).
All respondents under 30 30-59 60+
Factor receiving 
mention
Ask pharmacist 61 44 60 70
Read Package 52 63 58 41
Repeat Purchase 41 53 38 40
Ask Doctor 33 25 25 50
Advertised 15 13 15 15
Family/ Friend 12 29 11 7
Source: Kline & Co., 1996.
The higher the level of education, the greater the propensity to use labelling 
information, in line with Moorman’s finding on preventive health behaviour 
(Moorman, 1990, see below). Higher levels of education also correlated with 
greater use of word-of-mouth recommendation from family and friends (Kline & 
Co., 1996). In contrast, those with a lower level of education showed greater 
reliance on advertised brands, using coupons or buying the sale brand. In general 
this end of the educational spectrum utilise the pharmacist and doctor to a greater 
degree.
Income demonstrated little influence on OTC buying decisions, apart from less 
reliance on the doctor by higher earners; the opposite for lower earners, with a 
further lower likelihood of utilising labelling. Again this is reflected in findings 
on the peripheral role of income in the preventive health behaviour literature, 
discussed below.
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While these findings relate to OTCs in general, not to switch drugs in particular, 
limited research does suggest that younger, more educated, wealthy consumers 
also purchased switched OTCs (Kotzan et al., 1987; Leibowitz, 1989). However 
caution is needed in assuming such data to be indicative of switch drug 
consumers in general; research of such product switches to OTC status is at an 
embryonic stage. As a consequence, such switch drugs can be seen to be at the 
early stages of the product life cycle, and consumers may hail primarily from 
highly innovative and unrepresentative subsets of the population.
A single, cue-based longitudinal study of the users and their information sources 
for the switch of topical hydrocortisone (HC) skin ointments in Sweden provides 
some insights into the evolution of consumer behaviour when a prescription drug 
moves to OTC status (Branstad et al., 1994). This study examined users at four 
points in time; the first prior to switching to OTC status from prescription status 
in 1983, and at three other intervals after its launch over a six year span, through 
to 1989. Comparisons were made between consumers still receiving HC 
ointment on prescription (PHC group), and those purchasing it OTC (OTC 
group) through questionnaires administered in pharmacies. Respondents were 
asked about their sources of information on the switch to OTC status, as well as 
their attitudes towards the switch process itself. Results are reproduced in table 
2.3 below, highlighting those who purchased the OTC version of the drug in 
question.
Results for user characteristics illustrated two significant trends. First, the OTC 
group was younger than the PHC group at all stages and indeed younger than
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any other drug user groups in comparative drug studies. The average age of 
prescription purchasers became older as the study progressed, suggesting a 
contracting group of loyal customers. Second, those with a university education 
featured strongly at point two (42%), decreasing to 20% at point three. This 
reflected the expected profile of innovators who would typically have higher 
levels of education.
Initially the source of information on the availability of HC ointment OTC came 
from journal articles, such as health reports, reflecting the type of sophisticated 
media usage by this group. In regard to the PHC group, the initial source of 
information was medical journal articles, with 83% aware of the change in 
status, however over time the doctor became a very important information 
source, although they did not purchase the OTC product. Again this reflects a 
strong loyalty to the doctor and the importance of the prescription,
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Table 2.3 Information Sources About OTC Preparation Availability - OTC 
Group (%).
One Month After 
the Switch. 
(Time Point 2)
9 Months After. 
(Time Point 3)
6 Years After. 
(Time Point 4)
Information Source
Doctor 14 21 12
Nurse 5 16 27
Pharmacy 4 16 35
Journal article 56 20 5
Journal adverts 19 11 3
Other 2 16 15
Total 100% 100% 100%
Population size 100 104 100
Source: Branstad et al., 1994.
2.5 The Role of the Health Professional.
What appears to be significant for OTCs generally and switch drugs in particular 
is the role the doctor can play. An important role for the doctor is prescribing 
medicines, however this role is likely to be altered with the advent of OTC 
medicines that do not require a prescription from the doctor. Traditionally there 
has been little focus on the doctor’s role in relation to OTCs, but the imperative 
to research this area in the light of the increase in switches has been recognised 
(Snyder, 1995). Two studies have sought to examine this development. In the 
first, almost ten percent of all drugs ‘prescribed’ were OTCs (Snyder, 1995); in 
these cases the doctor actually wrote down the recommended OTC in the same
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manner as he/she would write a prescription. In the second when doctors 
recommend as opposed to prescribing an OTC medication, 26% of the time it is 
in verbal form only, 10% in written form only, and 64% both written and verbal 
(PAGB, 1996). Therefore in 74% of cases what is virtually the equivalent of a 
prescription is written. Interestingly not all visits to a doctor’s surgery are as 
prescription oriented as past literature has suggested. However the proportion 
still remains high, with 56% of patients expect a prescription prior to their visit, 
and 24% intend to buy an OTC product after their visit. Of those expecting a 
prescription but not receiving one, half planned to self-medicate in some form as 
a result (Rappoport, 1976).
In the case of NRT, research has demonstrated that, while on prescription, only 
20 percent of prescriptions were issued on the initiative of the doctor, the 
remaining 80 percent were on the initiative of the patient, with the patient asking 
the doctor to prescribe (Urde, 1994). The position in Ireland was quite similar. 
Niconil, in evaluating the market potential prior to launch, found that little time 
or attention was spent by doctors counselling their patients about smoking 
cessation, principally as it wasn’t in any way lucrative and met with resistance 
from most patients. In all, fewer than 15 percent of doctors recommended formal 
counselling or drug therapy including NRT (Irish Marketing Surveys, 1993). 
However, even for the fifteen percent of doctors who did broach smoking 
cessation with their patients, the actual request to prescribe came from the 
patients themselves and not from the doctor.
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The meaning of a prescription can refer to the written order to the pharmacist 
from the doctor, the end product itself, or the directions attached to a drug. There 
are a number of apparent functions the prescription serves such as a method of 
therapy, a legal document or a means of communication (Smith, 1989). At 
another level it has been suggested by Pellegrino that there are many latent 
functions of the prescription, interacting at three levels of symbolism. The three 
levels are the ingestion of the drug, the legitimisation of illness and therefore the 
enhancement of the prescription, and the symbolism inherent in the act of 
prescribing by the doctor (Pellegrino, 1976). A summary by Smith of 
Pellegrino’s work is contained in Table 2.4 below.
Table 2.4 Latent Functions of the Prescription.
Visible sign of the doctor’s 
power to heal.
Fits the concept of modern 
man that he can control his 
own destiny.
Means of patient goal 
attainment.
Symbol of the power of 
modern technology.
Means of communication 
between doctor & patient.
Excuse for failure.
Concrete expression that 
the doctor has fulfilled his 
contract.
Symbol of patient control. Expression of doctor’s 
control.
Source: Smith, M., 1989.
OTCs are often viewed as a great opportunity for pharmacists, with research 
demonstrating that consumers utilise the pharmacist for information and 
recommendation, often in place of the doctor (Branstad et al., 1994; Kline & Co.,
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1996). It is worth noting that there can be a discrepancy between consumers 
citing the pharmacist, for example, as an information source but not utilising this 
source at the time of purchase. Further research in this area has highlighted that 
80% + of OTC purchases are stimulated by verbal demand from the consumer. 
In only six percent of OTC purchases did the consumer ask for and receive 
information from the pharmacist. Typically it is the pharmacist’s assistant who 
provides the information when it is asked for (Kotzan et al., 1987).
This trend to take control of one’s health through self-care also reflects an 
orientation towards prevention rather than cure. It is this shift towards prevention 
as well as the adoption of the concept of an active, autonomous consumer, rather 
than a passive patient in health care generally that has begun to impact on health 
care research. While NRT and its switch to OTC status is an example of self- 
care, as an ingredient of smoking cessation it can be viewed as one of a range of 
preventive health behaviours along with taking exercise and dieting. The 
following section provides an overview of the literature on this emerging area of 
consumer behaviour.
2.6 The Development of Consumer Health Behaviour Research.
The evolution of consumer health behaviour research has mirrored a pattern in 
the wider area of management and consumer behaviour research, albeit at a 
slower pace. In the management context, attention has shifted from the emphasis 
on efficiencies of the firm, focused on production, to the study of the consumer.
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The medical profession has been dominated by a ‘technological imperative’ 
(Fuchs, 1968), an emphasis on progress resulting from advances in science and 
technology, with little regard to the needs for the consumers of health care 
(Stewart, Hickson, Rathneshwar, Pechmann, and Altemeier, 1982). As a result, 
the status of the consumer in the health care process has been diminished by the 
imbalance between patient and provider, identified as ‘psychological distance’ 
(Zaltman and Vertinsky, 1971) or ‘power imbalance’ (Kramer, 1972).
Changes in the increase of supply of health care over demand, coupled with the 
increasing confidence of the consumer, have resulted in a greater orientation to 
the consumer by the health care profession. Previously in the ‘production’ of 
health care, emphasis was on the creation of better drugs and procedures; the 
consumer or patient merely at the end of this chain of events.
This change parallels a broader emphasis on consumer empowerment in the 
consumer behaviour literature. No longer is the consumer at the conclusion of 
the production process; the consumer is viewed as central to it (McCracken, 
1988a). The consumer is not a passive recipient of the goods of production; the 
consumer can go as far as assuming a range of active roles including that of 
rebel, victim, activist, or citizen (Gabriel & Lang, 1995). An example of the 
consumer as activist was the establishment of organisations whose aims were to 
defend the ‘powerless’ consumers against corporate giants such as car 
manufacturers, insurance companies, and the health sector in particular. This 
trend has been termed Naderism, after the Harvard educated lawyer who formed 
the Centre for Study of Responsive Law and the Project for Corporate
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Responsibility in 1969 (Gabriel & Lang, 1995). While the consumer is being 
recognised as acting independently, almost subversively, there has been little 
attention to this aspect from a health research perspective.
It is necessary to note that while much research on health behaviour is viewed as 
an emerging rather than an established field, some attempts have been made to 
create a working definition, best articulated by Gochman (1988, p.3);
those personal attributes such as beliefs, expectations, motives, values, 
perceptions, and other cognitive elements; personality characteristics, 
including affective and emotional states and traits; and overt behaviour 
patterns, actions and habits that relate to health maintenance, to health 
restoration and to health improvement.
More importantly, Gochman expands his argument to state what is not health 
behaviour; it is distinct from the treatments, structures, and organisation of the 
health care delivery system but ‘it touches profoundly upon all of these’ 
(Gochman, 1988, pp. 5). In other words, health behaviour research must focus on 
the individual’s behaviour, but must also assess how any treatments and/or 
institutional structures affect this health behaviour. The use of nicotine 
replacement therapy, as an OTC, is clearly pertinent to health behaviour 
research.
From the particular perspective of consumer research, four main areas of the 
health care process have received focus, as identified by Langmeyer and 
Miaoulis (1981);
1) Consumer participation in the planning and delivery of health care,
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2) Consumer satisfaction with delivery systems,
3) Health care decision models,
4) Health promotion.
With the exception of some health care decision models, the research has 
focused on the traditional areas of health care; inclusion in the planning of health 
care facilities, doctor/patient relationships, and patient satisfaction with specific 
types of systems such as health plan coverage and post-operative outcomes 
(Langmeyer and Miaoulis, 1981). Clearly much of the emphasis has been outside 
the boundaries of health behaviour research, as defined by Gochman and has 
neglected the consumers’ own actions in particular.
While the ‘consumer’ is considered, he/she is viewed more as a ‘patient’ in the 
context of the powerful health care process. The idea of self-medication or the 
consumer choosing independently has been addressed by few researchers. More 
significantly for this study, the use of OTC and/or switch drugs, a clear 
indication of self-medication, has not been a topic of interest, as highlighted by 
Kotzan et al. (1987, pp. 44);
Quantitative research investigations of the impact upon consumers of the 
legend pharmaceutical to OTC switch are limited. A review of the 
general self-care and self-medication literature does not exactly relate to 
switched drug products but is certainly pertinent since the process 
introduces new OTC drugs into the marketplace.
A number of points about the nature of health behaviour research may explain 
this lack of focus on behaviour and on the use of specific treatments, such as
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smoking cessation behaviour and the use of NRT. Consumer researchers in the 
field of health behaviour have long emphasised that there are a number of unique 
challenges facing them. As a result of the long time horizons linked with health 
outcomes, effectiveness is difficult to evaluate (Moorman, 1994). Also the field 
is an interdisciplinary one, encompassing psychology, health education, 
sociology, and social marketing (Moorman and Matulich, 1993; Gochman, 
1988), thus researchers in this field have been described as ‘studying different 
parts of the elephant’ (Gardner and Harris, 1996). There is a clear need to put the 
consumer at the centre of any inquiry, and this is of particular relevance in the 
context of self-care and the use of OTC medications.
2.7 Preventive Health Behaviour.
Gochman’s earlier definition of health behaviour incorporates three aspects; 
preventive health behaviour, illness behaviour, and sick-role behaviour. 
Preventive health behaviour is distinguished by the fact that those undertaking 
such behaviours believe themselves to be well, have no symptoms of illness, and 
are doing so to remain well. Such actions can be divided into two areas based on 
their value to the individual. First, those with primary preventive value; usually, 
but not exclusively, daily non-medical activities, such as duration of sleep, 
dietary habits, weight management, exercise, moderating alcohol consumption, 
and not smoking (Belloc and Breslow, 1972). Second, those behaviours that have 
a secondary preventive value - activities that facilitate early detection to
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minimise the impact of a condition (but do not prevent a condition happening), 
such as regular check-ups with doctors, dentists, and cancer screening.
Preventive health behaviour research has encompassed behaviours and activities 
outside the traditional health care process, including nutrition information 
processing (Russo et al., 1986), exercising (Avis, McKinley, and Smith, 1990; 
Howze, Smith, and deGilio, 1989), healthy lifestyle (Muhenkamp, Brown, and 
Sands, 1985; Weitzel, 1989), healthy food use (Saegert and Young, 1983), and 
smoking cessation and modification (Avis et al., 1990; Colsher, Wallace, 
Pomrehn, LaCroix, Cornoni-Huntley, Blazer, Scherr, Berkman, and Hennekens, 
1990; Bernstein, 1970; Best, 1975; Best and Steffy, 1975; Eiser, Eiser, 
Gammage, and Morgan, 1989; Hjelle and Clouser, 1970; Keutzer, 1968; Kok, 
deVries, Muddle, and Strecher, 1991; Leigh, 1983; and Kviz, Crittenden, Belzer, 
and Wamecke, 1991). The scope of what is incorporated in any primary and 
secondary preventive health behaviour varies, depending on the particular 
behaviour considered, but appears to encompass three areas:
1) Performance of the preventive health behaviour itself and the outcomes. 
Central to the performance of any health behaviour is the consumer 
characteristics (dealt with below).
2) The acquisition of information regarding preventive health from professional 
sources such as doctors, nurses and pharmacists, casual sources, such as family, 
friends (termed word-of-mouth in this study), and information from media
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sources such as advertising, medical journals/pamphlets, and product labelling 
(Moorman and Matulich, 1993; Zaltman and Vertinsky, 1971).
3) The interaction with members of the health care profession, health care 
structures, and the use of treatments and other interventions (Gochman, 1988).
The focus of this study is on the first of the three aspects of preventive health 
behaviour as it applies to the primary preventive health behaviour of smoking 
cessation; the actual performance of the health behaviour itself. It goes without 
saying that this aspect is closely associated with the other two aspects; the 
acquisition of information on smoking cessation, the interaction with members 
of the health care profession, and the use of a specific treatment i.e. nicotine 
replacement therapy.
The bulk of preventive health behaviour research has centred on single 
independent variables or characteristics such as age, income, education, health 
locus of control etc., often approached from different fields of interest. A 
consequence of this orientation is that, frequently, conflicting results are found 
(Moorman and Matulich, 1993). There are eight consumer characteristics evident 
in the preventive health behaviour literature, each of which will be examined 
independently. With input from different disciplines, the consumer 
characteristics are sometimes conceptualised as either predisposing, enabling, or 
motivating in nature (Gould, et al., 1993; Moorman and Matulich, 1993). As 
there are no a priori assumptions in this study, the characteristics will be 
examined in relation to the part they play in the experiences of the respondents.
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Preventive health behaviour consumer characteristics can be divided into two 
groups; specific health characteristics (health motivation, health knowledge, 
perceived health status, health locus of control, and health behavioural control) 
and the more general characteristics of age, education, and income. Each of these 
characteristics will be examined, with particular reference to smoking and 
smoking cessation.
Health Motivation.
Health motivation can be defined as ‘goal-directed arousal to engage in 
preventive health behaviours; the willingness to perform or interest in 
performing health behaviours (Maclnnis, Moorman, and Jaworski, 1991). Health 
motivation has been found to exhibit a positive effect on a range of health 
behaviours such as regular use of dental services (Gelb and Gilly, 1979), prenatal 
visits (Zweig, LeFevre, and Kruse, 1988), and breast self-examination (Fletcher, 
Morgan, O’Malley, Earp, and Pegnan, 1989). It is worth noting that these results 
relate to behaviours with a secondary preventive value. Only one study attempts 
to evaluate the effect of health motivation on behaviours with a primary 
preventive value. Moorman and Matulich’s 1993 study focuses on the role of 
motivation on a range of five health maintenance behaviours (tobacco non-use, 
alcohol moderation, negative diet restriction, positive diet addition), and life 
balancing behaviours (stress reduction) together with health information 
acquisition.
2.7.1 Preventive Health Behaviour- Consumer Characteristics.
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Moorman’s results demonstrate that motivation increases the acquisition of 
information from media sources and health professionals, but not from casual 
sources. The nature of much health information is complex, and usually new or 
innovative such as information on new products, services, or practices. For such 
information, sufficient difference between the sender and the receiver of such 
messages is recommended in theory (Rogers, 1983). For this reason information 
from casual sources, such as friends, may not be sufficiently differentiated to be 
perceived to be of value (Moorman and Matulich, 1993). Most significantly, 
health motivation did not demonstrate any effect on either tobacco or alcohol 
consumption.
Although health motivation has not demonstrated any direct effect on smoking 
cessation, it appears to manifest itself in relation to other consumer 
characteristics. The scales used to measure motivation (Moorman, 1990) have 
more in common with health locus, and health behavioural control. The 
interaction of motivation with other characteristics is dealt with below.
Health Knowledge.
Health knowledge can be defined as ‘the extent to which consumers have 
enduring health-related cognitive structures’ (Moorman and Matulich, 1993). 
Health knowledge has been viewed as an ability that helps consumers engage in 
health behaviours. Typically health knowledge is measured on the knowledge of 
the roles of such elements as vitamins, calcium or sodium, amounts of 
knowledge, rather than its complexity. A small cache of authors has sought to
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investigate the relationship between consumers’ health knowledge, and a number 
of health behaviours. For example, health knowledge has exhibited a positive 
effect on many health behaviours such as exercising (Avis, McKinlay, and 
Smith, 1990), improved dietary habits (Boechner, Kohn, and Rockwell, 1990), 
and personal food selection (Bell, Stewart, Radford, and Cairney, 1981).
But apart from these authors, most of the studies focus on acquisition and 
retention of health knowledge (Brucks, Mitchell, and Staelin, 1984; Moorman, 
1990; Probart, Davis, and Kime, 1989). They looked on health knowledge as 
starting points in the preventive health care process, rather than as influencers of 
actual behaviour (Avis et al., 1990). For example the ability required to encode 
nutrition information was positively related to levels of health knowledge, but 
the reliance on such knowledge to inform brand beliefs was negatively related to 
the extent of this health knowledge (Brucks et al., 1984). It appeal's that 
knowledge may help the encoding of information and its subsequent acquisition 
(Brucks, 1985; Maclnnis et al., 1991). Conversely, high levels of health 
knowledge may reduce consumers’ need for more information, as they feel 
sufficiently knowledgeable (Maclnnis and Jaworski, 1989).
Avis et al.’s (1990) study of cardiovascular risk factor knowledge demonstrated 
that the amount of health knowledge correlated positively with education level 
and being female. On a further point, the respondents’ knowledge of the risk 
factors that reduce the risk of a stroke or heart attack tended to centre on those 
risk factors they felt they had control over, such as exercise and reducing fat
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intake rather than on the more serious risk, controlling blood pressure, something 
most likely seen as under the control of the doctor. In this sense, their health 
knowledge was biased in favour of factors the consumers themselves controlled.
While knowledge illustrated this bias towards factors under the consumers’ 
control, there was evidence that such control may have been more perceived than 
real. The smokers in this study included a list of steps that they could take 
control o f Not smoking was a key step for this group. In a similar vein, those in 
the study who were overweight listed weight control as a step they could take. 
This relationship between what the consumer knows and what he/she feels is 
under their control, can sometimes prove inconsistent. While health knowledge 
illustrated this bias towards behaviours under the consumer’s control, those who 
posses such knowledge can often fail to translate it into actual health behaviour. 
For example, respondents in this study who smoked registered smoking 
cessation as the number one step they could take control of. Likewise, those who 
were overweight reported weight control as the most salient item in their health 
knowledge.
The inconsistency between health knowledge and behaviour may be a result of 
the manner in which the former is measured. For example, one study 
operationalised health knowledge as the number of risk factors the consumer was 
aware of in relation to the control of blood pressure (Avis et al., 1990). In 
another it was operationalised as the amount of knowledge about dietary 
nutrients and their health outcomes (Moorman, 1990). Different definitions will
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thus yield different correlations with behaviour. Both of the proceeding 
examples refer to what is termed objective health knowledge (Brucks, 1985). 
Matters are further compounded when the consumer’s subjective health 
knowledge is considered. Where objective health knowledge relates to the 
amount and complexity of what is known about health matters, subjective 
knowledge refers to the individual’s confidence in their ability to use this 
knowledge (Park and Lessig, 1981). To date the role of subjective health 
knowledge has yet to be examined.
Health Status.
Health status, as a consumer characteristic, refers to the perceived physical and 
mental well-being of an individual (Moorman and Matulich, 1993). The effect of 
health status has produced mixed results. Positive effects have been reported on 
cancer detection behaviour (Antonucci, Akiyama, and Adelmann, 1990), dietary 
improvement behaviour (Contento and Maksymowicz-Murphy, 1990), and 
health/illness information seeking (Hickey, Rakowski, and Julius, 1988). These 
are clearly secondary preventive behaviours. In other words, they do not effect 
actual health in a direct manner but minimise the likely impact of an illness by 
prompting consumers to monitor or check their health.
In other research, poor perceived health status has been found to be positively 
related to smoking (Colsher et al., 1990), the use of books and pamphlets, and 
turning to doctors/health professionals (Feick, Herrmann, and Warland, 1986). 
The effect of health status on health behaviours can work both ways. Some
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consumers who perceive themselves to be healthy may engage in preventive 
health behaviours to maintain their health status, while others may be 
complacent in their good perceived health status and fail to maintain it 
(Moorman and Matulich, 1993). For this latter group, good health status could be 
viewed as a liability creating an impression of well being. To emphasise this 
point Taylor and Brown (1988) found that those with an unhealthy status 
performed more preventive health behaviours than those with higher status. This 
effect of health status as a liability has been found to operate for both primary 
and secondary preventive health behaviours.
When health status is viewed as the dependent variable with health behaviours as 
the independent variable, the relationship between the two shows the same 
paradoxical features. For example, Colsher et al., (1990) studied the effect of 
smoking behaviour on the perceived health status of a sample of elderly 
respondents. Counterintuitively, those who continued to smoke reported a higher 
perceived health status than those who had quit smoking. One possible 
explanation for this somewhat bizarre finding is that those who had quit may 
have been forced to do so in the first place because of illness or disease; hence 
their lower perceived health status. Whilst respondents who had never smoked 
did not feature in this study it seems plausible to presume that they would enjoy 
higher perceived health status than those currently smoking.
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Locus of control has been applied to health behaviour with increasing frequency, 
following Seeman and Evan’s 1962 seminal article on learning in a hospital 
setting, as described by Lau (1982). Locus of control can be defined as
the degree to which individuals perceive events in their lives as being a 
consequence of their own actions, and thereby controllable (internal 
control), or as being unrelated to their own behaviour, and therefore 
beyond personal control (external control) (Lefcourt, H.M., in Lau,
1982).
This single bipolar, general locus of control measure reflects the basis of Rotter’s 
social learning theory, that locus of control beliefs develop from past experience 
and reinforcement history (Rotter, 1975).
Further work on the development of a locus of control scale from a single to a 
multiple scale was by Collins (1974). Collins constructed four rating scales of 
general locus of control; a) beliefs in a ‘just’ world; achievements are as a result 
of effort, b) beliefs in a ‘difficult’ world; a world full of complications and 
unsolvable tasks, c) beliefs that the world is governed by luck and chance, and is 
therefore ‘unpredictable’, and d) beliefs in a ‘politically responsive’ world where 
all citizens have some control over political affairs (Lau and Ware, 1981).
The application of Collins’ multiple locus of control scale to health behaviour 
has resulted in a multidimensional health specific locus of control scale (Lau and
Health Locus of Control.
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Ware, 1981, Lau, 1982, Wallston, Wallston, and deVellis, 1978). Lau and 
Ware’s multidimensional scale is composed of four subscales; three of which are 
similar to Wallston, Wallston, and deVellis’ definitions, and one relating to 
Collins’ difficult world dimension.
1. Self-control over health refers to the individual’s belief in the efficacy of their 
own self-care; Wallston et al. refer to this as internal health locus of control 
(IHLOC).
2. Provider-control over health relates to beliefs in the efficacy of doctors; 
Wallston et al. refer to this as powerful other health locus of control (POHLC).
3. Chance health outcomes reflect the individual’s belief in the role of luck in 
health.
4. The final scale, modelled on Collin’s difficult world dimension, is general 
health threat, reflecting the perceived susceptibility to illness by individuals.
Lau and Ware’s exploratory work established that such health specific measures 
of locus of control predicted health related behaviours more accurately than 
general locus of control measures. This is reflected in Moorman’s extensive 
summary of studies of preventive health behaviour and locus of control; of 
fourteen studies utilising general locus of control, eleven report no effect. 
Conversely, those researchers incorporating health specific locus of control 
report an effect in eleven of the fifteen studies (Moorman and Matulich, 1993). 
IHLOC has been linked with the ability to stop smoking (Best and Steffy, 1975),
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and the ability to lose weight (Balch and Ross, 1975). Steffy et al’s findings 
suggest that IHLOC has been associated with the ability to stop smoking and, 
conversely, smokers have been found to demonstrate belief in chance, rather than 
POHLC or IHLOC (Eiser et al„ 1989).
While the health specific locus of control measures are more discriminating than 
a general measure, there has been little collective correlation among them, 
suggesting their ability to be independent predictors of behaviour (Lau and 
Ware, 1981). However a significant result was the positive correlation between 
self-care or IHLOC and POHLC over health outcomes, contrary to the general 
view of internal and external control being opposite ends of a spectrum (Lau and 
Ware, 1981). Not surprisingly, self-control and provider-control were found to 
correlate negatively with chance health outcomes and general health threat. 
However, the impact of early family illnesses resulted in a greater belief in 
chance health outcomes and a negative correlation with provider over health 
outcomes (Lau, 1982).
Family illness also exercised an effect on self-control over health and in a 
pronounced fashion. Extreme cases of such illness, such as people dying of lung 
cancer without ever smoking, had a negative effect on self-control. This may be 
explained by the fact that good health is the normal state for most people who 
typically ignore the relationship between their behaviour and its effect on their 
health. Serious illness prompts these onlookers to examine this relationship and
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to do so in a way that minimises the impact of their own efforts on their health 
and thus creates a bias against internal locus of control (Lau, 1982).
The experience of watching these ailing relatives suffer despite their health 
behaviour may lead them to conclude that control over health rests outside 
people’s and/or the health professional’s control and has more to do with chance 
than human agency. However, apart from this rather exceptional experience of 
family illness, routine and non-chronic experiences of personal illness appear to 
have minimal impact on locus of control beliefs. Whatever the impact of family 
illness on health locus of control beliefs, early health habits (such as regular 
doctor visits) had a lasting impact on the IHLOC and POHLC.
In this light, Lau’s results are in line with Rotter’s assertion that locus of control 
beliefs develop from past experience (prior experience with sickness and health 
and early health habits) and reinforcement history (prior self-care experience). 
Another important point that can be summarised from research in this area is that 
internal health locus of control is related positively to an individual’s propensity 
to take a long term view of their actions, rather than opt for immediate, or short 
term gratification (see education below). Furthermore health locus of control 
needs to be viewed as a multidimensional construct rather than a unidimensional 
one; as illustrated above, it is possible to attribute belief in the efficacy of one’s 
own efforts while retaining a belief in the efficacy of health profesionals.
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Health behavioural control, while closely aligned with health locus of control, 
differs in that it relates to an individual’s belief in their ability to perform a 
specific behaviour in a specific situation (Bandura, 1977). Health behavioural 
control has also been termed self-efficacy (Kok et al., 1991).
It relates to control over a specific behaviour (i.e. performance of that 
behaviour), rather than overall control over the outcome. For example, an 
individual can believe that they can successfully quit smoking, a specific 
behaviour; this is health behavioural control. On the other hand, locus of control 
relates to whether that individual believes this cessation is due primarily to their 
own agency or that of external forces. One’s experience with the specific 
behaviour, observations and the persuasion of others, and the degree of 
confidence in performing that behaviour are the determinants of health 
behavioural control (Kok et al., 1991).
Research on behavioural control almost universally demonstrated a positive 
effect on preventive health behaviours. The intention to stop smoking and stop- 
smoking behaviour (Kok et al., 1991; Moorman and Matulich, 1993), and 
registration in a smoking cessation programme (Kviz et al., 1991) all correlate 
with positive behavioural control. Other behaviours, such as compliance with 
prescribed medical treatments (Rosenstock, 1988), and dietary behaviour 
modification (Davis-Chervin, Rogers, and Clark, 1985) also correlate positively 
with high behavioural control. The nature of smoking cessation, where the
Health Behavioural Control.
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individual usually makes multiple attempts to quit, makes behavioural control of
great importance to the present study.
Education.
Education, in the context of health, can be viewed as an ability which enhances 
the desire for a healthy lifestyle and improves the efficiency with which the 
individual consumes health care services (Grossman, 1982). The effect of 
education has focused on information acquisition and comprehension, and the 
performance of a range of preventive health behaviours. In relation to 
information acquisition, use of books and pamphlets, labels, 
magazine/newspaper articles, and visiting doctors/health professionals (Feick, et 
al.; 1986; Worsley, 1989), correlate with higher education levels. Also the ability 
to comprehend nutrition labelling (Moorman, 1990), and provider information 
seeking (Anderson, Meissner, and Portnoy, 1989) have all reported registered a 
positive relationship with increasing levels of education.
In terms of health behaviours, education levels have been demonstrated to 
encourage a range of behaviours such as cancer detection behaviour (Antonucci 
et al., 1990), compliance with prescribed treatments (Rosenstock, 1988), and a 
range of healthy eating and health food consumption (Bassler and Newell, 1982; 
Saegert and Young, 1983; Yung, Contento, and Gussow, 1984). In contrast, 
continuing to smoke is negatively correlated with education and not smoking 
demonstrates a positive relationship with education levels (Leigh, 1983). Higher 
levels of smoking have been found in the less educated strata of the population,
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and as a result, registration in smoking cessation programmes has a positive 
correlation with education (Kviz et al., 1991).
As already highlighted, an important aspect in preventive health behaviour is the 
time frame involved. Termed ‘time preference’, it relates to the time horizons 
individuals utilise when evaluating health; a low time preference means that the 
individual assesses current actions in terms of how they will impact on their 
health in ten to twenty years hence. Those with a high time preference do not 
adopt this long term view. Increasing levels of education have been found to 
correlate with a lower time preference (Fuchs, in Leigh, 1983).
Age.
In a health context, issues regarding age focus on the individual’s mental and 
physical ability to engage in health behaviours (Moorman and Matulich, 1993). 
Increasing age has been found to reduce cognitive skills, resulting in less 
information acquisition, for example nutrition information (Cole and Gaeth, 
1990, Moorman, 1990), and a greater focus on health professionals for 
information (Probart et al., 1989, Pineault et al., 1989).
In relation to health behaviours, results are, once again, mixed. Increasing age 
has shown positive effects on good nutrition (Weitzel, 1989), and health food 
purchases (Yung et al., 1984). However alcohol consumption (Colsher et al., 
1990), taking exercise (Weitzel, 1989), and health clinic use (Williams and 
Dueker, 1985), all correlate negatively with increasing age. Smoking cessation is
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positively correlated with age, and associated with the increasing difficulties 
experienced with health (Colsher et al., 1990, Kviz et al., 1991).
Income.
Studies on income level show a positive relationship with a range of health 
behaviours, both with specific behaviours and with more general attitudes 
towards health. Examples such as contact with the doctor (Dawson, 1989), use of 
the doctor (Rosner, Tarler, Namazi, and Wykle, 1988), preventive dental care 
(Gelb and Gilly, 1979), and oral hygiene behaviours (Laiho, Honkala, and 
Nyssonen, 1991) reflect this relationship.
While the impact of income is important in the health care system generally and 
low levels of income in particular militate against full participation in the health 
care system (Zaltman and Vertinsky, 1971), it remains more peripheral when it 
comes to individual preventive health behaviours. As demonstrated by 
Grossman, the effect of income on education is well documented. Income should 
be viewed in the wider context as impinging on education.
2.8 The Need To Understand the Interrelationship of Consumer 
Characteristics.
Much of the focus on consumer preventive health behaviour has been on single 
independent variables discussed above such as age, and income, or specific 
moderating variables such as locus of control or health knowledge. With 
research spanning different disciplines, little attempt has been made to bring the 
different variables together, but there are many indications or recommendations
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to do so. One comprehensive treatment of preventive health care, by Moorman 
and Matulich, brings together research in this area. Their 1993 model draws on 
all prior research in an attempt to develop a complete framework of consumers’ 
preventive health behaviour. The study focused on the effects of consumer 
characteristics on health information acquisition and a range of health 
behaviours. Health behaviours include the three aspects of health information 
acquisition, and five health maintenance behaviours; tobacco non-use, alcohol 
moderation, negative diet restriction, positive diet addition, and life balancing 
behaviours (stress reduction).
The ambiguous results from previous research on variables that affect health 
behaviours have been attributed to the absence of motivation as a moderating 
variable. However the hypotheses forwarded by Moorman and Matulich, that 
health motivation moderates the impact of various health abilities on health 
behaviours, received little or no support. The whole issue is compounded by the 
somewhat vague nature of the dependent variable in this case - health 
behaviours. ‘Health behaviours’ can embrace a wide range of often contradictory 
behaviours. For example, a consumer may be highly motivated to improve their 
health by taking exercise while continuing to smoke. A study examining how the 
full range of consumer variables affects a single preventive health behaviour 
seems more promising than a study purporting to explain the full gamut of health 
behaviours.
Moorman and Matulich do recommend a more interactive treatment of consumer 
characteristics (Moorman and Matulich, 1993). Adopting an interpretive
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approach, rather than a cue-based methodology, will facilitate a more 
comprehensive exploration and understanding of these characteristics. Of equal 
importance to this comprehensive treatment of consumer characteristics is an 
understanding of how such characteristics evolve over time and how the use of 
products impacts on consumers’ health behaviour. For example, as illustrated 
above, experience of illness can have long term impact on locus of control. 
Therefore, the use of, or experience with, a medication will also impact on 
consumers’ preventive health behaviour. The next section draws on research in 
the field of illness to introduce concepts central to adopting a wider approach to 
consumer’s preventive health behaviour.
2.10 Consumer Characteristics in Action; the Impact of Experience.
Authors such as Gochman have stated that health behaviour research 
encompasses the consumer characteristics as well as the use of treatments and 
the structures of the health care system and therefore it is important to adopt a 
wider, holistic approach to understanding consumer’s preventive health 
behaviour. Any one illness could have given rise to a range of remedies and 
health behaviours and may have involved a variety of interventions on the part of 
health care agencies and professionals. This process may have taken place over a 
protracted period of time. The concept of an ‘illness career’, developed by Gould 
et al. (1993), consists of all consumption and non-consumption events that an 
individual experiences over the course of an illness. Therefore it is essential to 
view the consumers’ current health behaviour in terms of a ‘career’ or trajectory.
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This movement and change results from the experience gained over time. It must 
be highlighted that the concept of an illness career encompasses both primary 
and secondary preventive behaviours, as well as illness-related behaviour.
The illness career approaches the experience of the consumer in a holistic 
fashion, focusing on the evolution of the consumer’s behaviour over time. Rather 
than viewing consumer characteristics as static or fixed variables, they are 
viewed as one part of the evolution of an illness career. Gould et al. used in- 
depth, unstructured interviews to explore how allergy sufferers coped with their 
illnesses. The consumers’ characteristics, as well as their interaction with 
medical professionals, and most importantly, their use and experimentation with 
treatments contributed to a process described as ‘treatment shopping’ (Gould et 
al., 1993). The idea of treatment shopping mirrors the traditional consumer 
behaviour decision making process, with a key factor being the gaining of 
learning and expertise as a result of experimentation and experience.
Gould et al., in addition to utilising consumer characteristics as predisposing and 
enabling factors, introduced two response factors, deemed important for allergy 
suffers. The first response factor related to the idea of self-care and consumers 
taking responsibility for their health care decisions. The second related to 
consumers’ health perceptions versus those of health professionals; while the 
health professional was viewed traditionally as having the expertise, it is the 
consumer who often develops expertise and self-knowledge of their health far 
beyond that of the health professional. This accrued from the consumer’s self- 
medication, experimentation and theorising.
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A number of themes to emerge from this interpretive investigation of allergy 
sufferers are important for this study of consumers using NRT. Consumers trying 
to quit smoking usually take a number of attempts trying different methods 
before success and as such the concept of an illness career can be mapped onto a 
smoking cessation career. Their ‘condition’ requires much experimentation and 
self-medication, especially for those using NRT.
The central theme uncovered by Gould et al. was that the history of the allergy 
sufferer followed a path or illness career and reflected increasing consumer 
expertise, helping account for what appeared to be highly individualistic 
behaviour among allergy sufferers. There was a constant evaluation and cycling 
of experience throughout the career as the nature of the consumers’ allergies and 
their preventive health behaviour seemed to alter over time. The detailed 
knowledge of their condition and how to alleviate it were very precise and the 
altered use of medications was an important aspect of their self-medication 
practices. Such practices gave rise to increased perceived self-efficacy in the 
consumers’ ability to deal with their allergies.
Overall, Gould et al. demonstrated that a consumer centred approach to 
exploring health care, while revealing very individualised paths, can be best 
understood in terms of experience accumulated or as a ‘career’. In viewing this 
illness career as a whole, it is the consumers’ own understanding that is central, 
as described by Gould et al., (1993, p. 11);
Moreover, we have demonstrated, at least in the allergy domain, that 
consumers engage in a process of theorising and empirical self­
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observation that seems to be “scientifically” appropriate for their own 
situations and commensurate with their own illness perspective.
In summary, Gould et al. adopted a holistic approach to their study of allergy 
suffers, incorporating the consumer characteristics as well as the use of 
treatments, many of which were OTCs. Clearly the use of a treatment is central 
to the performance of any health behaviour as it both shapes and reflects the 
performance of that health behaviour. Also, approaching the study in an open- 
ended manner, from the perspective of the respondents themselves allowed the 
unique careers of different respondents to appear. In this case, unique often 
paradoxical behaviours of the allergy suffers could be understood with the 
concept of an illness career. This contrasts to Moorman and Matulich’s study, 
which attempted to establish uniformity across a range of behaviours and 
consumer characteristics. Clearly individual health behaviours have particular 
facets not common across all health behaviours.
For this study of smoking cessation a holistic, open approach should yield 
unique aspects to this particular behaviour and the role of the characteristics of 
those performing the behaviour. Certainly the concept of a career appears 
suitable, given the nature of smoking cessation, as outlined above. The particular 
consumer characteristics that will be most significant for smoking cessation are 
difficult to establish in advance, given that the use of a particular treatment, in 
this case NRT, has not been investigated before. But it is probable that the most 
important are health knowledge, health status, health locus of control, and health
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behavioural control. However, the approach in this study avoids any particular a 
priori assumptions, but attention will focus on these characteristics 
Finally, smoking cessation and its correlates are clearly located in the broader 
arena of health behaviours. It has been shown already that this arena is 
increasingly characterised by greater consumer autonomy. Consumers are more 
likely now than ever to choose, and continence specific health regimes on their 
own initiative than on the advice or direction of professionals. Increased 
pharmaceutical deregulation and wider availability of non-prescription drugs 
both facilitate and support this trend. However the specific constitution of switch 
drugs to this overall process has yet to be fully investigated. The following 
chapter charts the emergence and growth of the switch drug phenomenon in a 
more descriptive vein.
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Chapter Three.
The Prescription to Over-The-Counter Switch.
3.1 Introduction.
This chapter outlines the emergence of the OTC market in the context of the 
wider pharmaceutical market, with particular emphasis on the evolution of 
nicotine replacement therapy as an OTC, both world-wide and in an Irish 
context. In addition, the rationale for drugs switching to OTC status and the 
process of switching drugs is outlined. First, this chapter looks at the range of 
smoking cessation methods available to those wishing to quit and the process of 
smoking cessation itself.
3.2 Smoking Cessation Methods.
While smoking cessation has been identified as the single most preventable 
cause of deaths world-wide, there remains little agreement, even among health 
professionals, as to the best strategies to employ to encourage and ensure 
successful cessation (Paul and Sansonfisher, 1996). Ways of quitting smoking 
include conventional and alternative medical methods, behavioural modification 
and support strategies, and traditional ‘cold-turkey’ approaches. This section 
examines the types of methods used, with particular emphasis on nicotine 
replacement therapy
Efforts to reduce smoking levels or prevent people starting to smoke in the 
general population can be broadly divided in two; health education/promotion,
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highlighting the dangers and risks associated with smoking, and smoking 
control, including strictly controlled advertising and sponsorship, no smoking in 
public buildings, and no smoking zones. The result of both of these reduction 
strategies has been a gradual decline in smoking, from 43% of the adult 
population in 1973 (Irish Marketing Surveys, 1982), to 30% in 1996 (Irish 
Marketing Surveys, 1996). While apparently successful to date, there are two 
emerging trends that appear to hinder the planned target of reducing the numbers 
smoking to 20% of the population by 2000.
First, the number of younger children and teenagers, especially females, who are 
smoking is higher than ever; 18% of girls aged 12 to 18 smoked in 1970; this 
rose to 26% in 1980 (Irish Marketing Surveys, 1982). Recent indications are that 
50% of 10-12 year olds are now smoking (O’Conor, 1997). Second, the number 
of current smokers who are attempting to or intend to quit is reducing, 
suggesting that a core of heavy smokers remain who find it increasingly difficult 
to give up (Irish Marketing Surveys, 1996).
It is in this context that methods of smoking cessation need to be examined. Also 
it is worth noting that smoking cessation requires substantial effort, and the 
majority of smokers will try between three and six times before achieving 
success. As a consequence, most quitters will usually try a variety of methods, 
often more than once. Research on smoking cessation is mostly of a medical or 
psychological nature and has tended to utilise ‘captive’ or non-volunteer subjects 
(Hennrikus, Jeffery, and Lando, 1995). Placing subjects in such an environment 
predictably produced high success rates as a result of quite detailed and intensive
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support for the participants (see Table 3.1, below). Newer methods, such as laser 
therapy do not have independently verified results and are often prone to 
exaggeration by proponents1.
The actual methods available range from individual counselling from doctors, 
nurses and pharmacists, to telephone counselling, hypnosis, hypnotherapy, 
acupuncture and laser therapy. Other methods involve behavioural modification 
encompassing relaxation, rewards and punishment, and avoiding ‘trigger’ 
situations. Typically these behaviour modification methods are under the 
instruction of a psychologist. Many methods involve some combination of the 
above. However the focus for this study will be on nicotine replacement therapy 
only.
Smoking cessation treatments are available through a range of channels, 
including doctors, pharmacies, commercial advertising and, more recently 
through the workplace as part of a support programme. An example of how such 
a range of options are made available is the Irish Cancer Society who, under the 
umbrella of the Department of Health run Health Promotion Unit, provide advice 
and counselling in workplaces, hospitals, and to individuals with no one method 
receiving their approval or endorsement.
1 For example, the author’s initial review of cessation methods, through informal interviews, 
produced a reported 85% success rate for laser therapy.
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Table 3.1 Smoking Cessation Methods and Reported Results
Nature of Treatment Reported Result % not 
smoking after one year 
(unless otherwise stated)
Source
Unaided smoking cessation 8.5%- 13.8% Baillieetal. (1995)
6.4% Viswesvaran et al. (1992)
Self-help booklet 7% Curry et al. (1995)
Personalised feedback 9% Curry et al. (1995)
Telephone counselling 11% Curry et al. (1995)
Advice/encouragement from a GP on a 
single visit
2% Law and Tang, (1995).
Behavioural modification 2% Law and Tang, (1995).
Nicotine replacement therapy (general 
study)
13% Law and Tang, (1995).
Nicotine replacement therapy (gum) plus 39% for high dependence Herrera, et. al., (1994)
behaviour modification/support 49% for low dependence
Nicotine replacement therapy (gum) 2mg 44% Hall et al. (1982).
47% Jarvis et al. (1982).
38% Raw et al. (1980).
Nicotine replacement therapy (gum) 4mg 43% Blondal, (1989).
44% Tonnesen et al. (1988).
46% Tonnesen et al. (1988).
Nicotine patch (Nicotinell) 22% (after six months) Daughton, (1991).
Behaviour therapy plus patch 38% (after six months) Cinciripini et al. (1995).
3.3 The Process of Smoking Cessation.
In order to understand smoking cessation it is important to view it as a process 
rather than a single step. The Stages of Change Model (Prochaska and 
DiClemente, 1983), also termed the Transtheoretical Model for Intentional
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Behaviour Change was developed as a dedicated model to analyse the smoking 
cessation process and breaks it down into five principal stages;
1) Precontemplation, where the individual has not considered quitting,
2) Contemplation, when the individual is open to evaluating potential options 
and is receptive to education about the hazards of smoking,
3) Preparation, with a method chosen,
4) Action, the performance or use of the cessation method,
5) Maintenance, the continued adherence to the chosen method.
Using such a structure can help in tailoring any strategy to the individual needs 
at a particular time. For example, a doctor or pharmacist can help individuals to 
choose a method and set goals at the contemplation stage or offer support and 
reinforcement at the action and maintenance stages.
It is also worth noting that two people may posses different levels of nicotine 
dependence, even though they appear to be at the same stage of the process. In 
this case, both people may be at the contemplation stage but will have very 
different requirements for cessation due to their differing nicotine dependence. 
The Fagerstrom Tolerance Questionnaire (FTQ) (Fagerstrom, 1978), measures 
the individual’s level of nicotine dependence using an eight question test, listed 
in Table 3.2, below. A score of less than or equal to six indicates a low nicotine 
dependence, with a score of seven or greater indicating a high nicotine 
dependence, up to a maximum score of eleven. General results suggest that 
medium to heavy smokers (score of seven or greater) have more success with 
nicotine replacement therapies than with other available methods.
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Table 3.2. The Fagerstrom Tolerance Questionnaire.
Points 0 1 2
How soon after you wake do you smoke After 30 Within thirty
your first cigarette? minutes minutes
Do you find it difficult to refrain from 
smoking in places where it is forbidden 
e.g. library, cinema, church?
No Yes
Which cigarette would you be most 
willing to give up?
Any other First one in the 
morning
How many cigarettes per day do you 
smoke?
<15 16-25 >26
Do you smoke more during the morning 
than during the rest of the day?
No Yes
Do you smoke if you are so ill that you 
are in bed all day?
No Yes
What is the nicotine level of your usual 
brand of cigarettes?
<0.9mg l-1.2mg >1.3mg
Do you inhale the smoke from your 
cigarette?
Never Sometimes Always
Source: Fagerstrom, 1978.
In summary, the literature divides direct cessation strategies into motivational 
interventions, comprising behavioural interventions and broader media 
campaigns, and treatment interventions, principally comprising nicotine 
replacement therapies. The aim of the former is to encourage cessation; the aim 
of the latter to increase the chance of success. With the concentration of heavy 
smokers and the saturation of motivational intervention, an intervention that has 
had little success, it is suggested that the focus should now shift to treatment 
interventions instead. In particular, it is felt that such treatment interventions,
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NRT, holds the greatest promise of success for those seeking to cease smoking. 
(Foulds, 1996).
3.4 The Emergence of the OTC Market.
While the current focus on patient autonomy, self-medication, and the freedom 
to purchase medicines without prescription is reflective of a more positive, 
consumer-orientated era, the origins of OTCs have a less than positive history. 
The USA of the 1880’s is viewed as the highpoint of the ‘patent medicine era’ 2 
by many commentators (Mercill, 1983). At this time a vast array of exaggerated 
claims linked to mysterious potions challenged the consumer who, in this time of 
confusion, often opted for a home remedy instead of a visit to the doctor or 
pharmacist. Some of the OTC brand names are still available today, but bear 
little resemblance to their origins. Subsequent to this era, greater control by the 
medical professionals and the health care system generally ensured that most 
medicines came under their control, principally through the use of prescription 
status applied to pharmaceuticals.
Today the pharmaceutical market is valued at approximately US $ 206 billion, 
growing at 3% annually (Polastro, 1995). Two dynamics are shaping this market; 
the increasing competition from generic drugs and the focus on containing health 
care costs, both leading to an increase in the number of drugs switching to OTC 
status.
2 Patent medicines refer to the patents of royal favour granted by the kings of England to those 
who served the royal family. The term was adopted by English settlers in the USA who sold 
such prized medicines
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The term generic describes a pharmaceutical preparation based on active 
ingredients that are no longer patent-protected. Generics are usually marketed by 
a company other than the originator or its licensees. Generics account for 8% of 
the European pharmaceutical market, growing at 7% per year, over twice the rate 
of the total market. In fact US $12 billion worth of drugs will loose their patent 
protection by the turn of the century (Chapman, 1995). As a result of the loss of 
patent protection, drugs face direct competition from generic variants. Doctors 
have the choice of prescribing the original drug or its’ generic competitor. 
Typically the drugs facing generic competition are the ‘wonder-drugs’ or ‘legend 
drugs’, with US $ one billion-a-year sales and high profit margins. It is 
forecasted that with twenty-one such drugs in 1993, there will be no drug of this 
scale in 2000 (Alster, 1995). Also by 2003, 50% of all drugs sold by the top 
fourteen pharmaceutical companies will face generic competition.
The result of the introduction of a generic product is a 30% to 40% retail price 
discount on the original branded product in the USA, and approximately a 20% 
discount in the UK (Marx, 1996). Sales volume on the original branded product 
can drop by 90%, even in the first months of losing patent protection. This has 
resulted in the fact that 50% of all prescriptions in the UK are for the generic 
variants.
The second issue facing the pharmaceutical industry is the attempt by 
governments to contain health care costs. Drugs account for 7% of government 
spending on health care in the US and 12% in Europe. OTCs offer a way to shift 
the cost from the government, who often cover the costs of prescription drugs, to
56
the consumer by ensuring OTCs are the first option utilised by consumers. This 
reduces the time and money spent visiting doctors, and results in the consumer 
paying for the drug.
Allied to both these dynamics shaping the market is the rise of managed health 
care; Health Management Organisations (HMOs) schemes are taking over the 
role previously held by government health care programmes. HMOs are 
essentially private health care schemes and the equilivent in Ireland would be the 
Voluntary Health Insurance (VHI) or, more recently, BUPA. In 1994, 23% of the 
American insured population belonged to an HMO. The strength of HMOs is in 
their ability to purchase, at discount, drugs which they choose to make available 
to their members, even to the level of agreeing with pharmaceutical suppliers to 
cover individual patient’s pharmaceutical needs at pre-set prices. The financial 
attractions of both generics and OTCs to HMOs are clear.
3.5 The Rise of the Switch Drug.
The response from the pharmaceutical companies to both of the trends discussed 
above has been to prolong the life of the ‘wonder-drugs’ facing patent expiry by 
two means; enhancing the brand recognition through direct-to-consumer 
advertising and ‘switching’ the drug to OTC status.
Direct-to-consumer advertising, while banned in Europe since 1992, has become 
an accepted practice in the USA by the American Medical Association (AMA). 
Traditionally the doctor has been the focus of pharmaceutical companies 
marketing efforts. However, with the increasing importance of HMOs and the
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rise of a consumer more likely to ask questions, the objective is to use the 
consumer to ‘pull’ the drug through. In 1989, US $ 10.2 million was spent on 
direct-to-consumer advertising in the USA, rising to US $ 242.7 million by 1994 
(Marx, 1996). Direct-to-consumer advertising reflects the recognition of a 
powerful autonomous consumer concerned with health care decisions and such 
advertising attempts to remove the psychological distance between patient and 
provider and create brand awareness in advance of patent expiration.
While such direct-to-consumer advertising is restricted to the USA, throughout 
the world the pharmaceutical industry’s main focus has been to switch drugs to 
OTC status. Until recently the OTC category contained many familiar medicines 
for coughs and colds, pain killers such as paracetemol, mild stomach remedies, 
vitamins, and skin care products. Many of these are household brand-names, 
often available in supermarkets as well as pharmacies.
However today a whole new array of drugs are being switched to OTC status, 
many of them with a previously strong prescription history and associated with 
more serious health issues. Identified as the new switch paradigm (Juhl, 1997), 
these new switches require more than just recognition of the symptoms by 
consumers; they also require unique patient decision making and more complex 
product usage.
Therefore the greatest focus is on switched OTC medicines restricted to 
pharmacy sale only. Such switches are termed POM to P switches (prescription 
only medicines switched to non-prescription, pharmacy restricted sale). This 
contrasts to OTCs available in the retail grocery channels, which are termed
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general sale medicines, such as the examples above. The focus of this study will 
be on OTCs restricted to pharmacy sale only.
The resulting growth of OTCs in revenue terms has been staggering. For 
example, in 1993, OTCs grew 16.2% to US $ 8.9 billion in the USA, accounting 
for 26% of all drug sales. A total of US $ 3.7 billion came from switched drugs 
alone. Estimates are that the OTC market will double by 1999, and the savings in 
terms of health care, currently US $ 10.5 billion, will rise to US $ 34 billion by 
the year 2000 (Hoffman, 1995). There are now more than 600 medications 
containing ingredients or dosages that required prescriptions twenty years ago 
and the pace of switching is higher than ever. The two dynamics of generic drug 
growth and cost-control have resulted in the industry and government working 
together to speed up the introduction of switch drugs.
In Europe the trend has been similar, with large numbers of drugs switching to 
OTC status. Table 3.3 highlights the strong growth rates for the OTC and self- 
medication markets throughout Europe. A focus on non-prescription medicines 
in Europe has only recently emerged, and this is reflected in the nature of the 
data on the area. There is little consistency in what is included in the categories 
measured and there is a general lack of historical information. As illustrated in 
table 3.3, some countries subdivide the non-prescription market to account for 
the self-medication market, excluding products not used as a medicine, but now 
available without prescription. An examination of table 3.3 may lead one to 
conclude that the growth in OTCs as a percentage of the total pharmaceutical 
market is less than spectacular. For example, OTC market share in Ireland in
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1995 was 22 %  and in 1996, 21 .4% . However these percentages m ust be read in 
the light o f  an overall growth in the total pharm aceutical market, both 
prescription and non-prescription. In other words, a 2 1 .4 %  market share in  1996 
represented an increase o f  7%  in value terms on the 22 %  m arket share for 1995. 
Table 3.3 Non-prescription M edicines as a Percentage o f  Selected European
Pharmaceutical M arkets (Value)
Country; OTC/Self-Medication as a % of 
Total Pharmaceutical Market/ % Change
1994 1995 1996
Ireland
Total Non-Prescription Market 22.4% 22% 21.4%
Self-Medication Market 19.4% 20.9% 20.6%
% Change Vs Previous year +17.9% +6.99%
Belgium
Total Non-Prescription Market 22.7% 22.3% 21.2%
Self-Medication Market 18.2% 17.7% 17.2%
% Change Vs Previous year +5.4% +0.6%
Finland
Total Non-Prescription Market 18% 18% 17%
% Change Vs Previous year +2.4% +9.4% +0.8%
Hungary
Total Non-Prescription Market 10.9% 14.6% 15.5%
% Change Vs Previous year +68.6% +54.9% +31.2%
Norway
Total Non-Prescription Market 11.1% 11.4% 10.4%
% Change Vs Previous year +3.7% +16% +2.7%
Portugal
Total Non-Prescription Market 8.2% 10.2% 11.6%
% Change Vs Previous year +40.8% +25.7%
Spain
Total Non-Prescription Market 15% 15% 15.5%
Self-Medication Market 12% 12% 12.4%
% Change Vs Previous year +8.9% +8.1%
Sweden
Total Non-Prescription Market 11.2% 10.5% 9.3%
Self-Medication Market 9.2% 8.7% 7.8%
% Change Vs Previous year +9.3% +6.7% +6%
Source: IPHA, 1997.
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The process for switching drugs varies from country to country but essentially 
involves a subm ission by the manufacturer to the drug licensing authority (Food 
and Drug Administration (FD A ) in the U SA , M edicines Control A gency (M C A ) 
in the U K , and the Irish M edicines Board (IM B ) in Ireland) requesting the sw itch 
o f  a prescription drug to O TC  status. The typical requirements o f  the drug 
licensing authorities are contained in Table 3 .4  below. The decision rests with 
the authority who in turn stipulates conditions regarding dose sizes, labelling 
requirements, and advertising restrictions. Central to the sw itch process is the 
consum er’s ability to comprehend labelling and directions; the inclusion o f  a 
range o f  educational and support materials have becom e critical to consumer 
comprehension as a broader range o f  drugs are switched.
Table 3 .4  FD A  Guidelines for O TC  Submissions,
• Full knowledge o f  drug’s scientific base and pharm acology.
• L ack  o f  special toxicities.
• Large safety margin.
• E ffects o f  frequency o f  dosing on safety.
• Safety profile defined at high doses.
• M inim um  three years o f  prescription use.
• Adequate adverse reaction reporting.
• W orld-wide marketing experience.
• D ata from national prescription audit and national drug disease audit.
• Rigorous risk analysis.
• Literature review on safety and efficacy.
• Possible drug interactions.
3.6 The Switch Process
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The process o f  switching from  prescription only to O TC  status can be best 
viewed in the U S context. The U SA  has been at the forefront o f  the 
pharmaceutical industry for many years and the regulatory bodies have 
pioneered legislation for the move to O TC s for prescription drugs. Prescription 
drugs were first differentiated from  non-prescription drugs by the 1951 Durham- 
Humphrey Amendment to the Food, Drug, and Cosm etic A ct (1938), defining 
prescription drugs as those that are unsafe for use without professional 
supervision. Essentially all drugs were O TC  by default, and prescription drugs 
the exceptions. In  addition this amendment allowed the Food and Drug 
Adm inistration (FD A ) the authority to ‘sw itch’ a drug to O TC  status.
The FD A , from  1972, developed their OTC strategy in four m ajor steps:
1. The drive to switch drugs cam e from  the form ation o f  advisory review  boards 
who evaluated the safety and efficacy o f  potential sw itch drugs based on the 
product category rather than specific products or brands.
2. From  1976 to 1982 the FD A  switched 29  prescription ingredients, including 
metaproterenol, a drug for asthma sufferers, a switch driven by the FD A  
themselves. A s a result o f  criticism  from m edical professionals, its O TC status 
was revoked by the FD A . The cause o f  this criticism  by m edical professionals 
was as a result o f  the range o f  side effects experienced by users. Incorrect usage 
and com bining metaproterenol with other m edicines were the m ajor causes o f  
these side effects. Even so, one could summarise that the m edical professionals 
used this opportunity to keep the FD A  in check.
Source: Smith, 1983.
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3. The increase in switching was evident from  1982 to 1991, with a cum ulative 
total o f  40  ingredients receiving OTC status, accounting for m ore than 2 00  
individual products.
4. R ecognising what was termed the O TC revolution, the FD A  Com m issioner, 
David K essler set up the office o f  O TC  Drug Evaluations in 1994 to prepare for 
the rapid growth expected in both switches and direct to O TC  applications (Juhl, 
1997). Significantly the O TC  drugs Advisory Com m ittee, consisting o f  five to 
seven m embers, included consumers for the first time.
W hile it can be argued that the U SA  has developed a clearer policy  towards 
switch drugs, the situation in Europe is somewhat different. The A E S G P , the 
European body representing the interests o f  the consumer healthcare industry, 
surveyed all European national associations on their position in relation to 
switches, the regulatory environment, professional attitudes, and training in 
relation to O TC s (IPH A , 1997). Excluding France and Spain, European countries 
have few  regulations governing the switch to OTC status. Others have begun to 
classify  O TC s, issue guidelines, and develop regulations, but m ost switches 
happen through the ‘attitudes’ inherent in the countries regulatory bodies and are 
treated on a case by case basis. Generally the attitudes o f  doctors and 
pharmacists towards O TC s are favourable, unless they impinge on the earnings 
as a result o f  changes in reimbursement or where they are paid per patient visit. 
Training health professionals in O TC s is virtually non-existent, reflecting the 
peripheral nature o f  O TC s to the healthcare system.
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Ireland follow s this trend with no form al rules governing switches, outside o f  the 
usual efficacy and safety considerations. W hile pharm acists are receptive to 
O TC s, there is no training on O TC s currently but discussions are ongoing 
between the Irish Pharmaceutical Healthcare A ssociation (IPH A ) and the 
pharmacy bodies.
3.7 The History of Nicotine Replacement Therapy.
The principal treatment intervention available to those wishing to stop smoking 
is nicotine replacement therapy (N R T), developed in 1978. N R T  was initially 
available as N icorette nicotine gum, developed by A B  L eo , who was acquired by 
the Pharm acia Company in 1990. The emergence o f  N R T  on world-wide 
markets resulted from a distribution agreement with M arion M errell D ow  and 
Ciba-G eigy. The original concept was developed in response to a request from 
the Swedish R oyal Navy, who banned smoking amongst submarine crews. The 
navy wished to find a solution to the withdrawal effects experienced by their 
sailors. Previously smoking cessation methods relied on psychosocial 
approaches, with little attention to the physical addiction to nicotine.
The nicotine replacement therapy concept is based on tackling the physical 
addiction by continuing to supply the body with nicotine, at a lower dosage, to 
prevent withdrawal symptoms thus allowing the individual to break the habit o f  
smoking. Typically N R T  is designed as a twelve week/ three month programme, 
with a gradual reduction o f  nicotine until it is stopped. W hile essentially 
providing the same level o f  nicotine replacement, the nicotine gum and patch
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differ significantly; the gum allows the individual to get the nicotine whenever 
they feel the need. This is achieved by chewing a piece o f  gum and resting it 
betw een the cheek and gum, where the nicotine is absorbed. In  contrast, the 
patch delivers a regular supply o f  nicotine, the body absorbing the nicotine into 
the bloodstream  where the patch is worn, usually on the shoulder. Patch 
programmes are now available for daytime wear only, to counteract difficulties 
experienced by some users who suffered sleep disturbance as a result o f  a 
consistent delivery o f  nicotine, twenty-four hours a day.
Although clearly effective, there has been resistance from  m edical professionals 
aimed at the contradiction o f  using nicotine to com bat nicotine addiction and at 
the unregulated availability o f  N R T  through its O TC status. M edical 
am bivalence towards N R T  has been further compounded by developments in the 
tobacco industry. This industry is also regulated by the FD A  but in a manner less 
severe that for the pharmaceutical industry. Tobacco com panies are presently 
developing a range o f  less harmful product concepts them selves designed to 
assuage sm oker’s health concerns.
M edical am bivalence is however waning. The argument that nicotine addiction 
requires a nicotine-based remedy is gaining currency among the profession. 
However, for some doctors this support is an unwelcome reminder o f  their now 
discredited support for filtered and low  tar cigarettes in the 1 9 6 0 ’s. The prospect 
o f  N R T  manufacturers and the tobacco industry acting in concert to address the 
need o f  the same smoker segment to m inim ise the harmful effects o f  smoking 
seems quite ironic. This is heightened when one realises that the tobacco
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manufacturers can introduce a new brand to the m arket without impediment from 
the FD A , while an N R T  manufacturer can face a number o f  years o f  regulatory 
obstacles and immense cost in introducing a new flavour N R T  gum, through the 
same regulatory body (W arner, Slade, and Sweanor, 1997). The A M A  are 
presently seeking to correct this regulatory inequality betw een N R T  and tobacco 
manufacturers and are arguing for more widespread availability o f  the form er 
claim ing that ‘product availability and use will be defined by consum er demand’ 
(W arner et. al., 1997 p. 1090).
The biggest implication o f  the switch to OTC status is the transition from  drug to 
brand. This is best described by Christer Wernrud, a director o f  Pharm acia 
N icorette as follow s; ‘W e have to stop talking about our patients and start talking 
about our customers instead. After all our customers are no longer the doctors 
and the chem ists but primarily the people who use our products’ (Urde, 1994, p. 
25). This shift in focus resulted from  three factors; the expiration o f  the patent on 
N icorette in the early 19 9 0 ’s, the introduction o f  com petition from  other branded 
nicotine patches, and the opportunities afforded by the relaxation o f  marketing 
restrictions to develop branded products.
The period up to the nineties was concerned with creating a long-term  demand 
for N R T , rather than for a particular brand. Subsequently the focus was on 
creating a brand position for Nicorette. Pharm acia realised that positioning rested 
on the consum er’s perception o f  the product, not their own view. This shift to the 
consumer entailed the adoption o f  a less aggressive and more sympathetic
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com m unication generally, ignoring the temptation to lecture on the health 
hazards o f  smoking (Urde, 1994).
The positioning developed rested on the proposition: ‘Helps you through the 
hard tim es’, evolving to the current: ‘En joy life without cigarettes’ . This 
consumer rather than health professional orientation im pacts not only on 
marketing com m unication but has also permeated through all facets o f  
Pharm acia, including product development and clin ical trials to ensure that all 
work is in line with the brand vision.
There are a range o f  brands w hich are active in the N R T  market, many o f  them 
sold by different companies in differing markets. F or exam ple, Pharm acia &  
Upjohn distribute N icorette in Ireland, while Sm ithK line Beecham  hold the 
rights in the U SA  and the U K . K ey  brands in Ireland are N icorette and N icotinil 
(gum), and N icotinell and N iconil, and recently introduced N icorette (patches). 
The introduction o f  N R T  was in 1982, in the U SA , available on prescription 
only. The introduction o f  nicotine patches follow ed in 1991. A  more recent 
development was the introduction o f  the nicotine nasal spray, in  1995.
The U S m arket is o f  particular interest for two reasons. First, while the m arket is 
primarily restricted to prescription status, direct advertising to consumers is 
permitted, even though this advertising has not m et with Am erican M edical 
A ssociation approval. This advertising campaign paid a handsome dividend and 
patches saw an explosion in sales in early 1992 (see Table 3 .5 , below). Second, 
the market suffered a downturn in sales from 1992 (Sloan, 1992) as a result o f  
three factors:
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1) The two principal companies experienced supply shortages.
2 ) The FD A  expressed concern at the rate o f  heart attacks among those who 
continued to smoke while wearing the patch (W arner, 1992).
3) The anticipated drop in  sales during the summer resulted in a drop in  
advertising expenditure and decreased distribution and availability. However the 
drop in sales demand did not occur so that many potential quitters were unable to 
acquire the N R T  they needed and in the product waned. Subsequent efforts to 
revive the market failed.
W ith the success o f  nicotine gum as an O TC  in m any other countries, 
Sm ithK line Beecham , who took over the marketing o f  N icorette, approached the 
FD A  in D ecem ber 1994 with a view  to switching N icorette to O TC status. This 
was granted on April 19th, 1996 and was follow ed by a  huge increase in 
marketing spend o f  U S $50  m illion, with the intention o f  realising U S $3 3 0  
m illion in sales (M ehegan, 1996). Subsequently, N icoderm  and N icotrol, both 
patches, were switched to O TC status in the U S fuelling even further advertising 
expenditure.
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Table 3.5 US Smoking Cessation M arket & M edia Expenditure.
Y ear Sales U S $ M illion %  Change M edia Expenditure 
U S $ M illion
1989 79.5 - -
1990 81.5 2 .0% -
1991 123.5 51 .5% -
1992 670 531 .5% 86.7
1993 350 (47 .8% ) 371.1
1994 (e) 200 (42 .8% ) 3.4
Source; K line &  Company, 1994.
3.8 Clinical Support and the Benefits of NRT.
The results o f  clin ical trials have been used to support the launch o f  various 
versions o f  N R T  (see table 3.3 above). Support has also com e from  a growing 
body o f  literature. For example, the nicotine patch has been found to be m ore 
effective for smokers with moderate rather than heavy nicotine dependence, and 
for younger smokers (Yudkin, Jones, Lancaster, and Fow ler, 1996). These 
findings are further developed by a study o f  the characteristics o f  nicotine patch 
users in the U SA . A  survey o f  those refilling prescriptions for the patch showed 
the influence o f  media campaigns with 36 percent learning about the patch in 
this manner, 32 percent from  fam ily and friends and 25 percent from  doctors. 
Over h a lf tested with the FTQ  were not heavily dependent smokers. M ost o f  the 
respondents (87 percent) had requested the patch them selves, with only nine 
percent asked by their doctor to do so (Haxby, Sinclair, E iff, M cQueen, and 
Toffler, 1994). These findings would seem to support the switch away from
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prescription by doctors to O TC  status. However a note o f  caution has been 
sounded by F iscella  and Franks (1996) who, arguing on a purely cost effective 
basis, maintain that the costs o f  prescription and m edical advice are more than 
compensated for by the higher cessation outcom es they produce. In  this light 
they feel that these prescription and m edical costs should be covered by health 
insurance, whether state or private. Unfortunately for them, these views have 
been overtaken by events.
N icotine gum has been found to tackle many o f  the psychological needs satisfied 
by smoking such as stress modulation, feelings o f  arousal/pleasure, and 
hand/mouth activity (Parrott, and Craig, 1995). A  m ajor concern when quitting 
smoking is gaining weight, often as a result o f  the absence o f  nicotine and the 
subsequent increase in appetite; nicotine gum has been demonstrated to suppress 
weight gain in fem ale users (Leischow  et al., 1992).
The R x  versus O TC  debate has been conducted in other fora besides the m edical 
world. For exam ple, regulatory bodies in many countries have supported the 
introduction o f  N R T , as an OTC, on the basis o f  its proven efficacy  record. In 
the U S it was predicted that, given the current rate o f  smoking, the sw itch to 
OTC status would result in 45 0 ,0 0 0  additional smokers quitting (Oster, D elea, 
Huse, Regan, and Colditz, 1996). Indeed the elimination o f  many o f  the adverse 
side-effects o f  nicotine patches through education and product refinem ent has 
lent further support to the switch campaign.
70
The core benefit o f  nicotine replacement therapy is the actual delivery o f  lower 
levels o f  nicotine to tackle the craving; there is little or no pharm acological 
difference betw een brands. However all the brands available provide a varied 
range o f  support material to aid cessation attempts. In-pack leaflets, audio and 
video cassettes, free-phone help-lines, and the provision o f  practical guides to 
stop or avoid smoking are used. Also heavy advertising on T V  and the national 
press is utilised, focusing on the key quitting tim es o f  N ew  Year, Lent, and 
National No Sm oking Day.
Since nicotine gum secured OTC status in 1993, prom otion with and within 
pharmacies has increased. Point-of-sale material and leaflets are prom inently 
displayed alongside packs and the Pharmaceutical Society  o f  Ireland has begun 
conducting training courses on smoking cessation for pharmacists. This is in 
addition to N R T  manufacturers providing training courses for pharm acists and 
pharmacy assistants on how to counsel customers on the use o f  N RT.
Sm oking behaviour in Ireland has been tracked annually by Irish M arketing 
Surveys, on b eh alf o f  Pharmacia &  Upjohn the distributors o f  N icorette. This 
longitudinal study measures the numbers smoking, attitudes held towards 
smoking and motivations behind quitting among a representative sample o f  
adults aged 15 and over. Latest results show 30 percent o f  the population smoke 
(i.e. 800 ,000  people), with 17 percent smoking more than 15 a day, and 13 
percent smoking less than 15 per day.
3.9 NRT as an OTC and Smoking Cessation in Ireland.
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In  total 21 percent o f  the population have quit smoking com pletely. The key 
issues mentioned as reasons for smokers giving up were 1) to improve health 
(79%  o f  all smokers), 2) to save m oney (50% ), 3) for my
family/partner/children’s health (22% ), and 4 ) for social reasons (19% ). 
However the numbers o f  current smokers who have tried to quit in recent tim e is 
diminishing. Table 3 .6  illustrates the steady increase in  the number o f  smokers 
not attempting to quit. O f  those smoking in 1993, 48 %  had not tried to quit in the 
previous four years; three years later, in 1996, this figure had risen to 54% . K ey 
reasons given by smokers as obstacles to giving up were 1) the craving for a 
cigarette (2 6 %  o f  all smokers), 2) addiction (19% ), 3) irritable/cranky (17% ), 
and 4) can ’t operate properly without cigarettes (14% ).
W hen pushed for detail regarding the likely tim e frame within w hich smokers 
would consider quitting, 11 percent suggested quitting in the next three months, 
a further 11 percent in the next six months, 15 percent within the next year, and 
six percent within two years. O f those actually intending to quit, 37  percent 
hoped to do so in six months, but a corresponding number saw the tim e frame 
extending up to two years or longer, again supporting the view  that there is a 
core group o f  heavy smokers resisting any persuasion to quit in the short tim e.
Table 3.6. Attempts to Give Up Sm oking - Past Four Years.
Attempts to stop 1993 1994 1995 1996
Have not tried to stop 48% 48% 50% 54%
Tried once 17% 20% 15% 16%
Tried twice 13% 15% 16% 14%
Tried three or more times 22% 17% 19% 16%
Source: Irish M arketing Surveys, 1996.
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It is estimated by industry sources3 that 14 percent o f  the smoking population 
would have used or would consider using N R T  to quit smoking. The m ajority o f  
these aged 30 plus in  the A, B , C l social categories. The profile m ay be due to 
the relatively high cost o f using N R T. This represents a potential m arket o f 
1 12 ,000  users. W hile it is difficult to ascertain the impact o f  the O TC  status o f 
nicotine gum and patches on the pattern o f  smoking cessation, indications are 
that sales o f  N R T  are rising.
Clearly O TC s are becom ing increasingly important in  the context o f  health care 
yet little research has been conducted on this area. Given the existence o f  many 
heavy smokers resisting attempts to quit, it is vital to increase our understanding 
o f  the role N R T , as an O TC , can play in smoking cessation. The follow ing 
chapter details a methodology designed to uncover the meanings consumers hold 
in relation to their use o f  N R T, as an OTC.
3 Corroborated figures from two senior industry sources.
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Chapter Four.
Research Methodology.
4.1 Introduction
The use o f  N R T  as an O TC  has been demonstrated to belong to the consum ers’ 
domain, rather than to the domain o f  the health care system. A lso, the decision to 
stop smoking appears to be very individualistic in  nature. Therefore the 
methodology chosen for the study must reflect these two issues, placing the 
individual at the centre o f  any inquiry.
This chapter details the approach to, and use o f  existential-phenom enology as a 
paradigm and methodology to uncover consum ers’ experience when using N R T. 
Existential-phenom enology is presented in the wider context o f  interpretive 
approaches to seeking knowledge and proposed as the m ost suitable for this 
study. The chapter incorporates two main elements. First, the discussion 
incorporates many philosophical issues central to understanding existential- 
phenomenology. Such philosophical issues underpin the paradigm and also 
closely relate to the hermeneutical techniques used to analyse respondents’ 
experiences. The philosophical issues regarding hermeneutics are dealt with in a 
later section.
Second, at the m ethodological level, the precise nature o f  the phenom enological 
interview is discussed, incorporating the requirements o f  correct interviewing 
techniques from  the wider qualitative literature. The generation o f  the data and
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its analysis to uncover themes with the aid o f  both hermeneutics and the 
interpretive group is described. Finally, the source o f  the respondents and the 
method o f  recording the respondents’ experiences are listed, as are the criteria 
used to evaluate the chosen methodology.
Central to any methodology is the underlying paradigm; ‘the set o f  beliefs that 
lead to ways o f  approaching inquiry’ (Erlandson, Harris, Skipper, and A llen, 
1993, p, ix). A  paradigm incorporates axiological, ontological, and 
epistem ological assumptions about the nature o f  reality and inquiry, and the 
knowledge generated. M uch time and effort has been expended by consumer 
researchers demarcating or defending interpretive methods against the traditional 
positivistic standpoint. Any paradigm, while benefiting from  the scrutiny and 
criticism  o f others, must stand alone, and therefore it is not necessary to review 
such literature here. However a b rie f outline o f the interpretivist approach 
follow s more to contextualise the chosen methodology, demonstrating its 
suitability for this research, than to position it as being superior to any other 
paradigm (Hudson and Ozanne, 1988).
The choice o f  a paradigm is principally concerned with the researcher’s 
worldview as outlined above. However it is important in  choosing a paradigm to 
reflect on two other points; the nature o f  the problem and the audience the 
research is aimed at (Creswell, 1994). W hat is evident from  the previous review 
o f  the literature on health behaviour is a lack o f  focus on the consumer as the 
central point o f  their own health care and on the meanings that consumers hold 
in relation to their preventive health behaviour. Given the fundamental
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importance o f  health in our lives, it is ironic that the scientific, technological 
imperative (Fuchs, 1968) has persisted for so long in health research. This m ay 
not be surprising given the traditional provider-patient relationships that persist 
but the current emergence o f  self-care and a more autonomous consumer 
highlights the need for research to adopt a greater consumer orientation.
4.2 The Interpretivist Approach To Consumer Research.
In  this study, the terms interpretive or interpretivist refer to those paradigms at 
the opposite end o f  the spectrum to the traditional positivistic paradigm. As 
interpretive approaches require a fundamental shift in  thinking for m ost 
researchers, it is important to highlight a number o f  issues in  relation to the 
adoption o f  such an interpretive approach.
1. First, m ost commentators see an interpretive approach as being 
‘incom mensurable with the conventional [positivistic] inquiry’ (Erlandson et al., 
1993, p. x). Elizabeth Hirschman, supports this view  with an analogy o f  the 
futility o f  merging Buddhism with M ohammedansim based on the divergence in 
their fundamental beliefs (Hirschman, 1986). W hile this lack o f  ‘ fit ’ betw een the 
two is generally supported, some commentators wrongly pursue this argument to 
the level o f  methodologies employed. For example, Cresw ell (1 9 9 4 ) goes as far 
as designating quantitative and qualitative m ethodologies as belonging to 
separate paradigms. He equates quantitative methodologies with traditional, 
positivist, experimental, or em piricist studies and qualitative m ethodologies with 
constructivist, naturalistic, interpretive, postpositivist, or postmodern studies.
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It is important to note that the category o f  interpretive research incorporates 
m any distinct paradigms, often grouped together under the interpretive banner, 
or loosely placed alongside each other (see Sherry, Jr., 1991; Hunt, 1989). Peter 
and O lson (1989), in  their criticism  o f  Calder and Tybout’s 1987 article ‘W hat 
Consumer Research is ’ , go as far as separating quantitative, qualitative, and 
interpretive approaches as distinct methods, again m ixing paradigms with 
m ethodologies incorrectly.
F or this study, interpretive research incorporates naturalistic and hum anistic 
inquiry, phenomenology, hermeneutics, sem iotics, and literary criticism  (M urray 
and Ozanne, 1991), and each can be viewed as a distinct way o f  seeking 
knowledge. However, as demonstrated later, the use o f  a paradigm can result in 
using a com bination o f  various elements o f  different m ethodologies. Interpretive 
research is no exception in this regard. On a further point, it would appear that 
m any studies purporting to espouse one paradigm in fact incorporate facets o f  
other paradigms. The reality is that not every study stands up to the ideals o f  
paradigmatic purity, often com bining different facets o f  other paradigms 
(Cresw ell, 1994).
This fluidity over what precisely constitutes a  paradigm, what constitutes a 
m ethodology and what m ethodologies properly belong to what paradigm calls 
for some clarification.
For the purpose o f  this study;
a) The term  interpretive research incorporates a number o f  individual 
paradigms, as outlined above, which share some broad axiological and
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epistem ological assumptions. However, these individual paradigms differ on 
some finer epistem ological assumptions and the role o f  the researcher in  the 
generation o f  knowledge,
b) Existential-phenom enology is viewed as one paradigm under the broader 
interpretive banner. Its application in consumer research, principally by Craig 
Thompson, has been described as com bining the philosophy o f  existentialism  
with the m ethodology o f  phenomenology. W hile the particular aspects o f 
existential-phenom enology w ill be dealt with in the next section, it must be 
viewed in the wider context o f  one o f  the interpretive approaches available.
2. The second consideration when adopting an interpretive approach is that 
grasping the rationale for interpretive inquiry can be difficult given the ingrained 
positivistic thinking that m ost possess as a result o f  the dom inance o f  positivistic 
approaches in university teaching. Understanding an interpretive approach 
requires a substantial shift in thinking, best articulated by Erlandson et al. (1993 .
pp. 1):
M ost researchers treat their work as a routine exercise, follow ing very 
specific rules and denying m uch o f  the human capacity for flexible 
thinking, the extension o f which, we believe, is the basis for scientific 
advance and the m ost satisfying aspect o f  research.
3. The third and final consideration is that interpretive inquiry differs principally 
on the inclusion o f  the researcher as instrument and the concurrent nature o f  data 
collection and analysis; this impacts on methodology, which m ust be viewed as a 
process rather than a series o f  discrete steps.
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It has been noted that many o f  the details o f  interpretive paradigms rem ain 
hidden, often due to editorial requirements o f  journals, and as such are viewed as 
underdeveloped in contrast with the traditional positivist paradigms. However 
some authors, m ost notably Craig J. Thompson, have elaborated on the process 
o f  conducting phenom enological research, greatly facilitating researchers who 
wish to utilise these methods to their fullest extent. Such authors have 
demystified interpretive paradigms by addressing the core assumptions openly. 
The essence o f  Interpretivism is one o f  perspective; any researcher must look at 
the issue from the perspective o f  the consumers being researched (Ozanne and 
Hudson, 1989) with a view to enhancing understanding, rather than aiding 
prediction. W hile apparently sim plistic, this perspective is the very cornerstone 
o f  consumer research. An interpretive approach stresses the difference betw een 
the humanities and the natural sciences in its quest for understanding rather than 
explanation or prediction (Holbrook and O ’Shaughnessy, 1988).
These differences can be illustrated under three main headings. First, the 
physical and chem ical sciences enhance their knowledge through the continued 
separation and division o f  their subject matter into precise, discrete elements. 
Understanding each elem ent as a separate unit can help the scientist explain and 
predict the total subject. In contrast, in the humanities, knowledge can only be 
found when the subject matter is viewed in a holistic manner. Any division or 
separation o f  the subject matter loses the contextual aspects.
Second, in the physical and chem ical sciences there is understood to be a 
universal, objective, decidable truth which can be isolated, whereas for
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interpretivists there is 110 universal truth to be found in the humanities. In fact, 
there are a m ultiplicity o f  truths. As there is no single objective truth or reality 
‘out there’ to be found, this truth or reality is dependent on context, and exists 
rooted in the individual’s view o f  the world.
Third, the knowledge that is generated in the humanities is co-constituted, based 
03i the interaction between researcher and consumer. As consumer researchers, 
we generate understanding based on the contextual reality o f  the consum er in an 
interactive way; we are part o f  the generation o f  this understanding, not separate 
from or above it. Table 4.1 summarises the interpretivist approach and contrasts 
it with the traditional positivist approach.
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Table 4.1 A  Summary o f  the Positivist and Interpretivist Approaches.
Basic Assumptions. Interpretivist. Positivist. p t S Q t j W
Axiological - overriding 
goal.
Understanding. Explanation via subsumption 
under general laws, 
prediction.
Ontological - nature of 
reality.
Socially constructed, 
multiple, holistic, contextual.
Objective, tangible, single, 
fragmentable, divisible.
Ontological - nature o f social 
beings.
Voluntaristic, proactive. Deterministic, reactive.
Epistemological - knowledge 
generated.
Idiographic, time-bound, 
context dependent.
Nomothetic, time-free, 
context independent.
Epistemological - view of 
causality.
Multiple, simultaneous 
shaping.
Real causes exist.
Epistemological - research 
relationship
Interactive, co-operative, no 
privileged point o f  
observation.
Dualism, separation, 
privileged point of 
observation.
Source: Ozanne and Hudson, 1989, pp. 3.
Interpretation can be defined as ‘the critical analysis o f  a text for the purpose o f  
determining its single or multiple m eaning(s)’ (H olbrook and O ’Shaughnessy, 
1988, pp. 400). W e live our lives within a social system embedded with shared 
sym bols, signs, and language that create meaning and identity for each o f  us. As 
highlighted by Holbrook and O ’ Shaughnessy, what we strive to gain as 
knowledge are ‘facts-only-as-interpreted, that is data as socially, linguistically, 
or personally constructed’ (Holbrook and O ’ Shaughnessy, 1988). This means 
that what can be gained as knowledge com es from the context we live in; 
whether that is the research culture or the view  we have o f  the world. It is not 
possible to approach data in some context-free way.
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Existential-phenom enology draws from the philosophy o f  existentialism  and the 
m ethodology o f  phenomenology, incorporating hermeneutical analysis to gain a 
first-person description o f  experience in relation to a chosen phenom enon 
(Thom pson, Locander, and Pollio, 1989). Clearly this incorporates a wide scope 
o f  philosophical issues and m ethodological details and each w ill be exam ined 
separately, with a detailed explanation o f  the role o f  hermeneutics. The first 
objective is to ‘p lace’ existential-phenom enology in the context o f  the range o f  
interpretive approaches often utilised by consumer researchers.
A  particularly useful map can be seen in Table 4 .2 , where the range o f  
philosophical positions on the origins o f  knowledge available to consum er 
researchers is positioned according to the degree o f  reliance on either m ental or 
material determinism. One’ s position on this epistem ological question is 
contingent upon one’s ontological position on the nature o f  reality.
This table places both phenomenology and existentialism  in the category o f  
subjectivism , recognising that how we understand the world and the knowledge 
we have resides within the individual. W hile not exclusively determined by 
mental or cognitive structures, subjectivism  is primarily concerned with the role 
that mental or cognitive structures rather than social or cultural forces play in 
how an individual understands the world; essentially a subjective view. These 
mental structures, such as our perceptions o f  our experience and the view s and 
attitudes we form  as a result, are seen as the source o f  knowledge on a particular 
research question. W hile a number o f  individuals can have the same experiences,
4.3 Existential-Phenomenology as a Paradigm and Methodology.
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it is how we understand them mentally, and how we recount or describe these, 
that differ with each individual. For example, in this study o f  smoking cessation, 
two respondents could have the same superficial experience o f  using N R T . B oth  
respondents could use N R T  in  an identical manner and achieve the same result. 
However, it is the experience as they understand it them selves, demonstrated by 
describing their experience during an interview, w hich w ill differ. One 
respondent may relay their experience o f  using N R T  as a m edicinal therapy that 
helped them  quit smoking; another may describe their experience o f  using N R T  
as a substitute for cigarettes; the reality o f  N R T  is individually constructed 
through their respective experiences.
Table 4 .2  A  Continuum o f  Philosophical Positions on the Origin o f  Know ledge
Philosophy View o f Reality D eterm inism
Empiricism (Common- 
sense/Logical Empiricism)
Physical Construction o f  
Reality (PCR)
M aterial Determ inism .
t
Socio-economic 
Constructionism (Marxism)
Social Construction o f Reality 
(SCR)
Interpretivism (Hermeneutics, 
Semiotics, Structural Criticism)
Linguistic Construction o f  
Reality (LCR)
Subjectivism (Phenomenology, 
Existentialism)
Individual Construction o f  
Reality (ICR)
Rationalism (Ideals, Innate 
ideas)
Mental Construction of  
Reality (MCR)
4
M ental Determ inism
Source: Adopted from  Hirschman and Holbrook, 1992.
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Such a position on the understanding o f where knowledge resides contrasts w ith 
the empirical position, which takes the view that there is a single, decidable 
reality to be sought. A t the other end o f the scale is rationalism, which posits that 
we understand the world based only on our pre-existing mental categories, which 
are then used to understand our experience.
Phenomenology began as a movement in  contemporary philosophy, originally 
termed descriptive psychology and was developed by Edmund Husserl. The 
central aim o f phenomenology was to enhance empirical scientific study through 
viewing the core characteristics o f any subject matter fo r study and target these 
characteristics through a correctly focused methodology (Churchill and Wertz, 
1985). W hile this appears somewhat self-evident and positivistic in  intent, 
phenomenologists argued that human beings were a different kind o f object from 
physical and animal nature and needed an approach that would reflect this.
D ilthey summarised this position as; ‘we explain nature; we understand
psychological life ’ (D ilthey, in  Churchill and Wertz, 1985).
Phenomenology attempts to understand how individuals interact w ith  objects in 
their environment and the knowledge structures that are created as a result o f this 
interaction. The philosophical basis fo r this view came from  the be lie f that the 
only real source o f knowledge, for an individual or a researcher, was self- 
knowledge. The only true source o f knowledge was what we could acknowledge 
ourselves in  our own mind; knowledge that we could be certain of. Therefore 
Husserl put forward the notion o f ‘ certainty o f consciousness’ . W hile this
reflects that the source o f knowledge resides in  an individual’s mind,
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phenomenology believed that knowledge was a result o f the interaction between 
our m ind and our experiences. For example, what we understand to be a 
particular tree is made up o f our mental understanding (based on memory, 
image, and meaning to date) as to what a tree is and what we actually experience 
in reality, the outward appearance. In the case o f this study o f smoking cessation, 
the knowledge that w ill be generated is based on the description o f the 
respondents’ experiences o f using NRT. Each description w ill reflect how the 
experience o f the respondent is shaped by the way they view  the world and how 
the experience in turn shapes this view.
One further point on the phenomenological view o f knowledge is significant. 
Husserl believed that the way in which an individual understood the world could 
be reduced to an essential invariant structure; an ‘essence’ . I t  was through the 
rigorous phenomenological analysis or phenomenological reduction that we 
could isolate the central underlying meaning o f an experience. The detachment 
that was possible from  using such methodological rigour meant that the 
researcher could determine a single, fixed meaning o f an experience. 
Existentialism as developed by Heidegger, while an extension o f 
phenomenology, w ith  an understanding that the source o f knowledge was 
essentially the same, differed on its belie f regarding the nature o f the knowledge 
generated. Phenomenologists believed experience could be reduced to the 
essence or essential meaning; understanding could be distilled through the 
process o f interpretation. Heidegger rejected this idea that a privileged essence 
could be found or isolated. He described knowledge as being situated in our
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everyday life ; the Dasein ( ‘being there’). As a result our knowledge or how we 
understand the world was viewed as ever changing. In  the same vein, what we 
could interpret from the experience o f an individual was not fixed or invariant, 
but dependent on our own changing knowledge. The researcher changes through 
the experience o f researching a phenomenon. Such a highly individualistic, ever- 
changing view o f knowledge may appear impractical and too open-ended for a 
researcher to grasp but this is clearly rejected by MacQuarrie (1972, p. 78):
The fact that man is unfinished ... does not mean that a description is 
impossible ... [or] that we are confronted w ith a formless and 
indescribable m ultip lic ity, fo r there are lim its or horizons w ith in  which 
a ll these unique existents fa ll, and there are structures that can be 
discerned in a ll o f them.
This point is crucial to understanding the practical issues o f such a position on 
knowledge for research. W hile knowledge, and experience, is viewed as being 
individualistic, these individual constructions o f reality can be grouped or 
clustered together to create themes o f meaning common to a ll those respondents 
in  a research study.
The basis for this study revolves around Craig Thompson’s use o f existential- 
phenomenology in the area o f consumer research. Thompson and others have 
argued that consumer experience has been largely ignored in  the more 
behavioural/cognitive orientation o f much research and that most methodologies 
do not facilitate the exploration o f experience (Thompson, Locander, and Pollio, 
1994; Thompson, et al., 1990). In  contrast, existential-phenomenology does
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provide a way to explore consumer experience through first-person description 
o f lived experience. To explain how the individual’s experience is embedded in a 
context or pattern, the core assumption o f existential-phenomenology, Thompson 
uses three analogies o f Gestalt psychology. These are the Pattern Analogy, the 
Figure/Ground Analogy, and the Seeing Analogy.
The pattern refers to the view that the individual and their environment form  a 
totality, rather than being separate. This contextualist view  examines experience 
as it  occurs in a context; essentially as it is lived, described as human-being-in- 
the-world (Thompson et al., 1989), the life-w orld, or Lebenswelt. It is not 
possible to view experience in an objective, detached way removed from  any 
context. The meaning o f an experience is always situated in  the current 
experiential context and is coherently related to the ongoing project o f the life - 
world (Sartre, in  Thompson et al., 1989). This means that the experience reflects 
how the individual sees themselves, not merely retelling a story o f an experience. 
The figure/ground metaphor reflects the interplay between individuals and their 
environment. Each w ill affect the experience, allow ing fo r d iffering experiences 
in  different situations. Neither can be separated, or viewed as causing each other; 
they are co-constituting. The experience is not located inside the person, as a 
subjective reality, nor located outside, as a subject-free objectivity.
The seeing metaphor differentiates human experience as both reflected and 
unreflected. Many o f our actions, and therefore experiences, are unreflected; we 
make decisions w ithout pausing to detach ourselves and reflect on our actions. 
Existential-phenomenology recognises that our unreflected actions can, through
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the process o f the phenomenological interview, yield meanings or patterns that 
emerge on reflection. This lin k  between reflected and unreflected experience can 
be compared to the figure/ground metaphor, w ith  unreflected experience, the 
‘ground’ , emerging into prominence through the interview to become ‘figure’ .
A  summary o f the existential-phenomenological approach is given in  Table 4.3 
below, and is compared to Cartesianism or Rationalist philosophy, viewed as a 
broader set o f assumptions that underlies the positivist approach (Thompson et 
a l„ 1989).
Table 4.3 Two Approaches to Consumer Research
Tenets o f  paradigm Existential-phenomenology. Cartesianism.
World view Contextual Mechanistic
Nature-of-being In-the-world Dualistic
Research focus Experience Theoretical structure
Research perspective First-person Third-person
Research logic Apodictic Predictive
Research strategy Holistic Componential
Research goal Thematic description Causal Reductionism
Source: Thompson et al., 1989, pp. 137.
In  summary, the tenets o f existential-phenomenology clearly f it  w ith the broad 
axiological, ontological, and epistemological assumptions o f interpretivist 
inquiry as outlined above but can be differentiated by their focus on the 
individual and the role that experience plays in  generating knowledge. 
Existential-phenomenology principally, although not exclusively, utilises the 
phenomenological interview to gain the first-person description o f the 
experience. Such a phenomenological interview goes beyond the typical in-depth 
interview used in  qualitative research. W hile a phenomenological interview
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adopts a sim ilar open-ended, loose approach to ‘data generation’ as an in-depth 
interview, the phenomenological interview aims to uncover what an experience 
means to a respondent, rather than attempt to predict or explain the experience. 
As a result, the nature o f questioning is different. The role o f the researcher is to 
provide a context for the respondent to describe their experience. In  addition, the 
principle is avoid asking ‘w hy’ questions to prevent a respondent rationalising 
their actions rather than describing their experience.
4.4 Evaluative Criteria for Existential-Phenomenology.
A  key question for any researcher, in  addition to gaining an understanding o f a 
phenomenon, is assessing whether the study is accurate, right, or conducted to a 
reasonable standard. W hile clearly an emerging and complex question (Lincoln, 
1995), there has been a range o f possible criteria put forward as evaluative 
standards for qualitative research. Some o f these criteria fo r qualitative research 
utilise traditional positivistic terminology. I t  must be noted that there is some 
division amongst commentators regarding the use o f such quantitative or 
positivistic terminology for qualitative research. Some argue that using 
quantitative terms suggests that a ll research is essentially positivistic whatever it  
may claim for itse lf (LeCompte and Goetz, 1982). Others, notably Thompson, 
have confidently adapted such traditional terms to interpretive methods w ithout 
conceding that their subject matter is compromised in any fashion.
S till others have taken this debate further, arguing in  a postmodern vein, that 
such conventional terms as ‘va lid ity ’ and ‘re liab ility ’ are unsuitable and out o f
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hand, not so much because o f their positivistic connotation but because their 
rig id, two dimensional character renders them inherently unsuitable fo r gauging 
the quality o f multi-faceted consumer research. For example, Richardson’s 
(1994) metaphor o f the crystal makes this point to considerable effect (p. 522); 
What we see depends on our angle o f repose ... Crystallisation, w ithout 
losing structure, deconstructs the traditional idea o f “ va lid ity” ; and 
crystallisation provides us w ith  a deepened, complex, thoroughly partial 
understanding o f the topic. Paradoxically, we know more and doubt what 
we know.
Lincoln and Guba (1985) have reconceptualised positivistic researchers’ four key 
criteria - internal and external valid ity, re liab ility, and objectivity. These terms 
have been used as a broad template in  the development o f evaluative criteria fo r 
interpretive research and are now termed credibility, transferability, 
dependability, and confirm ability. W hile these have been specifically applied to 
humanistic inquiry (Hirschman, 1986, Erlandson et al., 1993), it  can be argued 
that, in  fact, they represent evaluative criteria for a ll interpretive research. 
Naturalistic researchers, like existential-phenomenological researchers, do not 
aim to remove themselves from  the process o f inquiry but aim to show that the 
data ‘can be tracked to their sources, and that the logic used to assemble the 
interpretations into structurally coherent and corroborating wholes is both 
explicit and im p lic it’ (Guba and Lincoln, 1989, pp. 243).
In the particular case o f existential-phenomenology, Thompson has argued that 
many o f the concerns o f existential-phenomenologists concerning their methods
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are shared in  common w ith  positivistic researchers concerning their methods. He 
concludes that the broad evaluative criteria fo r positivism  can be seen as 
‘reasonable standards fo r Existential-phenomenological research’ (Thompson et 
al., 1989, p. 142). That is, the research should be free o f personal bias; others 
should be able to agree that the conclusions are justified  by the data and are 
empirically based, and that criteria are provided to evaluate competing 
interpretations.
In  summary, while there is some contention over the use o f evaluative criteria, it 
is apparent that such criteria help increase the rigour o f a chosen method and 
should be assessed w ith in  rather than across different paradigms and 
methodologies. The particular evaluative criteria o f credibility, transferability, 
dependability, and confirm ability and techniques used to meet these criteria w ill 
be discussed in  relation to the present study at the conclusion o f this chapter.
4.5 The Phenomenological Interview
This section outlines the format, methods, and approaches adopted for the 
phenomenological interview, and incorporates guidelines for effective 
interviewing drawn from the wider literature on qualitative interviewing. 
Specifically it  addresses the areas to be ‘covered’ fo r this study.
Two points need to be highlighted at this stage. W hile this section deals w ith  
data collection and the fo llow ing section focuses on data analysis, each must be 
viewed as happening concurrently. As a result, neither one occurs in  isolation 
and the actual design o f the study is emergent. Lincoln and Guba (1985, pp. 226)
91
demonstrate this point in  their definition o f naturalistic design. It  ‘means 
planning for certain broad contingencies w ithout, however, indicating exactly 
what w ill be done in  relation to each’ .
W hile existential-phenomenology does not rely solely on interviews, it  does 
view them as probably the most powerful method o f gaining first-person 
description o f experience (Thompson et al., 1989). Equality between interviewer 
and respondent is crucial to the success o f any interview; the interview should be 
in  the form o f a conversation w ith  a structure and purpose (Kvale, 1996), an 
inter-change o f views between two people. The use by Kvale o f the gestalt 
figure/ground drawing o f two faces/vase on the cover o f his published text is a 
good metaphor for the interview and perfectly articulates the contextual principle 
o f the phenomenological interview. By definition, the co-construction o f the 
interview by both participants requires a sense o f equality, where the researcher 
avoids adopting a superior stance or a domineering role as instanced in Douglas’ 
(1985) doctor/patient analogy.
Essential steps to be taken throughout the interview can be grouped into three 
categories. First, before the interview, preparation should include deciding on the 
level o f form ality in  relation to dress; the general approach recommends 
underdressing (Douglas, 1985). Also the respondent should know in advance 
about the general area to be explored and the general purpose o f the research. 
Other key steps are assuring anonymity, explaining what w ill be done w ith  the 
data, and confirm ing the time, date, and place for the interview w ith  the 
respondent.
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Next, beginning the interview, it  is necessary to reiterate the purpose o f the 
interview; the objective is to put the respondent at ease. A t this point it  is 
recommended that the respondent should be told that the interview w ill be 
audiotaped but to refrain from starting to record for five to ten minutes, using 
general chat to build bridges w ith the respondent (Douglas, 1985).
As the main aim is to gain a first-person description o f the phenomenon or 
experience, the phenomenological dialogue is in  the hands o f the respondent. 
Apart from the in itia l opening question(s), the interviewer has no a priori 
questions. Such opening questions should be designed to put the respondent at 
ease and can be termed ‘ grand tour’ questions. Grand tour questions also help to 
demonstrate how the respondent construes the general characteristic o f the issue 
to be explored (Lincoln and Guba, 1985). Douglas (1985) describes this process 
as the sales pitch, stressing to respondents that they are the experts. The 
questions themselves are designed to get the respondent to relay their experience, 
not to explain or think in  abstract terms or answer a question per se. Descriptive 
questions, such as ‘te ll me what you were feeling when you bought nicotine 
gum’ aim to get the respondent to recount the experience, and are described as 
prompts. Prompts are used by the researcher to ‘nudge’ the respondent and 
should be free o f theoretical language, ideally using the respondent’s type o f 
language, identified during the course o f the interview.
The prompts to be used in this study can be grouped into five broad areas:
1. Health information acquisition - ‘Tell me, where did you hear about nicotine 
gum/patches’ .
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2. Preventive health behaviour - ‘Tell me about your health, are you doing 
anything to improve your health at present?’
3. Health professional interaction - ‘Tell me about the time you went to the 
doctor/pharmacist to quit smoking/buy nicotine gum/patches’ .
4. The usage o f NRT - ‘Tell me how it feels to use nicotine gum/patches’ .
5. The use o f OTCs or other medicines - ‘Do you use OTC medicines regularly, 
what do you th ink o f the idea o f them being available w ithout prescription?’
The third and final step, is to bring closure to the interview, allow ing the 
respondent to clarify or add to what has emerged and allow  the interviewer to 
review and summarise what has emerged (Erlandson et al., 1993). A t this point it  
is recommended to keep the dialogue open suggesting that, should the 
respondent subsequently remember something they feel would be valuable, they 
can contact the researcher. The researcher should ask i f  the respondent knows o f 
anyone else they feel would be o f value to the particular research. F inally, the 
respondent should be thanked for their time and thoughts.
4.6 Interpretation of the Phenomenological Interview.
The aim o f interpretation is to uncover themes or patterns from  the respondents’ 
experience which capture the meanings they associate w ith  the role o f NRT. The 
interpretation o f the phenomenological interviews is based on the practice o f 
hermeneutics, the hermeneutical circle, and the use o f an interpretive group to be 
discussed below. The central issue fo r any phenomenological interpretation is 
that it  remains at the level o f first-person experience, and not abstracted to some
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higher theoretical level. To achieve this, a ll interviews are transcribed verbatim, 
becoming the texts from which the interpretations w ill be drawn. Three 
methodological principles are used in existential-phenomenology; an emic 
approach, the belief in  the autonomy o f the text, and the principle o f bracketing -  
all aimed at ensuring that abstraction does not occur (Thompson, et al. 1989).
The Emic Approach.
The emic approach involves the researcher using the respondent’s own terms and 
category systems as they appear in  an interview. The primary reason for utilis ing 
verbatim transcriptions is to ensure that the experiences o f the respondents are 
relayed as lived, rather than abstracted into conceptual terms. For example, i f  the 
respondent states that the benefit o f NRT as an OTC was easy availability, a 
researcher’s tendency may be to explain this in  terms o f theories o f distribution. 
By remaining at the respondent’s level this tendency to move to abstraction 
should be reduced. It is essential to take the wider view  and uncover what this 
type o f statement means from the respondent’s viewpoint through the entire 
interview. For example, it  may be that the respondent feels that easy availability 
reflects their desire to avoid contact w ith  health professionals. Therefore it is the 
respondent’s category system, not the researcher’s, which is v ita l (Kvale, 1983).
Autonomy of the text.
The text o f the interview becomes autonomous in two ways. First, there is no 
attempt to verify or check that the content o f the interview is ‘true’ . For example, 
suppose a respondent reports that ‘deciding to stop smoking was because I only
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wanted to save money’ , and this claim is clearly seen not to be the case. The 
seeming lack o f veracity should not lead to the statement being dismissed out o f 
hand. Rather, the lack o f correspondence between claim and behaviour is an 
integral part o f the text. Secondly, autonomy is designed to prevent ‘ reading 
in to ’ the interpretation. For example, i f  a respondent mentions that ‘ I quit 
smoking for my fam ily’ , this does not entitle the researcher to infer that partner 
or child pressure was exerted. Only i f  such evidence exists elsewhere in  the text 
o f the interview can such links be made (further issues regarding autonomy o f 
the text are discussed in the section on hermeneutics).
Bracketing.
The fina l principle for existential-phenomenology, bracketing (or 
phenomenological reduction), involves holding back any preconceived notions 
or pre-understandings about the research topic that the researcher possesses. 
Apart from  the obvious practical d ifficu lty  in  trying to set aside or remove the 
theoretical understandings, there is some philosophical conflict on this aspect. 
Phenomenology, in  its earlier form, believed that pre-understandings could be 
put aside through methodological rigor, whereas the later existentialists accepted 
that knowledge resided in  a much wider context, so pre-understandings could not 
be bracketed or removed. This polarisation also appeared in  hermeneutic 
thinking and is detailed below. The concept o f bracketing has been taken much 
further by other paradigms, such as humanistic inquiry (Hirschman, 1988). Some 
humanistic researchers attempt to extract any pre-understandings through a range
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o f techniques such as member checks and reflexive journals; such measures 
appear to indicate a move away from  the co-construction o f data.
In  the case o f existential-phenomenology, bracketing does not suggest that the 
rich source o f knowledge about the phenomenon held by the researcher is not 
utilised in interpretation or that some bias-free positivistic stance is being 
adopted. Existential-phenomenology, in  line w ith  hermeneutics, does not 
advocate a neutral approach to research - the researcher in  the interview has 
some pre-existing perspective on the phenomenon being researched. Bracketing 
is used to ensure that text is treated from the view-point o f the first-person 
description, not abstracted and that room is given for the themes and meanings to 
emerge in  the context (pattern) o f the text, rather than being imposed or forced 
by the researcher (Thompson, 1993). Staying w ith  the respondent’s terms and 
categories and avoiding the tendency to apply conceptual ideas, however 
relevant they may seem, are practical applications o f bracketing. It  should be 
approached as a paradigmatic aspiration rather than an essential criterion. In  
general existential-phenomenology is not as stringent as say humanistic research 
in  that it  does not require researchers to lis t and continuously monitor their pre­
judgements over the course o f the research. The applications o f these 
methodological principles to this study are reviewed in  chapter five.
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4.7 Hermeneutics, the Hermeneutical Circle, and the Interpretive 
Group.
Hermeneutics, developed from  the practice o f studying religious texts to 
understand their divine meaning, is w idely used as a theory o f textual 
interpretation and has been adopted as a general method by the human/social 
sciences. As such, it  is a theory o f the interpretation o f meaning and 
understanding. Its most significant aspect is the recognition that individual parts 
o f the text must be interpreted in the context o f the whole text (Arnold and 
Fischer, 1994), described as a part-to-whole method o f interpretation (Bleicher, 
1980).
The philosophical development o f hermeneutics m irrors the progress o f much o f 
the thinking by consumer researchers, beginning w ith  hermeneutic theory which 
held a Cartesian view o f the world being objective and rational. Hermeneutic 
theory held that it was possible to find the objective meaning o f a text through 
rigorous adherence to a series o f interpretive steps. Subsequently the move from 
hermeneutic theory to philosophical hermeneutics, as put forward by Heidegger 
above, led to a more subjective view  the interpretation process. It  entailed more 
than the discovery o f the meaning o f a text. Interpretations were not a 
‘decidable’ or objective recognition o f the author’s intended meaning, but rather 
a process where the interpreter’s knowledge resulting from  the understanding o f 
a phenomenon goes beyond the phenomenon in  question. The researcher is not 
simply the recipient o f further knowledge but is changed; his/her interpretive 
frameworks are altered.
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The next phase in the development o f hermeneutics was the development o f 
critical hermeneutics, which sought to purge pre-understandings through the use 
o f various analytical methods. Pre-understandings were seen as perpetuating 
power interests and therefore as obstacles to be removed. C ritical theory, 
fem inist and Marxists theory have utilised critical hermeneutics.
Such wide and varied evolution has led hermeneutics to have ‘ all the trappings 
o f a Russian novel’ (Thompson, 1996, p. 391), incorporating Husserlian 
phenomenology, Gestalt psychology, and structural semiotics. Most recently 
phenomenological hermeneutics positions itse lf as incorporating aspects o f 
hermeneutic theory, philosophical hermeneutics, and critical hermeneutics 
(Bleicher, 1980). Its main proponent is Paul Ricoeur who viewed it as the linking 
o f the hermeneutic problem to the phenomenological method, described as 
‘recapturing o f an objective sense o f the text and an existential appropriation o f 
its meaning into understanding’ (Arnold and Fischer, 1994, pp. 56). This two- 
stage process, the central feature o f phenomenological hermeneutics, recognises 
that a grasp o f the meaning o f the text is in itia lly  achieved, and is followed by 
incorporating these meanings into the researcher’s understanding. This has been 
described as a ‘ fusion o f horizons’ (Arnold and Fischer, 1994, pp. 63) between 
the text, representing the understandings o f the respondents, and the researcher’s 
pre-understandings. As a horizon, it  is never a fixed point, but is only lim ited to 
what we can ‘see’ at any one time. The horizon constantly changes when the 
researcher fuses their own pre-understanding w ith  the understanding gained from 
the interpretation.
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Thompson also argues that hermeneutics helps to place the voice o f the 
consumer centre-stage, clearly facilitating the use o f first-person description o f 
experience to aid understanding. It is important to approach these consumption 
stories as a narrative form, where the consumer’s stories confer a meaningful 
order onto an experience, through the selective retelling o f experience in  the 
interview, as described by Robinson and Hawpe (in Thompson, 1997, p.439):
Experience does not automatically assume a narrative form. Rather, it  is 
reflecting on experience that we construct stories. The stories we make 
are accounts, attempts to explain and understand experience.
There are five key aspects evident in  the hermeneutic view  o f consumers’ 
experience as consumption stories, (Thompson, 1997):
1) Events and characters are structured by plot lines.
2) Symbolic parallels are found across different events and actions.
3) Consumers’ meanings o f different consumption stories become integrated in 
their story o f personal history.
4) Conceptions about their own self-identity are negotiated through consumption 
stories.
5) Their te lling o f experience reflects shared cultural views and conventions.
The Hermeneutic Circle.
The application o f hermeneutics to existential-phenomenology involves two 
steps. First, an understanding o f the individual text is sought, relating separate 
parts to the whole text. Next, the separate texts are related to each other to
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identify common patterns or global themes. Termed the hermeneutic circle, it  is 
both a methodological process as w ell as a philosophy o f how the actual process 
o f research works. The objective o f the global themes is to capture the patterns 
across the texts, not to provide an exhaustive description o f the phenomenon 
(Thompson et al., 1989). Evidence for each theme must be available from 
individual texts, described as ‘ seeing as’ , in  the sense that the situation or 
experience in  one text is experientially the same as another.
W hile presented as a two-step process, good interpretation requires a continuous 
back-and-forth process w ith in  and across each text to generate a more insightful 
understanding. In itia lly  a broad sense o f understanding is grasped but w ith 
continuous re-interpretation, better understanding is achieved.
The Interpretive Group.
The use o f the interpretive group or dialogic community, like-minded researchers 
w ith  a willingness to commit their time and effort, plays two roles for the 
phenomenological researcher. First, it  plays a part in  managing the huge volume 
o f data, reducing the boredom, helping the researcher ‘ see the wood for the trees’ 
and generating a shared dynamic in the interpretation process. More importantly 
the interpretative group serves as a check to ensure that no member steps away 
from  the respondent’ s experience using pre-conceived theoretical notions and 
that any theme identified is rooted in  the text.
The group also serves an important role in  ‘ seeing’ other’s interpretations, 
assessing them, and enhancing understanding. In contrast w ith  critical
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hermeneutics, existential-phenomenology aims to describe the respondents’ 
experience thematically, searching for the ‘best’ interpretation, not a range o f 
equally valid interpretations. So, again, there appears to be conflict at a 
fundamental level between existential-phenomenology and critical hermeneutics. 
However, this conflict is, in  fact, a small point. Both aim to achieve a good 
interpretation, w ith critical hermeneutics believing that no single interpretation is 
better than another as any interpretation is driven or shaped by pre­
understandings.
To this end, the interpretive group acts as a catalyst, bringing the texts into open, 
live ly  discussion. A t a practical level this requires each member o f the group to 
listen to the audiotapes, read the transcripts o f each interview and meet to discuss 
and establish understandings and global themes. It is important to note that the 
back-and-forth process entails many readings and discussions o f each text, not a 
single attempt and sufficient time must be allocated to the process. W hile the 
themes cannot be established in  advance o f ‘data generation’ , it  is important to 
establish the potential nature o f the themes and the broad terrain to be explored. 
These five broad topics, listed above in  the section on the phenomenological 
interview (p.93/4), represent the thematic areas used in  this study.
W hile the themes must be rooted in the respondents’ experience, analysis seeks 
to go beyond direct reportage o f that experience. Cause and effect relationships, 
so beloved o f positivistic research, are not sought, unless found in the text. Any 
interpretation must be free o f internal contradictions, w ith in  and across texts. 
This is one clear example o f a methodological ‘black hole’ in  the literature; there
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are few pointers as to how such contradictions are to be resolved in  practice. In 
reality contradictions usually exist in  the respondents’ own experience in 
addition to contradictions across texts. However, the principle o f insight, or 
achieving a good gestalt, where understanding can suddenly be seen, is 
suggested in  the literature as one such methodological technique, to address such 
contradictions. In  other words, a theme is suddenly seen to capture the essential 
meaning o f the respondent’s experiences, a theme that subsumes any smaller 
apparent contradictions.
In  summary, although there are differences between existential-phenomenology 
and hermeneutics regarding pre-understanding and the principle o f self- 
understanding, much commonality exists such as the lin k  between existential- 
phenomenology’s good gestalt and hermeneutics’ fusion o f horizons. Also they 
both rely on the contextual interaction between researcher and respondent, and 
the language they use to effect this interaction; the linguistica lity o f 
understanding. The relevance o f hermeneutics for existential-phenomenology is 
best articulated by Arnold and Fischer, (1994, pp. 66)
As such, it  [hermeneutics] leaves the way open fo r methodological 
innovation in  the pursuit o f the fusion o f horizons and for paradigmatic 
pluralism as to what constitutes a legitimate form  o f expression. The 
method o f hermeneutics is deeply democratic.
Clearly hermeneutics, as a methodological tool o f analysis and a way o f 
understanding how we understand, accepts that differing views on the nature o f
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reality, in  the form o f different paradigms, can benefit from  the application o f 
hermeneutical techniques.
The practical application o f these philosophical and methodological techniques 
w ill be detailed in  the follow ing chapter. Hopefully this w ill give some insight 
about the reality o f applying a range o f theoretical, and sometimes aspirational, 
techniques gleaned from a variety o f sources.
4.8 Sampling Procedure
In  the context o f existential-phenomenology, and most interpretive 
methodologies, the rule is that there is no rule for sample size. The principle o f 
purposive sampling is to ‘maximise discovery o f the heterogeneous patterns’ and 
not to generalise to the broad population (Erlandson et al., 1993). The nature o f 
the simultaneous generation o f the data and its analysis creates an emergent 
design and also impacts on the sampling process. The objective is to ‘bottom 
out’ on the phenomenon; continuing to research the topic until each subsequent 
interview provides no new dimensions on the phenomenon.
The type o f respondents sought for this study were those who have used NRT to 
quit smoking; they included those who have purchased NRT as an OTC and 
others who had come to NRT via their doctor. It is important to emphasise that it 
was not successful quitting that was important, but the role that NRT played in  
the respondents’ preventive health behaviour. Therefore failed as w ell as 
successful users o f NRT were included. Both male and female respondents were
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interviewed across a broad social spectrum and users o f the nicotine patch and 
gum were sourced.
The sourcing o f the respondents was drawn from  four pharmacies in  the greater 
Dublin area: Santry, Ringsend, Lexlip, and Balbriggan. When a potential 
respondent entered one o f the pharmacies to purchase NRT, they were asked to 
participate in  the study. This request was in  the form  o f a leaflet, b rie fly  
outlining the topic fo r research and explaining what was required o f them. I f  they 
chose to help, a ll they needed to do was f i l l  in  their name and phone number and 
hand the leaflet to any staff member. A ll pharmacists and their staff were briefed 
fu lly  and were able to answer any queries that potential respondents raised. The 
pharmacists then relayed their names and contact numbers to the researcher who 
then followed up and interviewed the respondents.
A  total o f ten respondents make up the sample in  this study. W hile there are no 
upper or lower lim its to sample size for such a study, a sample o f ten is typical, 
w ith three to ten respondents being utilised by M ick and Buhl (1992), 
McCracken (1988b), Thompson, (1996), and Thompson et al. (1990). As 
McCracken describes it  ‘qualitative research does not survey the terrain, it  mines 
it. It is, in  other words, much more intensive than extensive in  its objectives’ (p. 
17, 1988b). The nature o f the interviews are discussed in  detail in  chapter five 
but it  must be noted that the interviews appeared to meet the objective o f 
generating extensive descriptions o f the respondents’ experiences. More 
importantly, the interpretation o f the interviews ‘bottomed out’ on the topic. No
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new aspects appeared in later interviews that suggested that further insights 
could be achieved from  conducting further interviews.
4.9 Evaluative Criteria for this Study.
W hile the subject o f evaluative criteria has been discussed in  an earlier section, it  
is fe lt necessary to address the specific evaluative criteria for this study 
fo llow ing the complete review o f the many philosophical and methodological 
issues concerned w ith  adopting existential-phenomenology. To reiterate, while 
there is some division concerning evaluative criteria fo r qualitative research, 
there is a need for some methods to verify the quality o f a ll research, including 
qualitative research. Therefore, fo r this study, the four conventional evaluative 
criteria utilised in  positivistic research - internal and external va lid ity, re liab ility , 
and objectivity are adopted using the naturalistic terms o f credib ility, 
transferability, dependability, and confirm ability (Lincoln and Guba, 1985).
The four evaluative criteria to be used are listed and the methods and techniques 
used to satisfy the evaluative criteria, drawn from  existential-phenomenology 
and hermeneutics, are discussed.
1. C redibility. C redibility is established by determining i f  the results o f the study 
reflect reality. It must be noted that what is being sought from  the respondents is 
a reconstruction o f their experiences; there is no attempt to check up on them to 
see i f  what they say corresponds w ith  the facts. Follow ing Thompson et al. 
(1989), cred ib ility is operationalised in  two ways. First, by ensuring that the 
themes identified by the group captured key aspects o f respondents’ experiences,
106
in  other words, a thick description o f these experiences rather than an exhaustive 
one. Second, credibility rests on anyone viewing the results being able to identify 
w ith them and ‘see’ them as believable. This second dimension to cred ib ility is 
implemented via the interpretive group, who can question any assumptions made 
by the researcher regarding themes by referring to the transcriptions. U ltim ately 
this criterion is predicated on reaction to the themes in  the fo llow ing chapter on 
the part o f any reader.
2. Transferability. Transferability refers to how the results o f this study can be 
generalised to the wider population. W hile the sample is not ‘representative’ in  
the conventional sense, this does not prevent the results from being indicative o f 
the wider population. The themes that emerge should be representative o f a ll the 
respondents’ experiences and arguably could be themes that are applicable to the 
wider population. The objective is to understand the phenomenon, ‘to mine the 
territory rather than survey it ’ and therefore the themes should have resonance in 
the wider population. The techniques used in interpretive research to ensure that 
themes are representative are the hermeneutic circle, which ensures that any 
theme generated is reflective o f a ll the respondents’ experiences, and the 
autonomy o f the text, which ensures that any theme can be supported by 
reference to the verbatim transcriptions.
3. Dependability. The criterion o f dependability refers to the ab ility  to replicate 
the results o f the study. Replicating an interpretive inquiry should not necessarily 
produce a sim ilar interpretation, but rather an improved interpretation. The 
knowledge and insight gained from one study should enhance any further study,
107
resulting in  refinement and development. In  this study, the generation o f the data 
emerged in  a particular way, from  interview to interview, w ith  the researcher 
gaining in  confidence and gaining new insights into the phenomenon o f smoking 
cessation, as w ell as receiving perspectives and insights from  the interpretive 
group. If, fo r example, this researcher were to attempt to replicate this study, 
even w ith  the same respondents, the outcomes would be different. These 
differences would not necessarily result in  better insights, but would merely 
reflect new insights as a result o f new understandings on the part o f the 
researcher.
4. C onfirm abilily. This refers to how objective a study is. This does not require 
that the influence o f the researcher be removed from  the study, but that any 
personal bias does not influence the generation o f the themes. W hile personal 
bias on the part o f the researcher is to be avoided, it  is necessary to highlight the 
co-constitution o f the interviews, where both the researcher and the respondent 
interplay in the generation o f the data. As a result, it  would appear impossible to 
remove the influence o f the researcher or bracket pre-understandings. However, 
it  must be noted that the key role for bracketing, or holding back pre-conceived 
notions about the research topic, is at the stage o f interpretation, not during the 
interviewing stage.
The firs t technique used to meet the criterion o f confirm ability is the autonomy 
o f the text, which ensures that any theme is rooted in  the transcriptions o f the 
interviews and is not some abstracted notion o f the researcher. The second 
technique used is the interpretive group, who must be able to ‘see’ any theme
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that is generated both in  the literal sense (rooted in the text) and in  the figurative 
sense, where the theme ‘rings true’ and captures a particular aspect o f the 
respondents’ experiences that individual members o f the interpretive group may 
not have seen originally. The final technique used in the interpretive group 
setting to ensure confirm ability is bracketing, where members o f the group try to 
hold each member back from entering into conceptual abstractions on the 
experiences being reviewed. Although holding back any understandings one can 
have is d ifficu lt when trying to make sense o f an interview, the primary role o f 
bracketing is to let meanings emerge rather than impose them on the interview. 
For example, the tendency o f this researcher, in  the in itia l stages o f interpreting 
the interviews, was to search for themes and meanings that conveniently slotted 
into the theoretical categories identified in  the literature. This would have 
produced a restricted, predetermined analysis o f the interviews. The interpretive 
group recognised this absence o f bracketing and convinced the researcher to 
adopt a more open approach to the generation o f the themes.
The fo llow ing chapter presents the results o f this study and evaluates the use of, 
and challanges associated w ith the chosen methodology and the process o f 
interpretation using the criteria outlined above.
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Chapter Five.
Interpretation of the Phenomenological Interviews: 
Emergent Themes.
5.1 Introduction.
In  this chapter the themes that have emerged from  the interpretation o f  the 
interviews are presented. The objective is to capture som e o f  the patterns across 
all interviews o f  the role N R T, as an O TC , plays in  the preventive health 
behaviour o f  those attempting to quit smoking. A s a first step, a summary o f  the 
respondents interviewed is presented outlining their broad demographic 
characteristics, their chosen method o f N R T, and the ‘result’ o f  using such a 
method. It must be reiterated that the result, in terms o f  success or failure, is 
essentially unimportant; what are critical are the m eanings o f  the experience to 
the respondents.
Second, there is a review on the nature o f conducting and interpreting such 
phenom enological interviews. The unique challenges o f  this interview technique 
are assessed in light o f  both the literature on this topic and the experience o f  this 
researcher. A s a result o f  the emergent design, the evolving nature o f  the process 
led to the development o f  techniques and learnings by the researcher throughout 
the process. These were applied throughout the course o f  conducting and 
interpreting the interviews and are briefly outlined.
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In  line with the emergent nature o f the interviews, the process o f  interpreting the 
interviews also develops in a unique manner. Given its centrality to this study, 
this aspect receives extensive treatment. The ‘result’ o f  such a  process leads to 
the emergent themes themselves and the rationale for the structure adopted is 
explained.
The emergent themes are then presented through the use o f  ‘case exam ples’ , a 
technique used by Thompson et al. (1990) and Gould et al. (1 9 9 3 ). This 
technique aims to provide an illustration o f  the phenomenon and, while each 
respondent’s experiences have many individual facets, the cases presented can be 
seen as representative o f  all the respondents’ experiences o f  using N R T. Finally, 
the themes uncovered are then presented, capturing the patterns across all 
interviews, with a view  to demonstrating the m eanings that consumers hold in 
relation to their use o f  N R T as an OTC. These are then evaluated in light o f  the 
current literature on self-care and preventive health behaviour.
5.2 Summary of the Respondents Interviewed
A  total o f  ten interviews were conducted from January through to M ay, allowing 
time for the transcription o f  each interview and a review o f  m ost o f  them  prior to 
conducting subsequent interviews. Apart from two o f  the respondents, all were 
sourced through the pharmacies, as planned. The exceptions were the first 
respondent, who was known to the researcher, and one subsequent respondent, 
who was referred to the researcher by a colleague. W hile no attempt was made to 
generate a representative sample, the respondents did reflect a wide spread in
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age, social class, education, and occupation. However in terms o f  sex, there was 
a firm  fem ale bias. The ratio between using nicotine gum and nicotine patches 
was four-to-one; broadly in line with the market for N R T.
Table 5.1 Summary o f  the Respondents Interviewed.
N am e(Sex) Age
(est.)
Social
class
Education Status O ccupation Gum
P atch
R esult
Serge (M) 27 middle 3rd level Single Lecturer gum fail
Marian n (F) mid
20’s
Middle 3rd level Single Nurse gum success, 
still on 
NRT
Elizabeth (F) 18 Working currently 
2nd level
Single gum fail
Anne (F) mid
50’s
Working little
formal
education
married + 
children
housewife patch periodic
success
Ray (M) 30 Middle 2nd level partner + 
child
accountant gum success
Lynn (F) 28 Middle 3rd level Single garda patch fail
Bob (M) 37 Middle 2nd level married + 
children
mkt.
research, 
owns firm
gum success,
current
Bridget (F) early
50’s
Lower
middle
2nd level married + 
kids, empty 
nest
housewife gum success, 
still on 
NRT
Bernadette (F) mid
30’s
Middle 3rd level Single accountant ,
MBA
student
gum Fail
Hudie (F) mid
40’s
Middle 2nd level married + 
children
housewife gum Success
Four o f  the respondents were currently using N R T, and three o f  these could be 
described as long term users, with the other using N R T  at the tim e o f  the
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interview. The six others had previously used N R T, some with success, some 
not. However this simple classification hides the com plexity o f  the experiences 
o f  the respondents, which will be illustrated in greater depth later.
The interviews ranged in time from forty-five minutes to one hour and twenty 
minutes, averaging seventy minutes and generated 225 pages o f  transcribed text. 
A ll respondents were initially contacted by phone and were told about the 
objective o f  the interview, their role to relay their experience, the fact that the 
interview would be tape-recorded and transcribed, and that confidentiality would 
be assured.
The locations o f  the interviews varied, with six o f  them taking place in the 
respondents’ homes and four in a range o f  other locations, due to work or other 
commitments on the part o f the respondents. Two o f  these were conducted over 
lunch in restaurants, another respondent visited the researcher on campus, and 
one took place with a postgraduate student in the D C U  Business School 
restaurant. W ith the exception o f  two o f  these interviews, the locations outside 
the respondents’ homes did not create the preferred environment necessary for 
conducting such in-depth interviews. Am bient background noise interfered with 
introspection by the respondents and, in one case, the unfamiliar surroundings 
led to the respondent not being at ease. However, all respondents were generous 
with their tim e and thoughts and the topic was sufficiently central to them  to 
ensure that a rich  vein o f  experiences was uncovered.
All interviews com m enced with a period o f  general conversation, ranging from 
the weather to hom e furnishings, lasting from fifteen to thirty minutes before the
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tape recorder was switched on. Apart from  the opening question, asking for the 
respondent to tell o f  their experience o f using N R T, neither the wording nor the 
sequence o f  subsequent questions was set. Asking i f  the respondent had anything 
further to add and i f  they knew o f  any other potential respondents concluded all 
interviews. Finally the respondents were thanked for their time.
5.3 The Challenges of Conducting Phenomenological Interviews.
There are two central issues worth highlighting regarding the phenom enological 
interview; the difficulty getting respondents for the interviews and the 
unpredictable nature o f each interview. On a more practical level, it is also worth 
noting that the process o f transcription is lengthy, difficult, and extrem ely 
tedious.
The ten interviews did provide informants who were willing to talk in-depth 
about their use o f  N R T  and their smoking history in general, as demonstrated by 
the extensive transcriptions generated. In  reality, huge effort was necessary to 
actually get these respondents. Additional effort was spent trying to get a number 
o f  other potential respondents, who were contacted on numerous occasions, but 
were subsequently unable to facilitate this researcher and take part.
It must be noted that all the pharmacies went to great lengths to assist in  getting 
respondents to sign up to take part. A s w ell as the leaflets explaining the purpose 
o f  the research, A3 laminated posters were placed in three o f  the pharmacies and 
all the pharm acists’ assistants were briefed by the researcher on location. The 
respondents were sourced, often as a result o f the personal efforts by the
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pharmacists involved. In tandem with these efforts by the pharm acists, the 
researcher visited all the locations on a number o f occasions to keep momentum 
behind the search. W ithout such co-operation, it would have proven a far more 
difficult task
U nlike typical phenom enological inquiries, which utilise respondents who are 
usually known to the researcher, this study only used one respondent known to 
the researcher. Clearly this presented some difficulties, but also provided 
diversity in experience, background, and outlook o f  the respondents.
The main difficulty was the amount o f  prior knowledge about the respondents. 
Often, but not always, the pharmacist could provide some inform ation, w hich 
proved helpful principally in putting the researcher at ease. This absence o f  
knowledge about the respondents meant that each interview was essentially 
speculative. The diversity o f  their backgrounds resulted in each interview 
developing in a unique manner. W hile each respondent’s experience was 
different as expected, the ability to quickly tune into the respondents was 
exacerbated by the open nature o f  the interview.
On a positive note, it appears that the topic, which was o f  great interest and 
centrality to all the respondents, overcam e any apprehensions that the interview 
would not reveal extensive, detailed experiences. It may have proven more 
difficult to elicit such responses on other less central and em otive topics. As a 
result, the need to access ‘super-informants’ , as often indicated in the literature, 
proved unnecessary in this case.
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W hile the process o f  interviewing was emergent, with new aspects being 
incorporated with each subsequent interview, the m ost em ergent aspect was the 
learning process on the part o f  the interviewer. A n essential elem ent was the role 
o f  the members o f the interpretive group, who highlighted both the positive and 
negative aspects o f this researcher’s interview technique. A lso, the opportunity 
to transcribe each interview prior to conducting each subsequent interview was 
very beneficial in addressing weaknesses in the researcher’s technique and in 
identifying new aspects o f  the phenomenon to tackle in future interviews.
A  number o f  techniques were adopted throughout the course o f  conducting the 
interviews, which improved the quality o f  the material uncovered. Insight came 
from reviewing both the tape recording and transcription o f  each interview. The 
first interview suffered from poor location and a desire by the researcher not to 
be directive, and, as a result, the interview remained at a surface level. 
Subsequent interviews focused more on probing the respondent’s experience. An 
initial concern o f  the researcher was to uncover the way in which N R T  was used 
by the respondents, but this led to too many flat, descriptive questions that 
avoided the important experiential aspects. Again this was avoided in  later 
interviews. W hile a good rapport was developed with all respondents, it becam e 
important to balance the friendly, ‘yes I know what you m ean!’ type response, 
with a more serious tone to generate introspection on the part o f  the respondents. 
In the initial interviews, the researcher referred to the extensive prompt list to 
ensure coverage o f all the relevant areas. Subsequently, this was not referred to 
directly but, for particularly important areas, a range o f  different ways o f
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exploring the same area was developed to facilitate deliberation. The use o f  the 
third person was particularly effective in this regard (E .G . ‘Do you think it 
would make a difference to other people?’). The terms used by the respondents 
were adopted by the researcher throughout the interviews in order to avoid 
jargon  and to foster rapport.
The final point to be made relates to the practicalities o f  transcribing the 
interviews. Regardless o f  typing proficiency, a typical interview required 
approximately twelve hours to transcribe, due to the need to review  certain 
passages to capture the respondent’s words. W hile this results in an intimate 
knowledge o f  the interview, tedium does occur. The quality o f  the recording 
equipment does assist in clarity o f  the interview and in  the transcription. 
Technical features, such as the ability to slow down the recording, when playing 
it back, does help this process and it is recommended to invest in  a good, 
unobtrusive tape recorder.
5.4 The Process of Interpreting the Interviews.
To understand the process o f  turning 225 pages o f  text into them atic findings it 
is necessary to focus on two elem ents; firstly the role o f  the interpretive group, 
and secondly, the analysis o f  the researcher.
The process o f  interpretation involved presenting the two other m em bers o f  the 
interpretive group with a transcription o f  the interview, prefaced by a  b rief 
outline o f  the respondent, the source o f  the respondent, location o f  the interview, 
a summary o f  the interview, and any relevant notes. The tape recording o f  the
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interview was listened to in its entirety to gain an overall view o f  the 
respondents’ experience. Subsequent to this, the transcription was scrutinised 
and a wide ranging discussion was held, which was tape-recorded to capture all 
the points and observations made.
These recordings, as well as the notes made, were collated by the researcher and 
refined and brought back to the group for further discussion. The final themes 
and their patterns were presented to the group to ensure consensus, remembering 
that the aim is to capture patterns across the interviews, achieving a ‘good 
gestalt', not to provide an exhaustive description o f  the phenomenon.
W hile this process does appear logical and in accordance with the literature, a 
com plex and often confusing back and forth process occurred. B oth  the process 
and the themes that emerged becam e more tailored and sophisticated as mistakes 
made were rectified after the initial efforts becam e more streamlined. The actual 
focus on the interpretations adopted, by the researcher in particular, changed 
throughout the process. For example, after an initial review o f  the interviews, the 
first five were presented to the group in the form o f  summary themes uncovered. 
However, these were initially shoehorned into the pre-existing categories, as 
described in the literature and outlined in the prompts developed for the 
interviews. This proved unsuccessful. Subsequently, each interview was assessed 
as a single entity, with a description o f  the respondent’s experience, utilising 
verbatim transcriptions, translated into key themes. The key to interpreting such 
a phenomenon is to effectively start with no a priori themes or ideas; a blank 
canvas in a sense.
118
The real difficulty was to com bine all the interviews along com m on themes. The 
m ost important aspect o f  the development o f  the themes and the understanding 
o f  the respondents’ experiences was to allow them to develop, rather than force 
them. For exam ple, each initial assessment o f  any transcription left the 
researcher with a somewhat vague notion o f  the key issues, but no closer to 
seeing themes. Through a process o f listening to the tape recordings on a number 
o f  occasions and rereading the transcriptions, a better understanding developed. 
This understanding m oves from  simply being fam iliar with the content to seeing 
the underlying patterns. It appears that extensive analysis is the only way to 
m ove from  reading a description o f  som eone’s experience to seeing patterns or 
themes.
A  particular challenge was to highlight what was important to the respondent, in 
light o f  the literature on the area, but not to abstract the respondent’s experience 
into some theoretical arena. The development o f  a separate file, which took the 
themes apparent in an interview in the form o f  verbatims o f  the respondents, 
helped to distil the voluminous transcriptions and allowed the categories to 
emerge.
A n example o f  the emergence o f a theme helps to demonstrate the process at 
work. The central theme, that respondents used N R T  either to break free from  
the world o f  smoking or, alternatively used it to stay in the world o f  smoking 
developed over the course o f  interpreting the interviews. Initially the interpretive 
group viewed most respondents as successful or unsuccessful quitters. Sim ply 
looking at the evidence in any interview confirmed this apparently banal fact.
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However, as the interviews were assessed it becam e apparent that all facets o f  
any respondent’s experience related back to this central point. The way 
respondents classified N R T  as either within the world o f  smoking or as a way to 
break free from  the world o f  smoking subsequently provided a fundamental 
template or framework in w hich their other meanings for N R T  could be located.
It can be best described as achieving a deeper understanding o f  the interviews 
through the process o f  interpretation, encompassing reflection, insight, and effort 
on the part o f  the interpretive group. It must be noted that such insights appear as 
comments or observation initially and then develop into more refined themes. 
The need to retain notes and an open mind is essential so that the themes develop 
in a loose, fluid, yet progressive fashion.
The com position o f  the interpretive group obviously results in particular 
perspectives and thinking, as w ell as containing different areas o f  expertise. In 
this case the group consisted o f  three members. The researcher’s perspective 
included being a smoker and a background and understanding o f  the regulatory 
environment and O TC  industry. Another member, a senior academ ic, with 
extensive expertise in the area o f  interpretation, was a non-smoker. The third 
m ember was a post-graduate student, who moved from  being a smoker to a non- 
smoker during the course o f  the interpretation, although not as a result o f  the 
process apparently. It was clear from the process that all m embers could be 
described as moving to new horizons o f  understanding about the phenomenon o f  
smoking cessation. This, it must be stressed, resulted from  a huge input in tim e,
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thinking, and effort on the part of the members. A task such as this demands time 
and effort, and should not be underestimated.
5.5 The Rationale for the Structure of the Findings.
Two elements were at play in the development of the findings, presented below. 
First, in line with researchers utilising phenomenological interviews, it was felt 
necessary to present as much as possible of the respondents’ experience in the 
form of a narrative or description of their experience. Therefore, two case studies 
are presented in detail. The benefit of using case examples is to ensure that the 
overall experience of each respondent is rooted in its context and not removed or 
abstracted in any way. The cases also help to present the respondents’ 
experiences in terms of a narrative structure, again ensuring that the experience 
is not abstracted. While not exhaustive, the cases do serve as an illustration of 
the key aspects of the phenomenon of using NRT to quit smoking. The decision 
to use two cases resulted from a divergence in one overarching theme that 
emerged.
The second element refers to the structure of the themes. In a similar way to the 
analysis of the interviews, the structure was not pre-determined but resulted from 
a logical progression of the process of interpretation. The structure reflects a 
hierarchy of the themes in an attempt to highlight the most significant meanings 
of NRT to the respondents. As a result, there is some overlap of certain aspects 
of some themes but this is reflective of the nature of such an inquiry. For
o
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example, many of the meanings associated with NRT itself are linked with other 
aspects such as the meanings associated with health professionals.
A further difficulty was to integrate the themes from all the respondents’ 
interviews while retaining the individual meanings associated with each 
interview. There were some themes which occurred in isolation but could not be 
considered representative of the phenomenon generally. Such single themes have 
been termed non-linear themes (Gould et al., 1993) and, while not necessarily 
representative of all the respondents’ experiences, are none the less valid.
5.6 Two Case Studies on the Role of NRT.
Before detailing the case studies, it is worth reiterating the objective of this 
study. First, the use of NRT was examined in the context of an emerging trend of 
self-medication and increased consumer autonomy. A key feature of this trend is 
the switching of drugs from Rx status to OTC status. Second, smoking cessation 
was examined as one of a range of preventive health behaviours that consumers 
engage in. The central point to note in this regard is the previous lack of focus on 
the role that a product, such as NRT, could play in consumers’ preventive health 
behaviour.
It is worth noting that an overarching theme which emerged across all interviews 
was not so much the success or failure of the respondents in smoking cessation, 
but whether they used NRT to break free of the world of smoking or 
incorporated it into their world of smoking. Therefore two case examples will be
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presented reflecting these divergent positions, but bearing in mind that many 
facets were common to both of these cases as well as across other interviews.
A feature that characterised these cases was a sense of the respondents 
progressing or learning as a result of using NRT. Those who used NRT to break 
free of the world of smoking, even if only temporarily successful, demonstrated 
a sense of progress. The respondents demonstrated a range of learnings and 
accumulated experiences that led to the development of skills and strategies that 
were either successful or which they believed could be used in future smoking 
cessation attempts. This reflected the concept of an illness career, as forwarded 
by Gould et al. (1993). In contrast, others who used NRT to stay in the world of 
smoking showed little learning.
The two cases were chosen to demonstrate the two contrasting aspects of the 
central theme and to incorporate the majority of the themes that emerged. The 
particular respondents presented as cases both spoke extensively about their 
experience and were chosen by the researcher for this reason. However it must 
be noted that all the other interviews could achieve the same objective, each in 
their own way.
5.6.1 Case One: Non-Smoking Role for NRT: Hudie
Hudie, married with six children, was the 1997 Nicorette Stop Smoking 
Achievement award winner, a competition for the most inspiring quitter, 
regardless of the method used. Her story is often of epic or dramatic proportions, 
with a ‘road to Damascus’ event that contributed to her decision to stop smoking.
123
Another important aspect to her story was her background as a successfully 
recovering alcoholic. As a result, much of her language and thinking reflected 
the importance of this aspect of her life.
Hudie smoked forty to sixty a day, and smoking was obviously a central aspect 
of her life. Therefore her decision to stop was a difficult one, as described in the 
following excerpt;
I was crying an awful lot. My God I cried and cried. I just cried all the time, just, whether it was 
that I had lost my best friend which in a way I had you know. This was my friend who was 
always there for me when I was happy, when I was sad, when I was nothing, when I was you 
know. It was like a bereavement. It was. And then I was comparing it to the way I felt when m y 
father died. As I say, I can't say this to my mother because she'd think "Oh my God! comparing 
my cigarettes with my father". But that's exactly how I felt, I felt that bad as I did when he died 
and that's the only close death I ever had was m y father.
Her decision to quit came after a visit to a friend in hospital, a smoker with 
throat cancer. At the hospital another friend gave her a piece of Nicorette 
chewing gum which she took home and tried, almost unconsciously. There were 
no clear stages in the process, just an hour by hour, day by day approach, 
symptomatic of Alcoholics Anonymous’ approach to addiction. This style of 
thinking and use of AA’s techniques was clearly evident in this case.
Her own lack of instrumentality in chancing upon NRT was reflected in the 
manner in which she drifted away from it;
so I don't ever remember coming off the chewing gum, I don't know, there's no, there's no line 
there where I came off Nicorette chewing gum it happened so gradually you know I can't 
remember when I stopped, I can't remember stopping you know, it just happened that God I
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haven't had any chewing gum for a couple o f days! And prior to that it might have been once or 
twice a day or you know?
The manner in which she appeared to easily drift away from using NRT would 
suggest that, for Hudie, her cessation attempt was not challenging. This belies 
the fact that, for her, this was the most difficult thing she had ever done. While 
she was completely successful, she was acutely aware of how easy it would be to 
start smoking again. Her overall experience also shows that NRT, while vital to 
cessation success, was only a constituent part of it. She often referred to the 
support of friends and family, as well as walking as part of a holistic approach to 
her cessation. For Hudie, NRT was a necessary but not a sufficient factor in her 
successful attempt to quit.
Clearly NRT’s role was an instrument in an ‘armoury’ of different mechanisms 
used to cope with quitting. Apart from the techniques learnt at AA meetings, the 
support of family and friends played a big role. As she came out about quitting, 
she was joined by her husband and other friends who subsequently quit. Walking 
the local mountain, which she took up on the first day, was described as ‘another 
one of my kind of therapies’, and reflects her holistic approach. She did not rely 
on any single prop in her efforts to quit, preferring to incorporate a range of 
options into her cessation attempt. It was interesting to note that although Hudie 
had been the recipient of a holiday from the manufacturers and had completed 
many press interviews, she rarely mentioned the brand name, Nicorette. There 
was a clear sense that she had in no way become close to the product. The main
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role for NRT was the way it enabled her, on a psychological plain, to believe that 
it really was possible to quit smoking;
I think it made me see it was possible because once you got through the first few times that you 
needed a cigarette and didn't have it you realised you didn't die, because that's what I thought, I 
would actually die. So if  it wasn't for the gum I wouldn't have even got to the point o f  realising I 
could go a half a day or that fifteen minutes, you know [yeah] Like when she said it to me I 
really didn't think I could go fifteen minutes, I really didn't, I said no I couldn't. She said, "just 
try it"
The respondents, when describing Nicorette and NRT generally, uncovered 
much regarding the role NRT could play. For Hudie, in addition to the 
psychological benefit above, NRT served a more specific role as a painkiller or 
medicine to take when she was ‘sick’.
I. okay, yeah, so would you think of it as a medicine or how would you describe it?
R. Yes, Yes, I would consider it as medication when you'd be bad. You know, yeah. And you 
would only need to take it when you'd be bad, you know you'd never think o f  picking it up 
unless you badly wanted a cigarette ... There was a, there was no nice thing about it at all it was 
definitely purely medicinal just to get you over the attack, the bad attack, and boy did it do that.
Although NRT did work at a psychological level, allowing Hudie to see it was 
possible to quit, and a more functional level, in reducing the physical cravings, 
NRT still fell short in addressing the deep desire for a cigarette;
Well it eased the terrible longing, it did, it definitely worked. It didn't ease the goo for one, but 
the real need for one. You know I would still fancy one and want one but the craving, the terrible 
pain - it kills the pain. The pain o f wanting one.
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Aside from the physical and psychological aspects, what was most apparent was 
the private, almost secretive dimension to Hudie’s experience of using NRT. 
This was most apparent in her ‘decision’ to quit, but also extended to her family, 
friends, doctors and pharmacists, and even herself;
I. OK and did you know exactly what you needed or did you go in and have a chat with him [the 
pharmacist] and ask him about the ins and outs o f it?
R. No, I just went in and asked for a box o f Nicorette. Again I didn't want to discuss it. You 
know I didn't want to discuss it with anybody because if I said it I might have to do it. And I still 
hadn't really decided I was going to do it. I was going along with this thing. It was like there was 
two parts o f me. There was one that was saying nothing and there was one that was actually 
going through the process of stopping smoking, but I couldn't acknowledge i t ... It really was an 
hour at a time for the first couple of days definitely. So and I wouldn't discuss it with anybody 
else you see I was into three or four days before it could actually be openly said "Hudie's not 
smoking you know!" And I said "well I'm trying" you know but eh for the first few days, it was 
like I'd pressed pause you know, in my feelings, in my attitude, in my talk, and in everything, I 
just went through the motions and tried, you know but there was no talking about it definitely 
not with anybody, [okay] I couldn't bring m yself to talk about it.
Although articulate, vocal, and even passionate about revealing her experience, 
the initial stages of her cessation were characterised by secrecy and a reluctance 
to discuss it that extended to the use of the product itself;
I think I actually had it hidden for the first day or so because again that would advertise that I 
was giving them up, it was secretive like, I was, rather than being secretive about doing 
something I was secretive about giving it up which was the opposite, I didn't want anybody to 
know I was giving them up I suppose because I was sure, I was so sure I was going to fail maybe
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so I didn't want the failure to be seen. If I said nothing then nobody could see me as a failure or 
whatever, I don't know.
It is clear that the fear of failure was the primary reason for her secrecy as she 
began her cessation attempt and it is notable that this extended to NRT itself.
Various aspects of control were themes running throughout this interview. One 
way in which this control manifested itself was the manner in which she used 
NRT. Hudie described NRT as a painkiller to be used when necessary, rather 
than as part of a consistent regime. Her regime of compliance was sporadic, only 
using one to ‘kill the pain’, and she was unsure about the overall time she used 
Nicorette. Another facet to this personalised regime was Hudie’s method of 
chewing the gum. Hudie chose to break up the pieces, giving her control over the 
dosage;
I. .. did you kind o f take over the control o f Nicorette in that way? You know being able to take 
so many a day and split pieces or whatever?
R. Not really in a sense, because I took it when I got the craving, so my cravings were still really 
dictating with it, the same as it is with the cigarettes. You know, I wouldn't have really control 
over the cravings. So in that sense no, the only control I would have was the size o f the piece and 
that was only because I didn't like it
Her individualistic method reflected a belief in how central her own efforts were, 
but it was also possible to bolt on something else to her armoury. While 
remaining in control, she had no difficulty in adopting any remedy or treatment
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for her campaign to quit, including NRT. She described this aspect thus 
‘everybody is their own architect to their method of giving up’. She was adamant 
that, at least in the case of NRT, the individual should be in control of their own 
intake. This control was easier to exercise and was more clearly evidenced in 
self-medication, where it was possible to develop a personalised regime. This 
was evident when comparing the gum to the patch;
R. And, like, I went through all ray pains in the beginning, there was no pain at the end. Whereas 
with them {husband and friend using the patch} it was. But there is a weaker patch and in fact 
they went on to the weaker patch so I would think maybe there should be a weaker again patch. I 
think there's two levels, maybe there's three but maybe there should be an even weaker again, 
because with the chewing gum you can reduce it by the day...
Clearly the gum allowed greater personal intake and control especially when it 
came to reducing dosage.
She also described the role of NRT as a crutch, in a positive sense; something 
that helped, didn’t take over, and was only temporary. The following excerpt 
demonstrates that for Hudie, there was no sense that using a crutch was 
something that showed any weakness. Using NRT as a crutch did not suggest 
that you loose control. She stressed that there was nothing to apologise for when 
using a crutch;
I. But you wouldn't think of them as a crutch would you?
R. I would in a way but I mean I don't see any harm in the crutch to help you through to get over 
something. I mean if  you break your leg you'll take a crutch to help you off the leg until it's 
strong enough. So you know, and I think any crutch, once you don't use it or rely on it for the
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rest of your life, but I don't - crutches are there to help you until something gets strong, whether 
it be you or whether it be a broken leg or whether it be whatever, you know? I don't see anything 
wrong with a crutch, I don't see it as a sign o f weakness you know it's only an enabler to you to 
keep you going. I mean we all serve as crutches to each other in different times in life. You 
know? To help each other through things or over things, so I would see it as a crutch, yes, and a 
very good crutch really you know yeah for temporary use as crutches would be meant to be.
This view of NRT as a successful medicine or even drug contrasted with her 
more cynical views on other drugs and the pharmaceutical industry. The 
difference in her views related to the addictive properties of such drugs, which 
have the potential to become lifelong crutches. In addition she expressed concern 
at the lack of control of such drugs. She cited examples of doctors over­
prescribing medicines and a widely held view that Valium was used as a 
universal cure for many ailments, resulting in abuse. Her scepticism of drugs did 
not differentiate between Rx or OTCs, or even alcoholic drink and cigarettes for 
that matter; all had potential addictive properties. This scepticism applied to both 
doctors and pharmacists, who were viewed as operating to the same agenda, 
promoting reliance on such addictive drugs.
Hudie’s attitude above is vital to understanding her view of NRT as a switch 
drug. While aware of NRT’s previous status as an Rx, there was no sense of this 
switch being in any way important in her estimation of its efficacy. For Hudie, 
what really mattered was availability. Availability facilitated both privacy and 
not missing the moment;
I. What happens if  that was on prescription, it used to be on prescription?
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R. It used to be on prescription, that's right yes. [Would you have?] I probably wouldn't have 
lasted you see. Until I would have gone to... I mean that would have been going to a doctor and 
telling him. And I couldn't, I actually couldn't have told anybody I wouldn't have had the nerve 
because I couldn't tell myself, I myself, like I nearly sneaked down for it, like, like an addict 
would for a hit.
You know I wouldn't have gone to the doctor no I wouldn't so I would disagree with it being on 
prescription. I'd say it should be as freely available as possible [okay] I would definitely, no I 
wouldn't, because that would mean ringing and making an appointment and going down and 
sitting in a surgery, no way! [you wouldn't make it!] You wouldn't make it! that's for sure! ... I 
think the easier it is because it's so it is only a minute and it's all gone. It only takes a minute to 
pick up the cigarette and smoke it. And it's gone you know it's not like you can start again after 
having one cigarette. It doesn't happen like that. You know you have one and you are gone.
Overall, the involvement of health professionals and prescriptions militated 
against this desire for privacy. The bureaucracy of getting a prescription further 
meant that immediate availability was impossible.
Another important theme across the interviews was how the respondents 
contrasted NRT with smoking; whether they felt it was a direct replacement, 
similar, or completely different. Two points should perhaps be made in this 
regard. First, Hudie, like other respondents, saw similarities between smoking 
and NRT on some features and equally saw dissimilarities on others. Second, 
these similarities/dissimilarities were often more evident by the respondents’ 
reported behaviour than in any explicit comparison they articulated.
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For Hudie, NRT provided some of the oral gratification of smoking but was 
limited as a direct replacement for cigarettes. The role of NRT was not primarily 
to mirror cigarettes but rather to ease the pain involved in quitting, as she 
previously mentioned. Overall, NRT worked in the functional sense of easing the 
cravings and occupying Hudie to some extent, but did not take the place of 
cigarettes. It is worth recalling that she described her cigarette brand, Major, as 
her best friend and the loss of her Major as a bereavement. Hudie never came 
that close to the Nicorette brand in any manner;
I. And what would you tell people about going, or how would you describe it 
to them you know?
R. How would I describe. Well taste wise awful, but it functions perfectly on a par with a 
cigarette in terms o f meeting the requirements for a replacement for a cigarette. It would 
function just like a cigarette in that sense and you do get you know, a certain oral gratification in 
picking it up and putting it into your mouth. So, but it's still something it doesn't do obviously 
which is still you know you would be crying for a cigarette, and dying for a cigarette but it does 
well, it really does well.
Overall, the sense of learning Hudie gained from her experience of using NRT 
was reflected in her unique outlook on smoking that she formed having 
successfully quit. Her reflections on her experience of quitting smoking gave her 
and her family a unique perspective on the danger of smoking. This perspective 
was based not on the frequently cited health dangers of continuing to smoke, but 
the difficulty that a smoker would face, at some point in the future, when they 
had to attempt to quit:
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R. I think if  they really knew what it was like and I think my son hasn't smoked since, Orla 
hasn't. I think seeing, and the boys saw it as well, seeing what was involved in giving them up I 
think that scared them more than seeing people with cancer or seeing ... because they are all 
maybes whereas if  you start smoking you are definitely going to have to give them up and the 
giving up kind o f scared them because they saw what I went through and what Donal went 
through and they know it's not a pleasant thing.
In summary, Hudie was articulate and richly described her experience of NRT. A 
key concern was the availability of NRT as a switch drug and that there should 
be no medical or professional barriers impeding access to it. Hudie placed NRT 
outside the sphere of medicines, whether Rx or OTC. Availability, privacy and 
control were the key meanings for her in the role NRT played in her successful 
smoking cessation attempt.
5.6.2 Case Two: NRT Within the World of Smoking: Bridget.
Bridget, a housewife in her mid-fifties, lived with her husband, also an ex­
smoker. In brief, the past eleven years has seen Bridget quit for one year, with 
Nicorette gum, and then continue to use NRT and smoke for a further year. 
Subsequently she returned full-time to cigarettes for five years and, most 
recently, has been using NRT for the past four years.
What was most pronounced in this case was how central NRT was to Bridget; all 
questions or conversations, regardless of their nature, featured NRT and more 
particularly, Nicorette the brand. Experiences or aspects which she described 
were placed in a time context of either when she was smoking (‘Carrolls was my
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brand’), years ago (‘when Nieorette was on prescription’), or now (‘when I have 
my Nieorette’). While quantitative measures are unimportant, it is enlightening 
to note that she mentioned the brand Nieorette eighty times in the interview, in 
contrast to Hudie, who mentioned the Nieorette brand eight times.
Not surprisingly, with the benefit of reflection, Bridget expressed some concern 
about her consumption throughout the interview, but was very reticent to express 
any real desire to quit nicotine gum. She appeared basically content with her 
situation and Nieorette had clearly replaced cigarettes, although not as good as 
‘the real thing’.
An example of how central Nieorette was to Bridget, and how it was constantly 
used to frame her experiences, is demonstrated in the following two excerpts. 
One important facet to these stories was the inherent naughtiness in using NRT. 
Bridget viewed NRT in the same manner as she viewed cigarettes. The first 
excerpt is her response following inquiries about her health status;
R. Oh yeah, I am fairly healthy, fairly healthy yeah... And actually I, last year I did have reason 
to go to the hospital but em, they asked me if  I smoked. I said I did but I had given them up and I 
told them I was on the Nieorette. So, they didn't seem to mind, but one doctor said to me, well 
try and wean yourself off that as well you know [okay] Y ou’d hear my daughter she was with 
me the day, but ‘now did you hear him, you’re supposed to give up the Nieorette as w ell’ you 
know, but not not for any particular reason because there is nothing wrong with me, thank God
When asked what she thought of what the doctor said to her, she demonstrated 
the way she would usually reply to such a comment from anyone. She used an 
example of smoking and cigarettes and immediately followed this with a
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reference to Nicorette. In addition to the naughtiness associated with using NRT, 
this excerpt demonstrated her defiance. Again this would be typical of a smoker, 
rather than a non-smoker;
I. So what did you think o f  what he said?
R. I would, but I think that the more people tell you to do things, well with me anyway, I'd be 
kinda going my own way and maybe that used to be the same with smoking you know if  
someone said you should give them up or cut them down or whatever, I used to find that that 
would make me smoke more
It was increasingly apparent that Nicorette, while obviously the topic of our 
conversation, was much more; it was a central part of Bridget’s life. This 
centrality was evidenced in many unsolicited references to Nicorette even during 
areas of the interview when smoking cessation was not being discussed;
R. Last year I went, I’d be a bit nervous so I got some tablets for getting up in the aeroplane; 
drug addict! I asked for them Ah just fear, fear o f probably flying, that was the only thing but I 
got them, got back.... I got the Nicorette over there as well too, much dearer than here too it is, 
much dearer [is it?] But you can only buy it in bigger packets you see, there's more in them.
In other areas of the interview the centrality took the form of Nicorette as a 
constant companion. The role of Nicorette as a companion, was demonstrated in 
the following vignette, in which her reluctance to use the Valium prescribed by 
her GP for a plane journey was discussed;
R. But I got on all right. I'd do it again now actually And that was the funny thing too, when I 
was going anywhere, if  I was flying on a plane anywhere, I would never go into, I would never
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smoke on a plane so I wouldn’t But I had my Nicorette you see going over as well and I was 
grand, so I had...
Turning now to the role or function of NRT, especially its function in relation to 
cigarettes, rather than being an addition to any armoury of mechanisms designed 
to help her quit smoking, Nicorette simply took the place of cigarettes;
R. my son-in-law worked in the Airport and I knew the Airport also has a chemists and I said to 
him to get me a package o f Nicorette, I said because I forgot to get and the Chemists won't be 
open tomorrow. He came home without it and there was holy war, I nearly killed him. But, lucky 
enough m y sister over here had some and I was having her for dinner on the Sunday and she had 
bought me the Nicorette on the Saturday and had it over there for me for the Monday.
She described herself as ‘more of a smoker’ than most of her friends and 
continued this story by demonstrating that only a smoker could understand her 
attachment to Nicorette;
I. Because she knew it {the absence o f Nicorette} was going to happen?
R. She knew. She didn't know then that I had none and she didn't know that I had asked Matthew 
and that Matthew had forgotten to get me any. But she said, "I have them for you", because she 
is a smoker as well. So she had it for me and then it was grand.
Nicorette played a central role in Bridget’s life, replacing the role previously 
held by cigarettes. As a result, there was no attempt to control the amount of 
Nicorette she consumed or any effort to reduce it. The role for NRT was to take 
the place of cigarettes in the widest sense. Bridget was unable to specify exactly 
what NRT did for her, much less differentiate between its impact on physical
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cravings and its impact on emotional needs. The role it played was only 
explained by direct contrast to cigarettes once again;
I. And what is it {Nicorette} like to work, what kind o f sensation do you get, what did you feel 
with it?
R. Well actually none, I don’t know about me. I definitely haven't got the longing for the 
cigarette. Now as I said, when I started on the Nicorette there was always a cigarette in front o f 
me as well, because there's definitely nothing like a cigarette you know ... Now there's the odd 
time now, but it's growing less I must say. I used to wake up and there used to be a cigarette in 
front o f me you know what I mean, that was all I could see. Now I can get up and I don't - you 
know what I mean. Well I have my Nicorette there if  I want it [okay] you know.
While it appears that she may have struggled to articulate certain points during 
the interview, it was apparent that, despite her claims to the contrary, there was 
no clear separate function, sensation, or purpose to NRT, just a direct 
replacement for cigarettes;
R. The Nicorette...., I, I really can't say that it did anything, you know what I mean, unless it was
just m y the way, I don't know................... As I say I really can’t .............It doesn't make me
feel any different [okay] apart from the fact that I haven't got the longing for a cigarette since I 
started to take it.
I. How would you describe it. What does it do., what would you call it in that way?
R. Em, I ’m  trying to think.................... Well I have to say, to me, it doesn't do anything now  it
doesn’t, I don't feel any different, you know what I mean, it doesn't give me a buzz or anything 
like that, the Nicorette. It definitely doesn't. Apart from the fact that I'm not smoking .... I 
suppose the same as when I was smoking. I was smoking and that was it. Now I'm not smoking, 
now it’s Nicorette [yeah]. That's all I can tell you
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While NRT was definitely a replacement for cigarettes, it could not be described 
as being an equal replacement. Bridget’s descriptions often equated NRT with 
cigarettes however it enjoyed few of the more enjoyable aspects of smoking;
R. I can't see anything good about it, to be honest with you. Only I know that, you see I'd nearly 
have to prove to m yself that if  I hadn't got the Nicorette, would I smoke? But I don't think I 
would now you know, I don't know what it is, maybe it is only mental you know what I mean, 
the way you’re thinking, you might be thinking a bit differently now. But no ... Yeah because I 
can’t  see anything, Nicorette is nothing like a cigarette, you know what I mean, to me It's not! 
It’s not like a cigarette [yeah] but I'm delighted now to be, to be o ff the cigarettes. I am and as I 
say it's not for financial reasons. But I, I feel more healthier I think, I do now, than when I  was 
smoking.
Even four years later, Bridget continued to have vivid dreams about smoking, 
and showed her attachment to her brand. So, while NRT echoed the role of 
cigarettes in many ways and paralleled many of its functions, it could never 
address the emotional and satisfaction deficit that resulted when a brand of 
cigarettes was abandoned;
R. Oh but I often used to be nearly, I could actually taste the cigarette and everything else and I'd 
get up the next morning and say to myself, "was I dreaming, or was I smoking?" I used to love 
the Carroll's, I used never smoke anything other, only Carroll's the No. 1. I had the packets and 
they were gorgeous and I enjoyed every one o f them in my dreams. I loved them. Now that'll tell 
you how much I loved them. Now I'd never dream of Nicorette.
Leaving aside the role of NRT, a further aspect to this thesis was the meanings 
associated with NRT’s switch to OTC status. In addition to having a broad fear
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of doctors, Bridget also had a strong fear of medicines in general. She often 
described her tendency to stop taking or even to avoid collecting drugs 
prescribed for her. This was somewhat similar to Hudie, the first case study. 
However, Bridget, in contrast, was comfortable using and discussing many 
OTCs and NRT in particular. In the case of NRT, it was clear that she had no 
real concerns about her usage or side-effects, typical concerns for anyone using 
NRT;
R. Well as I say I had seen it and I talked to this girl and actually it does have a few side-effects 
when you start taking them first. You know you kind o f have a raw throat and your head can be 
a bit dizzy and that, but that kind of, it kinda wears off after a while.
Although Bridget was unclear about what the Nicorette actually did for her, she 
was aware that it was something with a ‘drug’ in it. She was concerned about 
this drug aspect to NRT. For Bridget, drugs had dangers such as their addictive 
potential. However, despite her concerns about this drug in NRT, she remained 
comfortable about her continued use;
R. Now that kind o f worried me [yeah] you know, I know that there's a drug in it, the Nicorette 
is in it The nicotine is in it you know.
I. When you say drug, what way would you, do you mean the nicotine itself?
R. Yeah, yeah, because they are coming out now with it, aren't they, that it's the nicotine that is 
the drug. I know it's not the cancer, what causes the cancer, it's the tar, and carbo- whatever else 
they have in the cigarette. But still surely that must have some effect on your system as well, the 
Nicorette, the nicotine in the Nicorette,
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Although NRT had drug associations, Bridget did not view NRT in the same 
manner as other medicines. The reason she was less concerned about the drug 
aspect to Nicorette was due to her clearly placing NRT outside the medicinal 
arena altogether;
I. Do you think o f it like, you know you get it in the pharmacy, do you think it’s like a medicine 
or anything?
R. No, no I wouldn't class it as a medicine, no [okay] would not, definitely not so I wouldn’t. 
The only thing now I can tell you about the Nicorette, I don't know what it is, but em„ all I know 
is that I am not smoking, but I'm on the Nicorette. I don't even know how they got the name 
Nicorette, unless from the nicotine [laughs] and the cigarette.
As stated above, there was a strong contrast between Bridget’s view of Nicorette 
as a drug and her approach to the use of medicines generally. In the case of 
medicines, there were many instances where she articulated her reluctance to use 
tablets, even those prescribed to her;
R. I don't like taking any kind o f tablets actually so I don’t, but, em, well I would take a Panadol 
or whatever for a headache but only.. I have tablets there now for arthritis and all, but I don't
take them  There does be murder. First o f all I think they don't agree with me and em, but I
would take a Panadol or a Nurofen, or anything like that [okay] you know. But I'm kind o f wary 
o f what I take. I'm a bit nervous. I'd take an odd Valium now, but actually the doctor prescribed 
them over at the hospital as well, but only one, but you could become addicted to them as well 
you see. I'd only take one at night if  I couldn't sleep, you see what I mean?
Clearly the dangers of more powerful medicines were the dangers of addiction. 
To understand her reluctance, especially to prescribed drugs, the following
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verbatim illustrates that the drug content of these prescribed drugs was the issue. 
Her use of the term ‘drug’ captured her fear of the addictive dangers. This was 
contrasted homeopathic non-prescription remedies;
R. I did be dad, I don't mind trying out anything that is natural. You know what I mean, herbal 
things, I would try them out. I'd try herbal tea or anything like that [right that’s quite nice 
actually] ah yeah I would 
I. So it's the naturalness that you go for.
R. Ah yeah I do, well there are no drugs in it, is there in the home remedies or whatever you like 
to call them, there’s no, there’s no drugs in them [yeah] so there’s not.
There was a marked contrast in her nervousness with drugs, especially those 
prescribed to her, and her confidence when using OTCs. On one hand there 
seemed to be an understanding that Rx drugs were powerful and had addictive 
potential. She did her utmost to avoid such drugs. OTCs were completely 
different in her view. She expressed no reluctance in using OTCs for many 
ailments and was knowledgeable about the ingredients of the OTCs she used. It 
was apparent that, in Bridget’s mind, drugs were in one category or the other. It 
must be noted that it took much effort to get Bridget to understand the concept of 
a drug switching status, even though she was fully aware of Nicorette’s previous 
status.
When she did discuss switching, she did so in terms of the doctor’s role in 
protecting the user from dangerous drugs, by only allowing something safe to 
move to OTC status. The doctor’s ability to ‘pass’ or legitimise the switch to 
OTC status was crucial to Bridget;
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R. Because would you not think then now if  it's readily available without prescription, after it 
being on prescription you'd kinda feel more safe using it, wouldn't you? [okay, okay] W ell I 
would, you know what I mean That you are not just going to be like a guinea pig, going down 
and getting something over the counter, and that you really don't know. So that if  a doctor kind 
o f could pass it [right] , you know, and then you would say to yourself, well they are not going 
to prescribe something bad for you are they [okay] you know...... so?
This safety aspect was explored further and revealed a trust in the doctor, rather 
than in the product as such. The product still had dangers, such as the dangers of 
addiction;
R. Yes, it would be more safer than just trying something, you know, what  willy nilly,
whatever you want to say A  doctor wouldn't, wouldn't prescribe something, surely, that wouldn't
be bad for you you know what I m e a n .....
I. This is true, okay so................
R. I'd feel more safer taking it, apart from the addiction part, for me, [okay] that I m ight get 
hooked on it. It's the same with prescribed tablets too, as they did, Valium or anything else, you 
can become addicted to them as well.
Her willingness to use Panadol above Nurofen was also described in terms of 
their safety. Such brands were clearly placed in the OTC arena. For Bridget, 
what became increasingly evident was that such purchases did not require any 
involvement with the doctor and any contact with a health professional. The 
meaning of getting something OTC was that there was no need for any 
interaction with the chemist. For Bridget, over-the-counter meant that she could
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pick up such products with the assurance that they were safe and had been 
passed by the doctor;
R. I don't like taking them, I'd take the Panadol quicker, I think they are the safest.
I. And what’s make them safe, the Panadol?
R. You can get them over the counter as well, you can get Panadol over the counter, so you can 
And you can get the Nurofen over the counter, without a prescription. In most chemists now you 
can buy over the counter.
This division between the doctor, prescribing drugs, and the safe, easy 
availability of OTCs in the chemist was reflected in the way she dealt with such 
health professionals. Her confidence in dealing with the chemist or simply 
picking up what she wanted contrasted with her general nervousness and 
avoidance of the doctor;
R. Yes, a little bit yeah, sometimes I do. I'm a little bit afraid of doctors, but if  I had to go, I will 
go. But I will avoid going to him as long as I can But if  I, if  he says I have to do something, I 
do, I do I'd work up my courage. No I don't go to the doctor that much as I said before [good] 
unless I feel there’s something not all right
Bridget’s apparent contradiction between concerns over drugs and her continued 
use of NRT can be understood by Nicorette’s prior history as an Rx drug. 
Bridget often alluded to ‘the time when Nicorette was on prescription’, 
promising safety through the doctor’s ability to ‘pass it’, as she described it 
above. This gave Bridget the reassurance she needed to continue to use Nicorette 
despite the addictive associations of nicotine in NRT. This reassurance was
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combined with her understanding that NRT was not a medicine in her terms. 
Medicines, especially powerful prescription medicines, had addictive potential. 
NRT was more like Panadol or Nurofen, and with the added benefit of a proven 
track record from the doctor. What was most appealing to Bridget was the ability 
to access Nicorette without any interaction with a doctor, or a pharmacist, in the 
knowledge that Nicorette was safe.
In her description of Nicorette she did not refer to any idea of therapy or process. 
In contrast to Hudie, where Nicorette was a means to an end, Bridget saw 
Nicorette as an end in itself. Nicorette took the place of cigarettes keeping 
Bridget in the world of smoking. The meaning of NRT for Bridget was of safety, 
where a potentially addictive product had received sanction from the doctor. 
NRT allowed her to remain in the world of smoking, using it in an identical 
manner to cigarettes despite the fact that NRT did not satisfy all the dimensions 
previously served by cigarettes.
5.7 Emergent Themes from the Phenomenological Interviews.
While the themes are presented as a hierarchical pattern, it is essential to 
understand the interrelationships and overlaps that exist between many of the 
themes. As a result, many of the themes can be viewed as forming non-linear 
patterns, typical of such a study (Gould et al., 1993). It must be noted that the 
emergent nature of the interviews resulted in uncovering many more diverse 
aspects to the consumers’ meanings of NRT than were originally anticipated. 
The primary purpose here is to present a coherent picture of the key themes.
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Such a thematic picture is the result of common aspects appearing across the 
experiences of the respondents.
The pattern of the themes is presented in three broad stages. First, a range of 
wider themes common to all respondents underpinning their particular meanings 
of NRT is presented. These themes are termed meta-themes. Apart from their 
own particular relevance, these themes inform and contextual ise the role that 
NRT, as an OTC, played in the experience of the respondents. Second, the 
central theme, that respondents used NRT to either stay in the world of smoking 
or break free from smoking, forms the core pattern of eight themes. Finally, a 
number of non-linear themes are presented that provide further insight into the 
meanings of NRT to the respondents, although these are essentially peripheral in 
nature.
5.7.1 Meta-Themes
These meta-themes set the scene for the particular meanings of NRT as an OTC 
for the respondents and help to make sense of what, in some cases, were 
apparent contradictions between key themes. It must be reiterated that the 
primary objective of this study was to explore the role of a drug switching from 
Rx to OTC status. According to the literature this status change remains within 
the medical sphere, albeit that the consumer has greater autonomy (Hoy, 1994). 
However, the two case studies above suggest otherwise, illustrating that there 
was a marked contrast between the usage of NRT and the usage of any kind of 
medicine by respondents. For Hudie, using NRT contrasted with her cynicism
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and avoidance of all other medicines. For Bridget, using NRT, as a drug with a 
recognised prescription history, was also in contrast with her avoidance of 
prescribed drugs. The same was true for many of the respondents who had no 
compunction in taking NRT while at the same time protesting that they were ‘not 
really tablet takers’. NRT and medicines were clearly in separate compartments. 
This difference in outlook towards taking medicines and NRT can be best 
understood by looking at the actual meanings associated with NRT. Essentially it 
is outside the medical arena. Smoking cessation is not a curative process. It is not 
recovering from an illness. It is not strictly speaking a health issue. As a result, it 
is not the proper concern of doctors or medical professionals.
Two aspects, common to all respondents, illuminated this distinction between 
medicines and NRT; a) the fact that smoking and smoking cessation were not 
viewed in any way as an illness or even a health issue, b) the subsequent absence 
of any role for the doctor or medical professional.
Smoking Cessation is not to Cure
a) While smoking cessation is clearly identified more as a preventive health 
behaviour than a remedy for illness, the respondents rarely made reference to 
health issues. Occasionally health issues such as the long-term effects of 
smoking did arise and if a more causative approach had been adopted in the 
research methodology, health would likely have been the ‘factor’ most 
mentioned. However, for all respondents using NRT the absence of any 
articulated health meanings was very apparent, despite a focus on many of the
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elements of preventive health behaviour by this researcher throughout the 
interview process. Therefore, at this level NRT was seen as being outside the 
conventional boundaries of medicines as described by Serge;
Eh well that’s a that’s a different issue... that’s a different issue emm because I would consider, 
any say kind o f direct ill-health different to what is proactive health move....[okay]..to give up 
smoking is proactive health when I ’m ill I’m coughing, I know I have an infection.... you know 
that there are different dosages o f different types o f antibiotics, and you know that there is a 
medical judgem ent that has to be called into play there where as with the nicotine substitutes or 
replacements you know you can make you’re own
b) Following on from this point was the fact that there was no role for any health 
professional in smoking cessation. If there were no illness connotations to 
smoking cessation it followed that the doctor had no right to play a role in the 
individual’s cessation attempt. Smoking or quitting was a matter of personal 
choice for the respondents and also one that required privacy. Furthermore, as 
smoking cessation was outside the remit of the doctor, any advice or help was 
seen as irrelevant at best or insulting at worst;
Ray. Ah the doctor, any time you go to the doctor no matter with what they’ll ask you how many 
do you smoke a day, you should really give them up or whatever, but you know....
Bernadette. I  just listen to him for the sake o f having to go and get a prescription for an i n h a ler . 
No, it wouldn't make any difference.
All respondents acknowledged that the doctor constantly gave advice, but this 
was never heeded, due to its perceived perfunctory nature. At first glance, many 
respondents highlighted that they had received advice from their doctor, and it
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appeared that this represented an ‘information source’. Further analysis revealed 
that this advice was of little relevance to the respondents. While it is widely 
reported in the literature that doctors do encounter resistance from patients 
regarding cessation advice, the doctor is nonetheless often cited as a source of 
information. In this case the doctor’s role in providing information was a 
perfunctory one. His/her views were listened to but not sought out.
Some took the doctor’s advice but it formed part of a game with the doctor, 
where both participants had a tacit understanding of each other’s position. For 
example, Ann, while relying totally on the doctor for all medical issues and even 
obtaining the doctor’s permission to use the patch, saw such advice as part of a 
game. Again at first sight, Ann appeared to be the quintessential good patient, 
highly respectful of the doctor and his advice. However, it became clear that this 
advice was part of a game where Ann continued to smoke despite the doctor’s 
advice and the doctor himself went along with the dissemblence;
He do say to me ‘Are you o ff the cigarettes A nn?’ and normally I just say yes, no point in saying 
no, and ‘good for you’ he says ‘Ann’ and he gave me a book and all on it, you know, first, first 
day your off them, how many did you smoke and all that, so I used to smoke one or two [okay 
so...] but he does really, he’s down on cigarettes
The result of smoking cessation being outside the realm of cures and beyond the 
remit of the doctor was that NRT was not viewed as a medicine or drug in the 
conventional sense. The extension of this was that switching from Rx to OTC 
was essentially meaningless. The switch is ‘medical’ whereas cessation is not in 
the medical sphere.
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In summary, this first meta-theme focused on how NRT, though available only 
through medical outlets, was itself seen as essentially being outside the medical 
domain. As a result of this perception, medical professionals, in particular GPs, 
were in a sense disenfranchised; it was simply not deemed appropriate for them 
to be consulted regarding this product.
While all respondents, in their own way, chose to locate NRT outside the 
medical sphere there was a parting of the ways when it came to the meanings 
associated with the use of NRT. This leads to the second meta-theme uncovered 
in the research. This theme was already evidenced in the two case studies 
discussed earlier (section 5.6). However, it also surfaced in most of the other 
transcripts and centred on whether NRT was used to either break free or remain 
in the world of smoking. Each of these two groups will now be examined 
separately and the range of sub-themes associated with each group will be 
explored beginning with those who used NRT to break free from the world of 
smoking.
5.7.2 Core Theme One
Breaking Free From the World o f Smoking
Respondents, such as Hudie, used NRT to break away from the world of 
smoking. In Hudie’s case this was clearly successful but for others it proved to 
be a temporary success. It will be remembered that this ‘break free’ group 
comprised both those who failed and succeeded in their cessation attempt. For 
those who lapsed back to smoking it would be plausible to assume that they
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returned to the world of smoking and that little had changed. However, what 
marked these non-suceeders from other non-suceeders was their experience of 
prescribing their own role for NRT and the learnings that resulted. Such 
respondents clearly expressed a sense of progress and a better understanding of 
how they could utilise NRT in the future by approaching certain aspects 
differently.
For the successful and unsuccessful respondents in this group there were clear, if  
varied understandings of the function and purpose of NRT. This notion of NRT 
serving some clear and definite purpose marked out respondents in this ‘break 
free group’. The specific function or purpose of NRT ranged from being a 
simple, direct replacement for cigarettes, a painkiller for specific moments, an 
aid as part of a wider battle, or a reward for not smoking. For some NRT 
addressed the physical aspects only and for others it acted in a more holistic 
manner, including many emotional aspects.
Regardless of the specific role that NRT played there was a clear understanding 
of the mechanics of nicotine replacement. This understanding of the mechanics 
was not necessarily the result of what would be described as health knowledge 
but the result of the respondents taking an active role in their smoking cessation 
attempts. Such an active role was primarily related to the individual remaining in 
control. In fact, control issues were the most salient themes for such respondents.
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The central meaning of NRT lay in its ability to allow respondents control many 
aspects of their cessation attempt. Control related to more than regulating their 
intake, although this was important. In fact, three control related meanings 
emerged from this ‘break free group’; control of the decision to quit, control of 
the dosage, and control of access and timing.
Taking Control o f the Decision to Quit
Typically in a health context, there is little privacy for individuals engaging in 
health behaviour. There is a range of health professionals, hospitals, clinics, all 
usually operating in a very public fashion. Much has been written on this topic 
and initially the respondents’ experiences of cessation appeared to highlight this 
lack of privacy. However, on closer examination, privacy appeared to be an 
important requirement in the sense that privacy facilitated control over the 
decision to quit. There was a desire to remove the cessation process from public 
scrutiny both medical and non-medical.
Like Hudie’s decision to purchase and use NRT secretly, many other 
respondents cited this aspect. For Lynn, both smoking and quitting were personal 
issues. The decision to stop was her own choice. This was apparent when the 
notion of NRT being on prescription was discussed. The decision to quit was not 
something that required permission;
Taking Control
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On prescription. I dunno, because I think, you know, smoking, it's your own personal thing and I 
mean it should be up to you, not a doctor, whether or not you know, you need to give up as such. 
Em, You know, it's almost as i f  you've to sort o f ask somebody's permission
While privacy in this sense of personal autonomy and owning the decision, there 
was an important private dimension to the use of NRT. Like Hudie, who cited 
the need to conceal her initial efforts when using NRT, many respondents felt 
that NRT aided secrecy and helped retain control. The concept of control and 
privacy was also important for those who felt that any disclosure to others of 
using NRT added unnecessary pressure on them in their attempt to quit. For 
Bernadette, her privacy minimised the pressure arising from social scrutiny, 
advice, and rebuke;
Yes. I'd prefer to use the patch. And as well as that if  you are sitting in at a meeting you can't 
really be chewing gum, and you couldn't be smoking either. Because nobody knows you are 
using a patch. I f  you are seen chewing on chewing gum people will say oh, you are giving up 
smoking now? I f  you are giving up smoking everyone decides to give you a lecture. But because 
the patch is not visible, yes I'd prefer it. You won't have someone saying, you gave in you're 
smoking. That's very difficult. You try to give up and people are very, and say you didn't stick it
This ability to retain control over the decision to quit and protect the individual 
in the initial stages of cessation was made possible with NRT. Of equal 
importance was the need to retain control throughout the cessation attempt. For 
this reason developing a personalised regime was crucial to these respondents.
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In contrast to the received wisdom regarding compliance with dosages for 
medicines generally, many respondents took control over their intake of NRT, 
ignoring the recommended dosages and instructions. Apart from meeting their 
individual physical needs for certain levels of nicotine replacement, the 
personalised regimes meant that the ‘break free’ respondents stayed in control. 
This was often illustrated by the contrast between the gum and the patch in the 
minds of the respondents. Although identical in nicotine delivery and clearly 
having the same function, the respondents had contrasting opinions on the merits 
of the gum and the patch. For Ray, altering the amount, frequency, and even the 
strength of Nicorette gum was vital to staying in control. This was best 
illustrated when he explained the reluctance to use the patch;
Yeah I....can I give you a good reason for that, em 11 don’t know what it is, I mean for want
o f a better way o f putting it, I mean you stick a patch on your arm and you, I mean I don’t  know 
the full details o f  the patches to be honest with you, but it’s the nicotine coming into the system 
the whole time is just...with ever thinking about it too deeply, it just never, never appealed to me 
[it didn’t?] at least when you’re chewing the gum you have the control yourself to take it off
In a similar vein, Lynn, who had used the patch as an experiment subsequently 
questioned the manner in which the patch put nicotine ‘directly into your 
system’. On reflection Lynn questioned this loss of control;
That might be better {nicotine gum} because you can control the level that you're actually taking 
in. You'd feel more in control that way.
Control Through Self-Medication
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Such issues regarding control were often disguised by more banal observations 
or comments by the respondents. The often-quoted aspect of the gum being 
associated with the ritual of smoking appears to be more related to the individual 
retaining control than necessarily being a better replacement. Respondents who 
referred to the ritual of gum placed emphasis on remaining in control and those 
who had used the patch often cited the lack of control. Serge emphasised the 
need to be in control of the ‘hit’ or impact of his nicotine replacement;
eh ... and there was no immediate satisfaction from putting on a patch as there would be with 
having a packet, which is something tangible, that you can take out and have some kind o f  ritual 
associated with it like there is with a cigarette, there’s matches, and there’s a wrapper and there’s 
is ..I don’t know. ... so my logic was choose the chewing gum because its a direct hit, its a quick 
immediate satisfaction
Control o f Timing: Quitting and Topping Up
As highlighted in Hudie’s case, a key role for NRT as an OTC was the ability to 
‘seize the moment’ and purchase NRT whenever the need arose. This aspect was 
also critical in an ongoing way when quitters found themselves without any NRT 
to hand; all it took was one cigarette to undo the cessation effort if NRT was 
unavailable. However equally important was the barrier presented to any 
potential quitter, in terms of access, when NRT was on prescription. The 
protracted process of visiting the doctor, gaining a prescription, and purchasing
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NRT meant that many viewed it in terms of losing control of the timing of their 
cessation attempt.
This benefit of retaining control over the time to quit was described by Lynn, 
who had made the decision to try patches only when she saw the packs on the 
counter in a pharmacy;
I think it's brilliant and it should be like that because, I mean, I'm sure it works for some people. 
You know, I mean you should be able to just, if  you feel, grand, sure I can give them up and 
there's an item that's going to help you that’s sitting there looking at you, why not? I mean, I 
think it's, I mean it's so much trouble going to give up anyway, why put some one under all the 
extra pressure o f having to go to the doctor, pay the fee and get the prescription, then head off 
the chemist as well. I mean, like, its, you know, if  it's possible to just pick it up over the counter, 
why not? Maybe think it should be more readily available than just chemists.
The three control centred dimensions just discussed might lead to the conclusion 
that this ‘break free’ group were exclusively pre-occupied with their own 
personal ‘internal locus of control’ resources in their battle against smoking. 
However this was not the case. Examples abounded of these successful and 
unsuccessful quitters embracing a range of stratagems and supports including 
NRT. The following section examines how this group availed of a range of such 
supplementary stratagems and supports but did so in a way that bolstered rather 
than minimised their perceived internal control. This is the second sub-theme 
evidenced in the break free group.
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This theme related to the inclusion of NRT into the armoury of tactics that 
respondents developed when attempting to quit. Rather than viewing NRT as in 
some way conflicting with their internal resources, NRT was commonly 
described as an aid or addition. Aside from any specific role that was demanded 
of NRT, the respondents held a collective understanding that NRT was a 
positive, helpful addition, but above all, they were in control of the NRT not vice 
versa. This was illustrated by Ray;
the hypnotherapist but ...no neither o f them would appeal to me really okay, you say
willpower but, I feel as though if  you have something to help you you might as well use it .. 
Well you do need the willpower ... I mean that, you need that foremost [yeah] em, like anything 
else that can help you, I know I could have, had I been stronger, I could have given them up but 
with the aid o f Nicorette....
Others described NRT as a crutch in a positive sense or even as a life belt to be 
used when needed. Bob, for example, extended this meaning of NRT as a 
positive additional resource by describing it, not simply as a replacement, but as 
something that could be used as a reward for his own efforts. In this case NRT 
could supplement and reinforce his own internal resources;
Em and that's another thing, one o f  the good things about Nicorette is that, say if  you use the 
example o f Friday night, that 1 was more or less able to reward m yself for being o ff cigarettes 
with still indulging m yself with the nicotine on the Friday night. Whereas any other time I tried 
to give up smoking it was always with a great feeling o f deprivation, that I was denying myself 
something.
Supplemented Control
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Closely related to the meaning of NRT as a supplementary resource to the 
individual’s efforts was the need to sustain their own willpower. While 
willpower and motivation typically feature in the literature as pre-requisites for 
quitting, here it is a case of willpower being expressed throughout the quitting 
process. Such willpower was not in any sense weakened or debased by 
incorporating an external agent such as NRT into cessation regimes. Many 
respondents, who emphasised the need to continue the effort, rather than become 
complacent, articulated the sense that willpower needed to be sustained. The 
respondents’ willpower benefited from the experience of using NRT, even if it 
ended in a failure to quit smoking. Such experience was added to the armoury of 
learnings and techniques that could be utilised during later attempts and 
willpower was not lost;
Bob. But it is all to do with the sustainability o f  your willpower, how long you can sustain the 
effort for. Because when it reaches the stage where the effort, particularly if  you are not 
suffering any health consequences because o f it ...
So the willpower to do it comes from the readiness to give up, just from it being the right time. 
And the willpower to sustain it comes from a combination o f that and also the sense of 
achievem ent... you have that sense o f experience then that you can say, well I have done it and 
I will be able to do it. And also having failed so many times. I know, basically I know there is a 
complete armoury now.
Clearly, the manner in which NRT was co-opted into the cessation efforts of the 
respondents suggests that internal and external control forces could work in 
tandem for this ‘break free’ group. In fact, it is hard to separate these two forces,
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the individual’s belief in their own efforts and their belief in the efficacy of a 
product like NRT. Crucially, it was the autonomous behaviour that was 
facilitated by NRT’s availability that resulted in such a close alignment of these 
two forces. NRT was a worthwhile, effective, external agent. At the same time 
its availability meant that this efficacy could be tailored and managed in a way 
that represented no threat to the user’s sense of internal control. Indeed, in a 
further sense, it reinforced user’s sense of control. By virtue of its OTC status, 
the prescription and expert power, previously vested in the doctor had now been 
transferred to the lowly NRT purchaser. This leads to the third sub-theme 
emerging from the break free group, the transfer of expert power from medical 
professional to lay consumer.
Control switches to the Consumer
As outlined previously, NRT’s unique aspects deemed it to be outside the 
medical arena. In the case of those who used NRT to break free of the world of 
smoking its meaning specifically as a switched OTC entailed three aspects. 
These were the consumer as expert, the subsequent lack of any role for health 
professionals, in particular pharmacists, and the notion of NRT requiring an even 
further switch beyond OTC status to even wider availability.
These three aspects were characterised by a struggle between the power and 
control of the doctor or medical profession and the desire of the consumer to 
gain control. This struggle for control is given added texture by the fact that 
NRT, unlike other switch drugs, should never have been on prescription in the
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first place. Advocates of greater NRT availability can point to its hannlessness 
and its lack of side-effects as compelling grounds for returning power to its 
rightful owner, the consumer. Such a sentiment was described by Ray;
Well to be honest I can’t understand why it was on prescription before, again I say again, 
because to me you’re getting just, it’s a substitute for cigarettes [yeah] so I can’t really 
understand it, why it was, as well as that it stopped an awful lot o f people trying to give up 
cigarettes like using the Nicorette or [yeah] whatever so I never saw the logic o f having them 
prescription......
Respondents noted the fact that, in cases of illness, doctors retained power 
through their specialist knowledge. This contrasted with smoking cessation, 
where the ‘patient’ would understand the diagnosis and the solution, thus 
negating the power of the doctor. Bob described this aspect in detail;
I can't think of any other medicine, or any other product that has been advertised to a potential 
market that then has to go to their doctor to get it all right So, if  I go to the doctor, or if  
somebody goes to the doctor, if they go with a problem and the doctor prescribes a solution and 
he prescribes a solution based on his specialist knowledge o f the problem okay, so your left toe 
is swollen up and your right ear won't stop flapping, well that’s such-and-such a disease so I'll 
look up my big thick book and I'll decide what to prescribe for you. Now the reason that I can 
justify paying the doctor for that is because he went to college for all those years and it’s his 
experience that enables him to diagnose a solution to my problem.
I f  I go along to the doctor with the problem and with the solution and really all I'm asking him to 
do is not even to buy it from him, but for him to enable me to get it, it isn't the same thing.
Inherent in Bob’s description of the control rightfully residing with the consumer 
is the concept of the power of the prescription itself (Pellegrino, 1976, detailed in
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chapter 2, section 2.5). In circumstances where an illness was the issue he 
emphasises the doctor prescribing a solution as well as prescribing a remedy. It 
was this ability to prescribe that gave the doctor the power. Bob emphasises the 
difference when it came to NRT; the only function of the prescription was to 
allow him ‘buy’ NRT. In this sense the power of the doctor to prescribe NRT 
was viewed as self-aggrandising. This was a power that was not rightfully the 
doctors.
A further aspect to the power of the prescription is the sense of mystery
associated with the act of writing a prescription. In the following excerpt Bob
extended the meaning of power switching to the consumer. In this instance he
refers to any OTC medicine, not just NRT. The removal of prescription status
negated the mysterious powers of the doctor, removing the secret
communication between doctor and pharmacist. The important point is that the
mysterious, almost witch-doctor behaviour was symptomatic of a power that was
inherently false and bogus when it came to NRT or other OTCs ;
... and it's all, I think, to do with this mystique that doctors have that if  it's ‘Patang-a-kiprobang’ 
if  the doctor has to scrawl it on a piece o f  paper in a code that nobody else can read, then it's 
obvious that this is like a secret elixir, or whatever and it's almost like power is given back to the 
people if  it is taken off prescription.
Throughout the interviews respondents demonstrated that they were the expert 
and knowledgeable regarding their smoking and smoking cessation. They 
understood what would work or not work for them and which option of NRT or 
other method would suit their particular circumstances. This expertise extended
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to their own tailored prescription regime which could be described as being 
‘scientifically appropriate’ to their needs (Gould et al., 1993). Respondents 
described how NRT worked, what combination of dosage, time and effort was 
needed to quit successful or the way NRT could be tailored to suit their desire to 
break free from the world of smoking. This personal expertise was demonstrated 
when respondents talked about their ideal method of quitting. Often the range of 
ideas captured the themes uncovered, such as privacy, control, and availability. 
This also explained why there were so many individualistic, tailored approaches 
to using NRT.
The most significant aspect of NRT, as either an Rx or OTC was the absence of a 
role for the pharmacist. As with doctors, so too were pharmacists bypassed for 
any influence they might have been expected to exercise. At the outset, this role 
was expected to be central. Initially, the transcripts appeared to make frequent 
references to the pharmacist. While the respondents related many stories about 
their experiences, featuring various characters including the doctor, family, and 
friends there were few that included the pharmacist to any depth, other than 
stories relating to a basic retailing role for the pharmacists.
It appeared that NRT, switching to OTC status, moved from the doctor’s control 
to the consumer’s control without involving the pharmacist. When the 
respondents described the battle for control between the doctor and themselves, 
the pharmacist was bypassed, as highlighted by Bob above.
The unique nature of smoking cessation and NRT may lead one to conclude that 
the product in this case would be atypical of OTC medicines. The fact that it
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served as a replacement for cigarettes, the very antithesis of a medicine, 
suggested that the meanings of NRT as an OTC were unique. However, a further 
dynamic to power switching to the consumer was the marketing and promotion 
of NRT as an OTC. Such marketing efforts as mainstream television advertising, 
a common feature of OTCs in general, placed NRT and by association other 
OTCs further into the consumer domain. Once again, as demonstrated below, the 
power switched from the doctor to the consumer, bypassing the pharmacist. 
Most importantly, NRT was described as a consumer product;
Bob. Because it's back to this thing about the powerful, the witch doctor medicine or whatever. 
So I think the problem with Nicorette is it's a consumer product. It's sold in the same way as 
washing powder, or sold in the same way as beer, or sold in the same way as anything that I can 
buy or have access to. So the doctor doesn't get any brownie points for knowing that that is 
something I should have.
The logical extension of this point was that the switch of NRT to OTC status was 
only a point along the road to a further switch to wider availability. NRT was a 
consumer product; a replacement for cigarettes that did not require any health 
professional involvement. With control being of paramount importance, NRT 
required a further switch to facilitate even greater access, at least as broad as that 
of cigarettes;
Bob. And also, like I mean, the principle o f  it is wrong because if  you can walk into a 
newsagents and buy cigarettes, then you should be able to walk in to a newsagents or somewhere 
else and buy a nicotine substitute. Because I f  you are controlling the replacement you are 
controlling the wrong substance. I f  cigarettes were available only on prescription then you could 
make a sustainable argument.
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In summary, those in the break free group, whether successful or unsuccessful in 
their cessation attempts, were distinctive in the manner in which they used NRT. 
They had a clear sense of purpose when it came to using NRT, however 
idiosyncratic the role or purpose was. Specifically, their desire to maintain 
control of all facets of their cessation was pronounced. Control was crucial in 
deciding to quit, regulating their usage, and ensuring access to NRT at all times. 
In spite of this desire for personal control, it was clear that NRT, as an external 
factor, could be incorporated alongside the respondents’ belief in their own 
personal control. While NRT could supplement their personal efforts, there was a 
clear sense that these personal efforts were the dominant force.
The need for control was also evidenced when the nature of NRT as a switch 
drug was explored. Given this group’s belief in their expertise, the switch to 
OTC status meant that power and control, previously vested in the doctor, 
returned to the consumer. Interestingly, this meaning resulted in the pharmacist 
being bypassed in the switch to OTC status. Finally, the logical extension of the 
power switching to the consumer was that NRT required a further switch from 
being pharmacy restricted to availability in line with that of cigarettes.
5.7.3 Core Theme Two
Staying in the World o f Smoking.
A number of specific themes emerged for those who used NRT to stay in the 
world of smoking. The experiences of these respondents were also characterised
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by the meta-themes discussed above. To reiterate, these were the fact that 
smoking cessation was not an illness and therefore did not require the 
intervention of any medical professionals. Also, the unique situation of NRT, as 
a replacement for cigarettes, meant that it was not a drug or medicine in the 
conventional sense. However, the meanings of NRT differed significantly for 
this group remaining in the world of smoking; the ‘stay in’ group.
What characterised the role of NRT for this ‘stay in’ group was the absence of 
any purpose or function for NRT. Like Bridget, the respondents struggled to 
describe what NRT did for them other than simply replace cigarettes. This 
replacement role was all embracing, simply mirroring the place held by 
cigarettes previously. Ann for example, constantly switched from smoking to 
using NRT, depending on her health. While she appeared to be a successful 
quitter when she was using NRT, the wider picture demonstrated that, in fact, 
NRT was used to remain in the world of smoking. Another example of those 
staying in the world of smoking was Mariann, who successfully quit smoking 
but was using NRT for the past two years. The manner in which she paralleled 
NRT with cigarettes was quite marked. The concerns about long-term usage of 
NRT might well have been voiced by a smoker expressing concern over the 
negative side-effects of cigarettes;
Yeah, yeah it is a dirty habit, a really dirty habit something I have to do....I was going to give
it up this year as my New year’s resolution, I was going to give up Nicorette chewing gum, it 
just didn’t happen, didn’t  happen ... on New Years Eve this year I eh, coming back from Lexlip 
and I eh called into the pharmacy there and I asked for a packet o f Nicorette, and your man says,
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at the counter, ‘Ah yeah oh congratulations you know giving up the cigarettes, I says no actually 
I gave them up a year ago, you know [laughs]
The lack of any role for NRT as part of a realistic cessation attempt was reflected 
in the respondents’ understanding of the actual mechanics of NRT. Many failed 
to grasp the basic function of NRT as a nicotine replacement. At the extreme was 
Bernadette who went so far as describing NRT as a gimmick, a form of placebo, 
with no actual function. This was in spite of her extensive experience of using 
NRT over many years;
I don't think they are a replacement, it's some psychological thing to convince you. I don't know 
if  they actually do anything physically to you. I just felt it was some sort o f  psychological 
gimmick to make you think that you are getting nicotine into you.
Hand in hand with this ignorance of any physical function went the absence of 
any sensation, feeling, or ‘buzz’ when using NRT -  a stark contrast with those 
who used it to break free from smoking (page 149). It was perplexing to find 
such a divergence on this point between the two groups of respondents, both of 
whom were using the same product.
The break free group was in control precisely because they had achieved the 
necessary ‘psychological distance’ from NRT. They had grasped its various 
functions, mastered its dosage, experimented with its effects and understood the 
sensation it could confer when cravings needed to be addressed. In the absence 
of such psychological distance, the ‘stay in’ group lacked this ability to stand 
back from NRT and gain an understanding and appreciation of how it could
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function for them personally. In summary, it would appear that control is 
predicated on achieving some such perspective, some psychological distancing, 
from the object over which one aspires to exert control. It became apparent that 
the lack sensation, feeling, and impact from NRT for the ‘stay in’ group was due 
to their lack of instrumentality in using NRT. In effect this ‘stay in’ group chose 
to hand over control to NRT.
Handing Over Control
The prevailing understanding regarding NRT, and medicines in general, was that 
control over the cessation attempt was given over to NRT and the individual 
played little or no part. Two aspects of this loss of control were apparent here; 
the sense that anything ‘taken’, whether NRT or any other medicine should work 
on its own in an almost undetectable manner and the role that others, especially 
the doctor, played in taking control.
The manner in which control was handed over in the first sense above, was 
demonstrated by the advantage of the patch, which could be put on and forgotten 
about, knowing it would work away on its own. This contrasted with the gum 
that required effort on the part of the respondents, something that was not the 
case with medicines generally. Bernadette described the way in which the patch 
took control, emphasising that the patch almost intuitively knew when to give 
you a nicotine boost;
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What I'd prefer about the patch is you can put it on and forget about it you can leave it there, 
you don’t have to think about eating it like a piece of chewing gum. It's supposed to release 
nicotine when you feel like you want some, isn't it?
This contrasted with the excessive personal effort that was required to use the 
gum. For Lizzie, the gum regime simply required too much effort on her part. 
Throughout the interview she made constant reference to the problem of 
‘chewing the chewing gum’. This constant reference to and description of NRT 
as a mere gum was summed up when she described the occasion when she first 
got NRT. She was surprised that she had such a large role to play with this 
product and felt it odd to be in control of the product;
I snuck up to my room with the tape and the booklet and the leaflet and everything..and I read 
the little instructions like, I mean the amount o f instructions that goes with this chewing gum is 
something else! for one piece o f chewing gum, you know ... and like all its basically saying to 
you is all that’s right, ‘chew it, stick it in the side o f  your mouth, and when the taste goes away 
chew it again, and that’s all their really saying, you know
She was emphatic about NRT being in no way like a medicine, again in line with 
all other respondents. However, her understanding of NRT not being like a 
medicine extended beyond the non-medical connotations highlighted earlier. 
NRT was unlike a medicine because of the excessive effort needed when using 
NRT. In addition, NRT, unlike medicines, would not produce a result. NRT 
would not ‘get you off cigarettes’ in the way that antibiotics would cure an 
infection. The following verbatim, while apparently about the inability of NRT 
to ‘cure’ smoking, reflects her understanding that NRT does not solve the
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smoking problem on its own. Medicines, on the other hand, do tackle the various 
illnesses and disorders they are targeted at;
so I wouldn’t think o f it as medicine now ... a medicine, if  you take a medicine as well it clears 
something up so if, some people that better, you know if  you antibiotics for clear something, by 
the time you’re finished the antibiotics it’ll be gone you know [yeah] but the nicotine, it’s not, 
you’re still em, still dying for a cigarette at the end of it, you know, its not making you better if 
you know what I mean, it’s not getting you off the cigarettes [yeah] no I wouldn’t  see it as a 
medicine
This verbatim encapsulates the feelings of many of the stay in group on handing 
over control to NRT. Handing over control to NRT was not dissimilar to handing 
over control to medicines. Both were expected to work independently of any 
input or effort on the consumer’s part. This expectation was fed in part by the 
relative ignorance of these respondents. It is easier to acquiesce in some external 
agent when one has not the critical knowledge to assess its efficacy. So, this 
group seemed content at the outset to cede control to NRT; just as they did for 
medicines in the expectation that it would secure smoking cessation on its own. 
However, as was seen above, this expectation proved to be misplaced. Handing 
over control to NRT did not deliver the same dividend as handing over control to 
medicines.
The propensity to hand over control also manifested itself in a second way. 
Several respondents could still see the value in the former Rx status for NRT. 
Under the old regime NRT was under the control of the doctor. If the doctor 
prescribed a course of the product, the patient could cede control, abdicate
168
responsibility and simply follow the prescribed dosage and instructions. The 
doctor is in charge, the ‘patient’ simply ‘on a course’. The way prescription 
status facilitated this desire to hand over control is best summed up by Lizzie;
and they go up to the doctor and say look my chest is killing me, my lungs, everything I have is 
in bits you know, where if  you’re able to give me something to help me give try and give up 
smoking and if  he can give them the nicotine patch on prescription, they will be there ‘That’s 
grand, like I know if  I need another packet I can go back up to him, cause you know, you’re on a 
course then once you start you’re on a course [yeah] and like doctor supplies them with the 
patches you know
The extension of this issue of handing over control to an external force 
highlighted a further theme in this vein. In contrast to the respondents in the first 
group who saw willpower and NRT as complementary parts of the cessation 
attempt, the respondents who stayed in the world of smoking emphasised a 
dichotomy of control.
Dichotomy of Control
Respondents viewed NRT as almost in conflict with their own efforts to quit 
smoking. There was no sense that both forces could work together. The choice 
was to use one’s own resources or seek help from external forces. This fissure 
between personal and outside resources for control, between willpower and 
cessation kit is borne out in the following verbatim by Bernadette. However, in 
her case, expectations in ringing up the Nicorette help-line were coloured by the 
fact that, in her opinion, the only advice she received was to chew the gum itself.
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She believed this advice in no way suggested utilising both willpower and the 
gum. She had hoped that the alternative to willpower might be something less 
mundane;
I thought it was just em, it said help giving up smoking, you know, and I thought it was just 
general help giving up smoking, and yet and withall you have to buy the nicotine chewing gum 
as well to help, like you it was kinda like he wasn’t telling people to kind o f give up with then-
own willpower, he was telling people to chew the chewing gum  like oh don’t bother with
willpower, just chew the chewing gum and you’ll be away, which I thought was lying, I thought 
lying you know
This incompatibility between personal willpower and NRT was further 
evidenced in the way in which the use of one resource was seen to minimise the 
impact of the other. Some respondents emphasised a loss of their willpower as a 
result of using NRT. In some way it was blemished or tainted by instance of the 
fact that it needed to be complimented by some agency in this case, NRT. For 
example, Lizzie understood that her willpower was used up in her first attempt to 
quit smoking without NRT. Using NRT on her second attempt meant that she 
was unable to go back to willpower as its efficacy was in some way weakened as 
a result of using an outside aid. Her first attempt to quit was successful, using her 
own resources. However, the next attempt was more problematic. Using NRT 
had emasculated her willpower, something that she regretted;
Lizzie. I don’t know I think if  your really kind of, if  you really just w ant to give up the cigarettes 
you will give them up when, and if  you don’t  give them up you really didn’t want to go off them 
at all....[right]  your willpower will do it, whereas if  it done it for me the first time, just
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willpower, and I went o ff them and I..., and now when I think o f it I wish I stayed o ff them, 
‘cause its a lot harder to go off them a second time then it was the first time.
So for the stay in group personal and external resources were incompatible. 
There was either an inability or unwillingness to employ one resource in tandem 
with the other. This failure to explore complimentary possibilities is not at all 
that surprising given that the tendency of this group to cede control to external 
agencies examined in the last section.
Paradox o f Control
The manner in which both groups used NRT reflected different emphases on 
control, however, in the case of those who used NRT to stay in the world of 
smoking this control had a paradoxical dimension. Many of the respondents 
described their initial experience of NRT as a form of conquest. This conquest 
was over different aspects such as the taste, the side effects or the sensation often 
experienced when using NRT originally. It must be noted that this awareness of 
the taste or sensation when using NRT later gave way to the absence of such 
sensations. Such descriptions were not seen initially as significant or remarkable 
in the analysis. Adverse comments such as these had been expected. However, 
subsequently, it became apparent that such descriptions were in fact based on the 
respondents trying to demonstrate some control. Mariann described her history 
of using NRT in graphic detail. Time and time again she had battled against the 
‘horrible’ effects of NRT, ultimately conquering such difficulties;
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... started on Nicorette chewing gum and the very, very first one I had I thought it was horrible, I 
nearly got sick, made me vomit, nearly fainted, it was horrible stuff altogether, but then emm 
when I was eating, my appetite increased an awful lot, then I eh decided well yeah maybe I’ll 
give this Nicorette another go ... when I went out at night and then I went o ff it and when my 
tongue swelled up, as I used it for a little while, and then my tongue swelled up and really really 
bad mouth ulcers, so I said right I have to give these up, so emm, when that all went away I went 
back on it again,
Such dramatic demonstrations illustrating how the respondents conquered the 
distasteful or distressing aspects of NRT, actually masked the reality that NRT 
had in fact taken full control of them. Mariann, in her description illuminated 
this paradox. In her experience NRT had taken over completely, consuming her;
Mariann. Its a distraction, it is, it is a therapy in a sense that..., you know you do em, you do 
become totally consumed by it and you kinda eh, its counselling and its eh therapeutic in the 
sense that it does relax you, so yeah, it is a therapy...
So for Mariann her ‘control’ over NRT consisted primarily in controlling and 
minimising some of the distasteful side effects of the gum. However it did 
extend to her being able to control the overall impact of NRT on her life. The 
NRT managed her, not vice versa. Apart from this paradoxical side to their 
control, this stay in group can be summarised as follows.
Those who used NRT to stay in the world of smoking were characterised not so 
much by their failure to quit, but by their inability to see any role for NRT other 
than as a direct replacement for cigarettes. When it came to control, they 
understood that control rested with an external agent -  in this case either the
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product itself or the product as prescribed by a medic - and that it was not 
possible to combine one’s own resources with such an external agent. Given this 
overall disposition, this group tended to invest most of their confidence and 
expectations in such outside agencies and remedies. Control was readily 
surrendered; something that may well have something to do with the fact that 
members of this group had never in effect left the world of smoking.
Although these respondents used NRT to stay in the world of smoking and often 
directly replaced cigarettes with NRT, their cessation attempts must be seen as 
genuine and equally as valid as the attempts of those who used NRT to break 
free from smoking. The objective here is not to advance reasons for success or 
failure in cessation much less to determine the contribution if any that NRT 
played. It is the meanings of such a product that are important.
While section 5.7.2 and 5.7.3 have highlighted themes that differentiated each 
group from the other, break free group from stay in group, this contrast between 
them will conclude by discussing features of NRT that they actually had in 
common. This commonality was a result of their understanding that smoking 
cessation was not curing a sickness and therefore NRT can be liberated from the 
restrictions of medical sanction and this wider availability can in turn facilitate 
aspects such as privacy and personal choice. Despite this general consensus, the 
meanings of NRT as an OTC were paradoxical to some extent between the 
groups. Those who used NRT to stay in the world of smoking emphasised that it 
was in no way like a medicine. Yet their understanding of the ideal crutch or tool 
to help them quit was something that was legitimised by medical professionals
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and that functioned in a way similar to the way they perceived medicines to 
function.
In contrast, those who broke free from the world of smoking treated NRT like a 
medicine which for them meant something they could incorporate into their own 
personal regimes and self-medicate. Indeed they emphasised the need for greater 
access and autonomy by moving NRT away from the medical arena into more 
mainstream distribution and retailing channels.
Before moving on to examine the themes uncovered in this research in relation 
to the literature in chapter two, two further themes are outlined. Their separation 
from the main themes is due to their non-linear nature. These themes were 
viewed as significant but isolated and could not be seen as indicative of the 
experiences of all respondents. They do not relate to the break free, stay in 
distinction in any systematic way.
5.7.4 Non-Linear Themes
Medicines are only Rx.
For those respondents at the lower levels of income, OTCs were in no way 
viewed as being within the medical arena. While this was not surprising for NRT 
for the reasons outlined above, it became apparent that for other drugs this was a 
defining issue. All OTCs, including NRT, were simply not medicines. The 
notion of a switch drug per se was essentially meaningless.
When it was a question of health the doctor was the only route, and the outcome 
being a prescription for a particular drug. Since OTCs did not involve the doctor
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they were not seen as medicines. This meant that OTCs were viewed as a waste 
of money or irrelevant, as eloquently described by Lizzie;
Well if  I have to get vitamin tablets or whatever, I ’d just go in and pick it up, but say the likes o f 
em, cough bottles, I just, if  I have a cough or a bad flu, I ’ll just go up to the doctor and say Ah 
here, got a bad flu, can’t  breath or whatever, which like I ’m always stuffed up or whatever 
[yeah] and he’ll say well get blah blah drugs or write it down on a prescription or whatever, but I 
wouldn’t go into like a chemist and just buy stupid stuff for, just for the sake o f it, for having it 
in the medicine cabinet or whatever like ...
Lizzie was surprised that a product that was ‘only a gum’ without medical 
associations actually involved a range of side effects and a complex set of usage 
instructions. While this was in no way unusual for respondents describing NRT, 
it became apparent that Lizzie’s emphasis on the complexity of a simple chewing 
gum was symptomatic of her view of anything that could be bought in the 
pharmacy. OTCs were not viewed as complex, serious, or effective medicines;
I snuck up to my room with the tape and the booklet and the leaflet and everything..and I read 
the little instructions like, I mean the amount o f  instructions that goes with this chewing gum is 
something else! for one piece of chewing gum, you know ...
If Lizzie was surprised by the complexity of OTCs, she was equally surprised by 
its efficacy. OTCs as seen previously were not medicines and therefore could not 
be expected to share in any of the benefits or efficacy of medical products. Her 
experience of using an OTC recommended by the pharmacist, that successfully 
cured a sore throat, came as a complete surprise. She did not intend to purchase 
an OTC, but was forced to do so because the doctor’s surgery was closed.
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Despite the success of this isolated OTC she still expressed an inherent 
reluctance to use OTCs;
And she gave me, she’s very good and they, so I started taking it and it is its actually, I actually 
made, I didn’t believe it myself, its actually good like, but I wouldn’t be mad to go into places 
you know to like, buy any, stuff there was no need for like [yeah] you know.
Ann mirrored this understanding that true medicines were those prescribed by 
the doctor when she contrasted going to the chemist as opposed to going to the 
doctor. Anyone who had a minor complaint was wasting their time going to 
purchase an OTC on his or her own initiative in the chemists. The only occasion 
where medicines should come in to play was when the doctor had legitimised the 
illness;
Ann. Ah there’s people go in to the chemist, go in for this I have a pain in their finger and they 
want to run to the shagging chemist but, run to the doctor, but you just have to wait to see, takes 
it’s own course [yeah, yeah] you know it gets better, it gets better, which a lot o f  things do, and 
then if  it gets worse go to your GP.....
R x is Free, OTC You Pay.
An extension of the preceding theme, among the same respondents, was that 
there was an implicit understanding that when the doctor provided a prescription, 
the recipient would not have to pay. This issue, the reimbursement of 
prescription charges or State coverage of health care costs, is outside the 
boundaries of this study. However, the implications for OTC drugs appear 
crucial; OTC status meant paying for the drug in the minds of these respondents.
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In the following simple extract, Ann captures this issue. The inquiry revolved 
around her experience of asking the doctor to allow her use the patches;
I. Okay, and did he give you a prescription for it {patches} or what you...
Ann. No I have to pay him ... Yeah, if  the doctor could, if he could give you the prescription, but 
he can’t  [yeah] you have to pay for them yourself.
This financial burden only compounded the futility of purchasing OTCs. Not 
only were they ineffectual but, unlike ‘real’ prescription medicines, you had to 
pay for them.
5.8 Summary of the Emergent Themes.
This section will attempt to give an overview of all the themes to emerge. The 
most striking aspect of the themes that emerged was a lack of focus on health, 
albeit that most respondents alluded to health ‘concerns’ as reasons for quitting 
smoking. This aspect was given further credence when one considered the nature 
of the interviews, which focused extensively on the respondents’ preventive 
health behaviour. In reality, most respondents who owned up to a desire to 
improve their health through smoking cessation rarely articulated this in any 
great detail. The relationship between respondents’ presents health status and 
their future health status if they continued to smoke did not arise in most cases. If 
future health status was not a factor of respondents’ use of NRT, control 
certainly was.
Indeed the notion of control was arguably the most significant and overarching 
theme to emerge in this research. Put succinctly, smoking cessation does not
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involve curing an illness, it is outside the provenance of professional medical 
providers, as such it enjoys OTC status and can lend itself to a range of self­
controlled regimes and self-medication.
Indeed, this latter theme was the grounds for separating respondents into two 
groups; those who chose to exert control over their use of NRT and break free 
from the world of smoking and those, for whatever reasons, chose not to explore 
these possibilities, and relinquished control to NRT thereby leaving themselves 
still within the world of smoking. Each of these groups had their related 
repertoires of meanings. These meanings were seen to relate to the degree of 
distance the real/potential quitter had created between themselves and the world 
of smoking. In the case of the break free group this distance permitted them to 
envision a clear and distinct role for the product, to grasp how it could be used in 
tandem with other supports, and to assume control over dosage and timing of 
cessation. On the other hand, those respondents who did not enjoy this distance 
saw no function for NRT other than that of a cigarette substitute. They readily 
relinquished control to NRT, as they did to all medicines (even though NRT was 
not itself seen as a medicine) and trusted that it would produce the desired result 
without any demands being made on their own internal resources. Control for 
this group was only understood in a rather reactive sense -  the ability to 
overcome the negative side effects of NRT. There was scant evidence of any 
proactive ‘managerial’ meanings attaching to their use of the product.
In terms of the significance of switching, almost all of the respondents viewed it 
as an irrelevance in the case of NRT. The consensus favoured increasing the
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availability of NRT even further for a variety of reasons. In the wider context of 
prescription drugs achieving OTC status, there was a certain understanding that 
better, stronger drugs came this route. However, over and above the strength or 
lack of strength of OTCs, the key issue was the removal of certain barriers; 
barriers, which had denied consumers, access to such drugs previously.
Such sentiments expressing the change of status in terms of barriers removed 
reflected an understanding that power switched from the doctor to the consumer. 
The traditional mystique of the doctor and the secret coded nature of a written 
prescription ensured that the doctor retained power and remained in control. In 
the case of NRT this power of the doctor was clearly bogus. The switch to OTC 
status had given power back to the consumer; power that rightfully belonged to 
the consumer.
The logical progression to the above point was that NRT in particular, and OTCs 
in general, were clearly established as being within the independent consumer’s 
remit. At no point did the pharmacist appear to be of significance, other than as 
executor of the doctors’ instructions by acting as the retailer for prescriptions 
written by the doctor.
As the individual was the hub of his or her smoking cessation efforts, the role 
that NRT played revealed much about each respondent. The distinctive nature of 
the usage, compliance, length of regime, and ‘knowledge’ developed about NRT 
by some respondents demonstrated that there is clearly an autonomous health 
care consumer, who develops their own ‘scientifically appropriate’ 
understanding of the role NRT could play. The paradoxical and idiosyncratic
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approach to taking NRT contrasted with the traditional view held by the 
scientific/medical community regarding prescribing and compliance for drugs 
generally. However viewed as a learning or accumulation of personal experience 
by the respondents, the unconventional, non-traditional and personalised usage 
of the product took on a clear and more coherent aspect.
Overall, no simple picture emerged of the factors that could lead to successful 
smoking cessation using NRT. It was not the characteristics of the product, as 
either gum or patch nor the strength or dosage that determined whether NRT 
would prove successful. Individual respondents adapted NRT to their own needs, 
based on the meanings NRT held and the role that the product could play. The 
traditional view of a product having one purpose or function is clearly not 
relevant for those using NRT.
5.9 Thematic Findings in the Context of the Current Literature.
This section examines the findings in relation to the two theoretical homes 
identified in chapter two; self care/self-medication, and consumer preventive 
health behaviour. The themes identified in the previous section are those that 
emerged from the process of interpretation and no attempt was made to shoehorn 
the themes into the categories identified in the literature. This creates some 
difficulties when trying to compare this study to cue-based, primarily 
quantitative, data in the current literature. An extension of this point is that the 
methodological approaches between this study and the literature differ to a great 
extent. For example, what is considered significant in this study of ten
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respondents is compared to representative, generalisable data from previous 
studies. However it is both possible and desirable to examine the findings in this 
study in the light of the current literature. Such an approach is recommended by 
Thompson (1990). The findings will be contrasted with the current literature by 
highlighting any conflicting aspects or any new findings. Elements of the 
findings that concur with the current literature will be reiterated where necessary. 
First the findings will be contrasted with those in self-care/self-medication 
literature. In terms of switch OTCs, this study demonstrated significant 
differences in relation to the typical user profile of OTC medicines. While there 
was a large proportion of the respondents who could be described as young, 
educated, and exhibiting ‘consumer sophistication’, there were respondents who 
could be described as being diametrically opposed to this classification.
In fact, some of the more independent, strong-willed respondents were older and 
less educated. This may be due to the extra-medical status of NRT, and in 
normal circumstances an OTC would be not the preferred option. But then again, 
Bridget, who was older and less well educated sought OTCs whenever possible 
and did so whilst remaining reliant on the doctor in the conventional sense. For 
such respondents, prior prescription history was a positive factor in OTC usage, 
ensuring safety rather than efficacy. Perhaps switch OTCs need to be examined 
without the assumption that the older, less educated are more reliant on the 
health care system generally.
The switch to OTC status impacted solely on respondents’ views of the 
availability and access it afforded to NRT. It did not impact on their views of its
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efficacy. In fact, NRTs’ non-medical aspects negated any efficacy issues 
completely. When it came to OTCs in general however, there seemed to be a 
haziness and lack of clarity concerning the links between Rx, switch, and OTC 
both with regard to grasping the schematic properties of each and their respective 
efficacies. However, with specific reference to switch OTCs, the properties of 
safety and reassurance, resulting from their previous prescription status appeared 
more important that any change in their strength or efficacy. Put simply, all these 
respondents needed to know about a switch drug was that the medical profession 
had agreed to its deregulation and that it was safe to use. Indeed it probably had 
been safe all along.
The literature in chapter two suggested that an OTC such as NRT would not be 
part of the doctor’s remit and that, as a result, greater influence would accrue to 
the pharmacist. The results of this research did support the absence of any 
substantive role for the doctor, however, surprisingly, there was little or no 
support for any input from pharmacists. Their principal purpose was to function 
primarily as retailers rather than advisors. The self-care literature also 
acknowledges the role of the pharmacist’s assistant as an information source in 
the purchase of OTCs. This role is supported in the current research. However a 
caveat should be entered as respondents who spoke to such assistants or asked 
for their advice showed little evidence of implementing or using it subsequently. 
The literature demonstrated that there was a contrast between consumers citing 
something as an information source and actually using this information in their 
purchasing. In this study, the pharmacy was mentioned in the context of its
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retailing role rather than as a provider of product information utilised by the 
respondents in their usage of NRT. The little information sought or received by 
the respondents was indicative of the peripheral role the pharmacist played, 
where little contact or dialogue was the norm.
In a wider context, lower income, and perhaps lower education, illustrates a key 
issue for OTCs. Income has been relegated to a secondary position as a concern 
in health care, principally because the health care system takes care of those in 
such circumstances. For these people in society who rely on the medical card 
system, OTCs and self-care were viewed as an irrelevance, wasteful, and ‘not 
part of the system’. Any focus on encouraging consumers to adopt a more 
proactive approach to health care or to self-diagnose, self-medicate, and of 
course pay for a range of OTC medicines flies in the face of the meanings 
associated with OTCs for these consumers.
The final issue for self-care and self-medication related to sources of 
information. The literature indicates two main approaches taken by consumers in 
sourcing information on OTCs. The first of these sources is the pharmacist 
and/or the pharmacist’s assistants, which was discussed previously. The second 
source of information on OTCs identified in the literature can be grouped 
together under the area of sources other than health professionals; mainly family, 
friends, or word-of-mouth. This area appeared relevant for respondents in this 
study, using NRT. Much of the ‘information’ about NRT that the respondents 
relayed appeared to be a mixture of facts, stories from friends, and the 
respondents’ own expertise, resulting from their use of NRT.
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Overall, what shapes consumers’ behaviour or usage appears to be the meanings 
ascribed to the information rather than the source of the information as such. The 
profusion of information in health care generally through leaflets and media 
campaigns and the emphasis on specific sources of information in health 
research in particular may result in a neglect of the pivotal role played by a 
variety of interrelated, informal beliefs and meanings. These meanings exert a 
tangible impact on self-care despite there being neither knowledge nor concern 
as to where they have come from.
Next, turning to preventive health behaviour, it is worth reiterating its scope as 
defined by the literature to highlight a number of broad observations. The 
literature defines preventive health behaviour as being primarily concerned with 
the performance of the behaviour itself, in this case smoking cessation. In 
addition, while not central, preventive health behaviour it is also closely related 
to the treatments and structures of health care. In this study, the treatment, NRT, 
would appear to be central to the performance of the health behaviour, smoking 
cessation. NRT appeared to both define the manner in which the behaviour was 
conducted and reflect the characteristics of the respondents themselves. Both the 
break free group and the stay in group were defined by the way they used NRT. 
For example, in the case of the break free group NRT facilitated their need to 
exercise control over their cessation. In the case of the stay in group their use of 
NRT was reflective of their belief that it would work on its own and achieve 
successful cessation.
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Another overall aspect of the literature which merits attention is the three areas 
that have been identified as being the primary concerns of health behaviour 
researchers; the performance of the behaviour itself, interaction with health 
professionals, and the acquisition of information (Gochman, 1988). The first two 
aspects are clearly relevant to this study. Before detailing the performance of the 
behaviour itself the two other areas will be addressed.
With regard to the second area, interaction with health professionals, the 
assumed role of such professional was tenuous at best in the majority of cases. In 
the minority of cases where there was such a role, the health professional’s 
advice was often adapted and modified to suit personal ends. The final aspect as 
indicated above, the acquisition of information, requires research to address the 
meanings associated with the actual information rather than its contents or 
sources. For example, the focus in the literature revolving around the amount of 
knowledge held by consumers neglects the manner in which the knowledge is 
used. Respondents in this study volunteered a range of so called information that 
they had gathered from a variety of sources, including doctors, friends, family, 
and the media. What was important was the way this information was distorted 
and the credence that the respondents gave to this information. Ann, for example, 
believed that smoking and wearing the patch was ‘allowed’ provided it was only 
in the morning. In her opinion, this gave her licence to combine the patch with 
cigarettes. This issue clearly relates to the nature of knowledge in terms of 
subjective knowledge. It is not the content of the knowledge per se but the
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manner in which it is used that is significant. Meanings not amounts of 
knowledge are crucial to understanding its role in smoking cessation.
Turning to the actual behaviour itself, eight consumer characteristics were 
identified in the literature as being salient to performing any preventive health 
behaviour. The findings in this study, in relation to these characteristics, will be 
discussed by focusing on their apparent differences with those in the current 
literature. Also, these findings relating to the characteristics will be presented in 
order of their significance.
Clearly the most important characteristic in this study was locus of control. Most 
of the findings in the current literature on this topic were supported. The ability 
for the different types of locus of control, internal and external, to act 
independently (Lau and Ware, 1982) was clearly evidenced with the break free 
group exhibiting their belief in the importance of their own efforts while at the 
same time expressing a belief in the efficacy of NRT. A significant factor was 
the manner in which self-control was clearly ‘in control’ of the external agent, 
NRT, despite the belief in NRTs efficacy.
Another notable feature of control in this study was the extent to which a 
medicine - an OTC in this case - could act as a powerful other health locus of 
control factor. While powerful other health locus of control includes a belief in 
the role of the health care system generally, and could arguably include the 
medicines provided as part of that system, medicines on their own have not 
featured in the literature to date.
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The fact that an OTC can act in such a distinct pronounced fashion might stem 
from an OTC being a product with an identity, brand name, and even a 
personality. Also, the more an OTC is removed from the health care system, the 
greater the propensity for an OTC to develop its own web of meanings in the 
minds of consumers. Unlike prescription drugs, whose names, origins, and 
contents are unfamiliar, unpronounceable, and unapproachable due to the control 
of the doctor/pharmacist, there appears to be a closer relationship between 
consumers and the OTC products they choose independently. While this is well- 
documented in consumer behaviour literature, it merits attention in health care 
research on the use of OTCs.
Other aspects of locus of control did appear, though not central to the meanings 
generated in the analysis. In Lizzie’s and Ann’s cases there was evidence of the 
belief in chance health locus of control that resulted from the impact of prior 
family illness. However, these instances appeared to be of little significance in 
their usage of NRT. In a similar vein, the impact of prior self-care experience on 
internal locus of control (Lau, 1982), such as using other OTC medicines, did 
arise in the break free group but cannot be viewed as central to their usage of 
NRT.
The second area of control which was significant in the context of the current 
literature was behavioural control; the individual’s belief in their ability to 
perform a health behaviour (Bandura, 1977). The significant aspects in this 
research were the polarisation in the respondents’ views on their ability to 
perform the behaviour and the manner in which behavioural control could be
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modified or controlled. The interesting aspect of this behavioural control, often 
termed ‘willpower’ by the respondents in the study, was the way in which NRT 
could influence this behavioural control.
On one hand, the expectation of the stay in group, that medicines work in an 
independent fashion, meant that they felt the need to disengage and hand over 
control to NRT. It is reasonable to assume that these respondents believed that 
they could quit smoking using NRT at the start of their cessation efforts. They 
probably had a positive compliment of behavioural control at the outset. 
However, it appeared that by handing over control to NRT, their behavioural 
control was diminished. Also, there was a dichotomy of control between the 
individual and NRT in this stay in group. It was impossible to believe in one’s 
own ability to perform the behaviour if one handed over control to an external 
agent.
On the other hand, respondents in the break free group took a more pragmatic 
approach. They viewed NRT as an addition to their armoury and something that 
could be added to their individual efforts. Behavioural control could be 
managed, supplemented, or even rewarded, as evidenced in Bob’s case. Rather 
than viewing behavioural control as a stable characteristic, it appeared important 
to adopt a more fluid approach to its role. It could be modified, adjusted or even 
diminished through the use of a product such as NRT.
Behavioural control appears to be of particular importance in smoking cessation, 
where numerous attempts are made and many different approaches are tried. 
Prior experience with the behaviour is identified as a determinant of behavioural
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control (Kok et al., 1991). For the stay in group, who relinquished control to 
NRT in the belief that it would work on its own, successive attempts to quit may 
continuously erode their behavioural control. Two other influences on 
behavioural control have been identified the literature. These are the observation 
of others performing the health behaviour and the persuasion of others when one 
is performing the behaviour oneself. Given the individualised, personal, and 
private nature of smoking cessation identified in this study, it is unlikely that 
behavioural control could be influenced in this manner.
Income was identified as being peripheral to consumers’ preventive health 
behaviour in this case, in agreement with the literature generally (Grossman, 
1982). This is due to the nature of such a characteristic, which, while important 
to the individual, is not viewed as a core behavioural characteristic. In the case of 
smoking cessation, the actual cost of NRT in comparison with the cost of 
cigarettes is not an issue, although some studies report saving money as a reason 
for quitting.
What was surprising was the meaning of an OTC for the lower income 
respondents. In such cases, OTCs, as a result of being paid for by the 
respondents rather than being provided gratis by the doctor through the medical 
care system (GMS) were not seen as medicines in any sense. Medicines came 
from the doctor only. The added insult in the case of OTCs was the fact that, in 
addition to not being medicines, they had to be paid for. This applied in the case 
of NRT and to OTCs generally. While it can be argued that income is not a
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behavioural characteristic, such an assumption is not appropriate in the case of 
OTCs.
The role of health knowledge also needs attention. As indicated above, in 
relation to the sources of information used in OTC selection, health knowledge 
must be more concerned with the nature and meaning of information, rather than 
the volume, scope, or content of the knowledge. The literature does indicate that 
health knowledge should focus on what individuals believe is under their control, 
rather than the actual knowledge pertinent to any behaviour (Park and Lessig, 
1981), but this has received little attention. The concept of an illness career 
(Gould et al., 1993), comprising the accumulated experience and knowledge an 
individual gains through the course of an illness, is perhaps the correct approach 
to adopt when exploring health knowledge. Health knowledge, in this context, 
consists of a range of facts, anecdotal evidence, and personal experience; an 
evolution of detailed knowledge that increases self-efficacy. The benefit of such 
an approach to health knowledge is the recognition that highly individualised 
regimes developed by individuals engaging in health behaviours are the norm. 
They should not therefore give rise to undue concern on the part of those who lay 
stress on strict compliance in the consumption of medicines.
One characteristic, age, did appear to be significant, albeit in one case in this 
study. Age is typically viewed in the same manner as income; less a behavioural 
characteristic and rather something the health care system makes adjustment for, 
through a range of controls, for example, through the issuing of a prescription. 
Young and old are therefore to be totally covered by the health care system for
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all their needs. This of course does not include OTCs, which have to be paid for 
by all age groups. This oversight has meant that health behaviour research to 
date has failed to address the possibility that younger age groups, in particular 
teenagers, might attach their own specific meanings to NRT in particular. This 
seems quite remarkable given that smoking begins in this age group and that 
cessation campaigns directed at them have proven so unproductive.
The other characteristics identified in the literature, health status, health 
motivation, and education, did not highlight any significant features in this 
study. Certainly health status exhibited its double-edged nature (Moorman and 
Matulich, 1993), operating on one hand as a driving force for those with poor 
perceived health status, encouraging them to engage in a preventive health 
behaviour. On the other hand, good health status could operate as an inhibitor to 
respondents engaging in preventive health behaviour; those in good health status 
seeing no need to engage in any preventive health behaviour.
Health motivation identified in the literature as playing no role in primary 
preventive health behaviours (Moorman and Matulich, 1993), especially 
smoking cessation, was also evident in this study. Health motivation, as an 
antecedent in health behaviour, appears to be less important over the course of 
engaging in a health behaviour. What appears to be of greater importance is 
behavioural control in the manner in which willpower can be altered, enhanced 
or diminished throughout the performance of a health behaviour.
The final characteristic of the eight preventive health behaviour characteristics, 
education, was positively linked with the acquisition of information (Feick, et
191
al., 1986) and the wider desire to improve lifestyle. As such it is not a core 
behavioural characteristic. Lower education levels are clearly associated with 
higher levels of smoking in the wider population but this study did not aim to 
measure such factors. Clearly the role of education in relation to the acquisition 
of information needs to focus on the meanings and usage of such information, 
rather than its volume or source as outlined above.
In summary, the findings in the context of the current literature highlight a 
number of important issues. Most important is the need to combine the two 
theoretical areas of self-medication and preventive health behaviour in order that 
a better understanding of such behaviour is achieved. This means incorporating 
the use of medicines, especially OTCs, into the framework of factors that 
influence or guide health behaviour. In other words, to see what light if any 
might be gleaned by looking at how self-medication might impact on the eight 
independent preventive health behaviour consumer characteristics. In the context 
of individuals using NRT and other OTCs, such individual, personalised product 
usage is an integral part of their behaviour.
This would make a new departure in both bodies of literature on self-care and 
preventive health behaviour. Gochman’s definition of preventive health 
behaviour states what is not health behaviour; it is distinct from the treatments, 
structures, and organisation of the health care delivery system (Gochman, 1988). 
This study on the other hand highlights the fact that the treatment, NRT, does 
appear to be central to the performance of the behaviour and the nature of the 
characteristics. The performance of the behaviour itself, smoking cessation, was
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completely dependent on the manner in which NRT was used. The manner in 
which respondents started their cessation, continued it, and completed it was a 
function of the product, NRT. In addition, the respondents’ usage of NRT 
reflected and illuminated their characteristics and, more importantly, shaped 
them. For example, the stay in group required products and agencies they could 
hand over control to. NRT was seen by them as such a product; it would perform 
the ‘donkey work’ of cessation in lieu of their own efforts. This understanding of 
how NRT worked had a considerable impact on their sense of behavioural 
control. So, behavioural control, one of the eight characteristics mentioned 
previously, far from being an antecedent internal variable affecting behavioural 
control, was in fact seen to be mediated by the nature of the treatment used in 
pursuit of that goal. In light of this it should be obvious that health behaviour 
research should begin to address the broader area of how health-related products 
or treatments are an integral part of preventive health behaviour. In consumer 
behaviour terms this reflects the truism that the study of consumer desires and 
meanings cannot be divorced from the study of the products and services used to 
achieve them. As a result the boundaries of health behaviour research need to be 
expanded.
The second core issue is that the switch process, for NRT as least, is not relevant 
to consumers. Perhaps this is surprising from a health perspective, given the 
emphasis on ‘structures’, but it reflects a new understanding of the consumer 
who is no longer in awe of the health professionals and the health care system. In 
fact, the autonomous health care consumer has a greater understanding of the
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elements of the health care system and less mystery surrounds the doctor in 
particular. What is important to the consumer, for NRT at least, is access and 
availability, and the privacy they afforded. The switch is primarily viewed as a 
process that is the concern of the health care authorities rather than something 
that affects the product being switched in any intrinsic sense.
Viewed from the consumer’s perspective, a product switching to OTC status 
moves into a world where the modem day, sophisticated consumer is in control. 
This is in complete contrast to the health care or pharmaceutical arena, shrouded 
in mystery where the expert, the doctor, holds power. As a result, it is the 
meanings as determined by the consumer that dictate the role that a product, such 
as NRT, plays in the consumer’s behaviour, not the intended meaning of the 
producer, in this case the manufacturer. In fact, this perspective on the 
production of meanings can be extended to research on such behaviour. It can be 
emphasised here that adopting a consumer-centred approach facilitates the 
uncovering of meanings, meanings not originally anticipated at the outset of this 
study.
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Chapter Six
Conclusions, Implications, and Future Research.
6.1 Introduction.
Health care research has been dominated by a variety of disciplines, such as 
psychology, pharmacology, and sociology, but has received little attention from 
the field of consumer behaviour. As a result the ‘consumer’ of health care has 
been viewed more as a patient, especially in the scientifically orientated medical 
community. While there is recognition that consumers are increasingly more 
powerful, vocal, and autonomous in their health behaviour, research on 
consumers’ health care is limited.
The centrality of the consumer’s role in their health care behaviour continues to 
increase with the advent of self-medication and a more preventive orientation 
being adopted by consumers. The most apparent manifestation of these changes 
is in the rise of OTC drugs. Today there is a wider range of OTC drugs, many of 
which can be described as complex both in terms of their make-up and in terms 
of the medical conditions they are intended to address.
The switching of prescription drugs to OTC status has been the main reason for 
the increase in OTC drugs of this nature. Even so, switch drugs have received 
little focus and attention from the medical profession and health care researchers. 
Perhaps the medical community views them as being peripheral to the health 
care system. An imperative rests with consumer behaviour researchers to address 
this switch drug phenomenon for a number of reasons. First, the nature of switch
195
OTC consumption, including their purchase and use, together with the nature of 
switch OTC marketing, places them in the domain of an everyday consumption 
activity. As an everyday consumer activity OTC usage can now be considered an 
appropriate area for consumer researchers. It seems reasonable to suppose that, 
after five decades of study, consumer behaviour will be able to shed some light 
on this growing phenomenon. Also, as consumer research continues to widen its 
horizons, examining every facet of everyday life, the horizon should include the 
consumption of health care. Health is such a central aspect to individuals that a 
better understanding of such an area could deepen understanding of many other 
aspects of consumption.
6.2 Towards a New Understanding of Consumers, Consumption, and Health 
Care.
The consumption of OTCs should be viewed as a consumer behaviour 
phenomenon and not simply a research topic for the medical community. For 
this reason, health care research must shift the discourse to one of discussing 
consumers rather than discussing patients. For example, much of the research on 
NRT has been in the form of strictly controlled medical clinical trials, far 
removed from the actual nature of its everyday use. However simply adopting a 
basic consumer focus is insufficient. Some consumer researcher has developed 
an altered understanding of the consumer; essentially an interpretive view. This 
view emphasises the central role that the consumption of products can play and 
the meanings that ensue and inform such consumption.
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The topic of smoking, and smoking cessation in particular, has been dominated 
by a scientific/medical orientation, with smokers and those attempting to quit 
smoking often portrayed as helpless addicts to nicotine. However this study has 
illustrated that many consumers remain in control of their behaviour and develop 
their own personal methods and regimes in their smoking cessation behaviour. In 
fact, aspects of personal control were the key themes to emerge in this study. 
More importantly, the consumption and ensuing meanings of NRT were not 
always those intended by the manufacturer but were dictated and shaped by the 
consumer. Such an understanding of consumption may be far removed from 
view of the medical community, however, in this study, these meanings were 
readily volunteered and were not the product of any anti-medical establishment 
agenda. It is the respondents relaying their experiences that has uncovered these 
patterns. As a result, future research might benefit from adopting a more 
consumer orientated holistic focus, examining what the consumer does with the 
product rather than what the product does with the consumer. In addition, the 
thrust of this research should be more open-ended and sensitive to the range of 
personalised meanings and regimes that consumers engage in.
This post-positivistic view is in contrast to the implicit assumptions in much 
research on smoking cessation and switch OTCs. These assumptions are based 
on the expectation that OTC usage generally, and NRT in particular, are 
primarily health behaviours that include doctors and pharmacists as central 
figures. This study clearly rejects these assumptions. The meanings of NRT to 
consumers in this study were primarily concerned with the role that the
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consumers themselves had generated. This may be due to the product itself, 
being seen more as a cigarette replacement than a cure for an illness or sickness. 
Even so, the fact that control and power could switch to the consumer, rather 
than being mediated by the pharmacist for example, suggests that the meanings 
of OTC consumption need to be addressed in a wider context than traditional 
health care alone. The fact that NRT research has been medically sponsored and 
that the product itself has only being available through what might be termed 
‘medical’ channels may have blinkered researchers to the breadth of non-medical 
meanings that consumers attach to it.
6.3 Implications for Switch Drugs.
Although this study only focused on one switch drug and while there appear to 
be a variety of unique facets to NRT, there are some important implications for 
switch drugs generally. Put simply, the switch of a drug from Rx to OTC status 
was not important for the respondents in this study. Either the respondents 
struggled to grasp the concept or were primarily concerned with other aspects. 
For example, the key implication of the meanings that emerged for NRT was the 
expressed desire to widen availability and reduce the barriers to access; 
essentially a further switch outside the confines of the pharmacy. Apart from the 
obvious financial benefits to the manufacturers, there is a clear consumer 
demand to widen availability beyond the pharmacy channel.
NRT, in the eyes of the users, was outside the medical domain and this aspect 
should receive more consideration. The expressed desire for privacy in the
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respondents’ efforts to quit smoking also needs attention. As a result the role of 
health professionals in the campaigns to either reduce the number of people 
taking up smoking or help those smoking to quit needs to be reviewed. The 
impact of this research is that the importance of medical professionals in the 
smoking cessation process may be less decisive than was thought hitherto.
In the wider context, meanings of safety and security were more important than 
meanings relating to efficacy for respondents in this study. The switch did not 
mean that the drug had become any more or less effective but it did mean it was 
safe to use. Doctors simply would not have agreed to waive the prescription 
requirement unless it was safe to do so. This security could be described as a 
halo effect of the doctor’s previous ability to prescribe a given drug. This 
contrasts to the received wisdom that efficacy, the power of the product itself, 
can be either diluted when switched to OTC, or alternatively it can be enhanced 
as a result of a drug’s prior prescription history. Again it is the consumer 
perspective that dismisses the assumption that changing product efficacy is a 
prime concern.
6.4 Implications for Health Care Policy.
There are two areas of consideration in regard to health care policy - OTCs 
generally and smoking cessation in particular. Probably the most far-reaching 
implication is the position of OTCs in the health regimes of those at lower levels 
of income, the medical card holders. While this study does not purport to 
generalise to the wider population, OTCs, for those at lower income levels, were
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viewed as irrelevant and costly. The desire of health care policy makers to reduce 
the expenditure on drugs through the current medical card system, and the much 
promoted benefit of OTCs as a first step in health care appears at odds with some 
consumers relying on the doctor to legitimise illness and provide free 
prescription medicines only.
Throughout the health care system OTCs receive little focus and attention and 
can be viewed as being on the periphery. The move to switch prescription drugs 
is being driven by the pharmaceutical industry with little proactive effort from 
regulatory authorities. Switch drugs use a range of marketing techniques, such 
as branding and advertising, and this opens up a new array of meanings in the 
mind of consumers. Most importantly, OTC consumers are competent and 
marketing literate as a result of their everyday experiences of many other product 
categories and that they are likely to absorb, modify, and construct meanings 
associated with OTCs as they do with any other mass-market goods. For the 
moment however, OTCs, on foot of health policy restrictions, remain confined to 
the pharmacy and health policy makers may well assume that these restrictions 
inoculates OTCs from this meaning-making process. This research suggests that 
in so doing they are quite mistaken.
Health care policy for NRT in particular needs review, given the findings in this 
study. Of primary importance is the need to clarify the policy on NRT itself. 
Given that reducing the levels of smoking in the population is one of the major 
aims of health care policy, there is ambivalence towards the role NRT can play. 
It has been demonstrated elsewhere that NRT is probably the best option for the
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remaining smokers in the population as they are usually more ‘nicotine 
dependent’, yet NRT has received little overt support in health care policy.
This study highlights a number of important points in relation to NRT. First, 
allowing consumers to describe the role played by NRT in their smoking 
cessation, it was apparent that NRT was outside the medical domain. NRT was 
described as a simple, consumer product, and a direct replacement for cigarettes. 
As a result, the priority was for even greater access to NRT. Second, although 
evident in only one respondent’s case, consideration needs to be given to 
younger teenage smokers who wish to quit. Again there is a lack of direction on 
health care policy towards this particular problem, although many commentators 
have highlighted the growth in teenage smoking, especially among females.
6.5 Implications for Health Professionals.
The switch to OTC status for a drug suggests a decreasing role for the doctor and 
an increasing role for the pharmacist. While the former was certainly evident, the 
latter was not. To understand this it is necessary to look at the result of the drug 
switching to OTC status. From the viewpoint of the medical community, a drug 
changes status within the medical system. However from the viewpoint of the 
consumer, a drug moves from the domain of the doctor into the domain of the 
modern day, marketing literate consumer. Essentially in the consumer’s eyes, it 
is a move from the dispensary to the marketplace. The result is that the doctor 
looses his/her control of power and knowledge but this control of power and
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knowledge bypasses the pharmacist completely, switching entirely to the 
consumer.
This study suggested a minimal role for the doctor in particular, especially in 
light of the product chosen for the study, NRT. In this study doctors were heard 
but not listened to. While they advised respondents to quit smoking this was seen 
as conversational foreplay before the real purpose of the visit was addressed. 
Doctors were perceived to advocate cessation simply because this was what they 
felt they should do. Nonetheless, the doctor did appear to play a role of sorts in 
the consumer’s use of switch and OTC drugs generally. The doctor could, in a 
tacit way, add a sense of safety and security to the use of an OTC if it had a prior 
prescription history. One area where the doctor could play a greater role is in the 
broad promotion of OTCs as a realistic option for their patients, in place of 
prescription drugs. Doctors are at the front line and are ideally placed to help 
‘switch’ consumers to OTCs.
OTCs are often presented as an opportunity for pharmacists to use their 
professional knowledge to assist consumers in their product choice. As 
illustrated previously, the pharmacist is not utilised to the extent cited in the 
literature. This applies not only to NRT, but also to OTCs in general. Essentially 
the pharmacist is viewed as an extension of the doctor’s power to prescribe 
medicines, providing a dispensing service for prescriptions. When the aura of the 
prescription is removed, so too is the power of the pharmacist.
The most important implication for pharmacists is the need to be aware of the 
existence of a confident, autonomous consumer. As OTCs become more like
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consumer products, with advertising, branding and positioning commonplace, 
pharmacists need to understand the nature of modern consumption patterns.
6.6 Implications for Consumer Health Care Research.
There is an imperative for health care research to adopt a consumer focus, 
especially in the area of OTC usage. With health care research being rooted in 
the medical arena for so long it is now perhaps timely for consumer researchers 
to contribute to the field of health care research. Consumer research can offer a 
vast body of knowledge on consumer behaviour as well as an array of 
methodologies ideally suited to exploring consumer health care issues. There has 
been some notable research by consumer researchers on the area of health but 
further efforts are needed.
Interpretive research paradigms can provide a platform for health care research 
with an aim of enhancing understanding, rather than increasing predictive 
abilities. The benefit of such paradigms are in placing the consumer at the centre 
of any study and adopting a level of equality between researcher and respondent, 
rather than placing the researcher above the respondent. In particular, the latest, 
cutting-edge thinking on the role that products play, the postmodern view of 
consumption, offers new insight into OTC usage in particular. Adopting such a 
position does help in clarifying some of the more paradoxical aspects of 
consumers’ behaviour.
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Certainly this postmodern position, with its’ ‘anything goes’ philosophy, urges 
researchers to explore any aspect of consumption and health care research should 
benefit from such a pluralist approach.
6.7 The Benefits and Drawbacks of Existential-Phenomenological Research.
The choice of the Existential-phenomenological paradigm for this study was to 
achieve the objectives of placing the consumer at the centre of the inquiry and 
uncovering their experience of using NRT in their smoking cessation behaviour. 
These objectives were achieved resulting in both benefits and drawbacks. In 
terms of benefits, the topic of smoking cessation proved to be a rich area of 
experience and was so important to the respondents that they talked openly and 
extensively on the subject. However, it would appear that not all topics would 
generate as much discussion. It would be hard to imagine more particular topics, 
such as brand choice or the use of an OTC for a minor complaint, eliciting such 
extensive discussion. The greatest benefit to the chosen approach was the scope 
of what was uncovered. While no a priori assumptions were made in advance of 
the interviewing, an even greater scope of meanings was uncovered than 
anticipated.
On the other hand, findings beyond what are expected at the outset can be 
disconcerting for a researcher, especially when it is their first occasion to use 
such a methodology. The result of the emergence of findings beyond the 
expected also makes linking these to findings in the current literature somewhat 
difficult. This is exacerbated further when the current literature is primarily cue-
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based and quantitative in nature. The shadow of the current literature tends to 
hamper the process of interpretation. The process of interpretation itself is 
challenging as both skill and patience are required when one is faced with hours 
of varied, apparently inconsistent transcriptions with few, if  any, directions as to 
how to proceed. It must be reiterated that the benefits of the interpretive group 
cannot be underestimated. Apart from the obvious benefit of sharing the burden, 
the interpretive group provides expertise and a range of perspectives essential to 
developing good interpretations.
Overall, while there are some difficult challenges to using Existential- 
phenomenology, it does add a new dimension to research on the area. It must be 
viewed as an alternative way of seeking knowledge; complementing rather than 
conflicting with other paradigms.
6.8 Future Research.
Given the extent of switch drug activity in the marketplace this study highlighted 
the need to examine other categories of switch drugs and their meanings to 
consumers. While NRT was viewed as outside the medical domain, many other 
products that have recently switched to OTC status could be viewed as more 
medical in nature. As a result, a different pattern of meanings remains to be 
uncovered. High profile switches, such as Tagamet, once the largest selling 
pharmaceutical in the world, have recently moved to OTC status and such drugs 
merit attention.
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The switch to OTC status reduces the power and control of medicines by the 
doctor, switching this power and control directly to the consumer. Conspicuous 
by its absence was a role for the pharmacist in this study. Further research on the 
role and meanings of the pharmacist is vital in the context of OTC consumption. 
For NRT in particular, there is a need to research the benefits of widening its 
availability. This must be approached from a non-medical perspective given the 
findings in this study. One further issue, albeit that it arose with a single 
respondent, was the need to address younger smokers and their desire to quit. 
The recent rise in teenage smoking, despite all the efforts to contain it, presented 
a unique situation regarding NRT. Although there are clearly safety implications 
for widening the availability of NRT to younger and possibly ‘underage’ users, 
there appears to be a need to consider this delicate point. It clearly comes under 
the heading of socially ‘sensitive’ marketing activity but is nonetheless 
important for consideration.
Ultimately it is the field of consumer research that can lead the way forward to a 
better understanding of the ‘new’ health care consumer in the emerging switch 
drug market. Placing the consumer at the centre of any inquiry, adopting a level 
of equality between researcher and respondent, and recognising the often 
paradoxical, individualistic patterns of consumption present a unique opportunity 
to enhance our understanding of health care consumption.
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